BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russo JJ, Bohenzky RA, Chien MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA. 1996;93:14862-14867. [PMID: 8962146 DOI: 10.1073/pnas.93.25.14862] [Cited by in Crossref: 1106] [Cited by in F6Publishing: 1050] [Article Influence: 44.2] [Reference Citation Analysis]
Number Citing Articles
1 Kanno T, Sato Y, Nakamura T, Sakamoto K, Sata T, Katano H. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan. J Med Virol 2010;82:400-6. [DOI: 10.1002/jmv.21715] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
2 Wang L, Pietrek M, Brinkmann MM, Hävemeier A, Fischer I, Hillenbrand B, Dittrich-Breiholz O, Kracht M, Chanas S, Blackbourn DJ, Schulz TF. Identification and functional characterization of a spliced rhesus rhadinovirus gene with homology to the K15 gene of Kaposi's sarcoma-associated herpesvirus. J Gen Virol 2009;90:1190-201. [PMID: 19264656 DOI: 10.1099/vir.0.007971-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
3 Sugaya M, Watanabe T, Yang A, Starost MF, Kobayashi H, Atkins AM, Borris DL, Hanan EA, Schimel D, Bryant MA, Roberts N, Skobe M, Staskus KA, Kaldis P, Blauvelt A. Lymphatic dysfunction in transgenic mice expressing KSHV k-cyclin under the control of the VEGFR-3 promoter. Blood 2005;105:2356-63. [PMID: 15536152 DOI: 10.1182/blood-2004-08-3364] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.6] [Reference Citation Analysis]
4 Oktafiani D, Megasari NLA, Fitriana E, Nasronudin, Lusida MI, Soetjipto. DETECTION OF HUMAN HERPESVIRUS-8 ANTIGEN IN HIV-INFECTED PATIENTS IN EAST JAVA, INDONESIA. Afr J Infect Dis 2018;12:43-6. [PMID: 30109285 DOI: 10.21010/ajid.v12i2.7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
5 Wakao K, Watanabe T, Takadama T, Ui S, Shigemi Z, Kagawa H, Higashi C, Ohga R, Taira T, Fujimuro M. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells. Biochem Biophys Res Commun 2014;444:135-40. [PMID: 24434142 DOI: 10.1016/j.bbrc.2014.01.017] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
6 Katano H, Sato Y, Sata T. Expression of p53 and human herpesvirus-8 (HHV-8)-encoded latency-associated nuclear antigen with inhibition of apoptosis in HHV-8-associated malignancies. Cancer 2001;92:3076-84. [DOI: 10.1002/1097-0142(20011215)92:12<3076::aid-cncr10117>3.0.co;2-d] [Cited by in Crossref: 63] [Cited by in F6Publishing: 40] [Article Influence: 3.0] [Reference Citation Analysis]
7 Cousins E, Nicholas J. Molecular biology of human herpesvirus 8: novel functions and virus-host interactions implicated in viral pathogenesis and replication. Recent Results Cancer Res. 2014;193:227-268. [PMID: 24008302 DOI: 10.1007/978-3-642-38965-8_13] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
8 Ouyang X, Zeng Y, Fu B, Wang X, Chen W, Fang Y, Luo M, Wang L. Genotypic analysis of Kaposi's sarcoma-associated herpesvirus from patients with Kaposi's sarcoma in Xinjiang, China. Viruses 2014;6:4800-10. [PMID: 25431948 DOI: 10.3390/v6124800] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]
9 Yoo SM, Ahn AK, Seo T, Hong HB, Chung MA, Jung SD, Cho H, Lee MS. Centrifugal enhancement of Kaposi's sarcoma-associated virus infection of human endothelial cells in vitro. J Virol Methods 2008;154:160-6. [PMID: 18755221 DOI: 10.1016/j.jviromet.2008.07.026] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
10 Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 1998;72:8309-15. [PMID: 9733875 DOI: 10.1128/JVI.72.10.8309-8315.1998] [Cited by in Crossref: 321] [Cited by in F6Publishing: 215] [Article Influence: 13.4] [Reference Citation Analysis]
11 Cai Q, Verma SC, Choi JY, Ma M, Robertson ES. Kaposi's sarcoma-associated herpesvirus inhibits interleukin-4-mediated STAT6 phosphorylation to regulate apoptosis and maintain latency. J Virol 2010;84:11134-44. [PMID: 20719954 DOI: 10.1128/JVI.01293-10] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.6] [Reference Citation Analysis]
12 Wang XP, Zhang YJ, Deng JH, Pan HY, Zhou FC, Gao SJ. Transcriptional regulation of Kaposi's sarcoma-associated herpesvirus-encoded oncogene viral interferon regulatory factor by a novel transcriptional silencer, Tis. J Biol Chem 2002;277:12023-31. [PMID: 11821384 DOI: 10.1074/jbc.M108026200] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
13 Takaoka A, Tamura T, Taniguchi T. Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Sci 2008;99:467-78. [PMID: 18190617 DOI: 10.1111/j.1349-7006.2007.00720.x] [Cited by in Crossref: 105] [Cited by in F6Publishing: 100] [Article Influence: 7.5] [Reference Citation Analysis]
14 Zhang T, Wang L. Epidemiology of Kaposi's sarcoma‐associated herpesvirus in Asia: Challenges and opportunities. J Med Virol 2017;89:563-70. [DOI: 10.1002/jmv.24662] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
15 Cunningham C, Barnard S, Blackbourn DJ, Davison AJ. Transcription mapping of human herpesvirus 8 genes encoding viral interferon regulatory factors. J Gen Virol 2003;84:1471-83. [PMID: 12771416 DOI: 10.1099/vir.0.19015-0] [Cited by in Crossref: 48] [Cited by in F6Publishing: 49] [Article Influence: 2.5] [Reference Citation Analysis]
16 Dietz M. Viral cytokines. Stem Cells 2000;18:69-72. [PMID: 10661577 DOI: 10.1634/stemcells.18-1-69] [Reference Citation Analysis]
17 Paun A, Pitha PM. The innate antiviral response: new insights into a continuing story. Adv Virus Res 2007;69:1-66. [PMID: 17222691 DOI: 10.1016/S0065-3527(06)69001-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
18 Jenner RG, Boshoff C. The molecular pathology of Kaposi's sarcoma-associated herpesvirus. Biochim Biophys Acta 2002;1602:1-22. [PMID: 11960692 DOI: 10.1016/s0304-419x(01)00040-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 44] [Article Influence: 0.5] [Reference Citation Analysis]
19 Aresté C, Mutocheluh M, Blackbourn DJ. Identification of caspase-mediated decay of interferon regulatory factor-3, exploited by a Kaposi sarcoma-associated herpesvirus immunoregulatory protein. J Biol Chem 2009;284:23272-85. [PMID: 19553679 DOI: 10.1074/jbc.M109.033290] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 2.8] [Reference Citation Analysis]
20 Shinjyo N, Kagaya W, Pekna M. Interaction Between the Complement System and Infectious Agents - A Potential Mechanistic Link to Neurodegeneration and Dementia. Front Cell Neurosci 2021;15:710390. [PMID: 34408631 DOI: 10.3389/fncel.2021.710390] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Searles RP, Bergquam EP, Axthelm MK, Wong SW. Sequence and Genomic Analysis of a Rhesus Macaque Rhadinovirus with Similarity to Kaposi’s Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. J Virol 1999;73:3040-53. [DOI: 10.1128/jvi.73.4.3040-3053.1999] [Cited by in Crossref: 204] [Cited by in F6Publishing: 128] [Article Influence: 8.9] [Reference Citation Analysis]
22 Watanabe A, Higuchi M, Fukushi M, Ohsawa T, Takahashi M, Oie M, Fujii M. A novel KRAB-Zinc finger protein interacts with latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus and activates transcription via terminal repeat sequences. Virus Genes 2007;34:127-36. [PMID: 17143723 DOI: 10.1007/s11262-006-0048-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
23 Griffiths R, Whitehouse A. Herpesvirus saimiri episomal persistence is maintained via interaction between open reading frame 73 and the cellular chromosome-associated protein MeCP2. J Virol 2007;81:4021-32. [PMID: 17267510 DOI: 10.1128/JVI.02171-06] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
24 Greenblatt RM. Kaposi's sarcoma and human herpesvirus-8. Infect Dis Clin North Am 1998;12:63-82. [PMID: 9494830 DOI: 10.1016/s0891-5520(05)70409-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
25 Chang P, Chen L, Shih Y, Tsai P, Liu A, Hung C, Liou J, Wang S. Role of the cellular transcription factor YY1 in the latent-lytic switch of Kaposi's sarcoma-associated herpesvirus. Virology 2011;413:194-204. [DOI: 10.1016/j.virol.2011.02.013] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
26 McAllister SC, Früh K, Moses AV. Functional genomics and the development of pathogenesis-targeted therapies for Kaposi's sarcoma. Pharmacogenomics 2005;6:235-44. [PMID: 16013955 DOI: 10.1517/14622416.6.3.235] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
27 Roan F, Inoue N, Offermann MK. Activation of Cellular and Heterologous Promoters by the Human Herpesvirus 8 Replication and Transcription Activator. Virology 2002;301:293-304. [DOI: 10.1006/viro.2002.1582] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
28 Cannon ML, Cesarman E. The KSHV G protein-coupled receptor signals via multiple pathways to induce transcription factor activation in primary effusion lymphoma cells. Oncogene 2004;23:514-23. [DOI: 10.1038/sj.onc.1207021] [Cited by in Crossref: 57] [Cited by in F6Publishing: 58] [Article Influence: 3.2] [Reference Citation Analysis]
29 Okuno T, Jiang YB, Ueda K, Nishimura K, Tamura T, Yamanishi K. Activation of human herpesvirus 8 open reading frame K5 independent of ORF50 expression. Virus Res 2002;90:77-89. [PMID: 12457964 DOI: 10.1016/s0168-1702(02)00142-9] [Cited by in Crossref: 31] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
30 Matsumura S, Persson LM, Wong L, Wilson AC. The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains. J Virol 2010;84:2318-30. [PMID: 20032179 DOI: 10.1128/JVI.01097-09] [Cited by in Crossref: 54] [Cited by in F6Publishing: 39] [Article Influence: 4.2] [Reference Citation Analysis]
31 Lee H, Trimble JJ, Yoon DW, Regier D, Desrosiers RC, Jung JU. Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src. J Virol 1997;71:3817-25. [DOI: 10.1128/jvi.71.5.3817-3825.1997] [Cited by in Crossref: 35] [Cited by in F6Publishing: 17] [Article Influence: 1.4] [Reference Citation Analysis]
32 Rady PL, Hodak E, Yen A, Memar O, Trattner A, Feinmesser M, David M, Hudnall S, Tyring SK. Detection of human herpesvirus-8 DNA in Kaposi’s sarcomas from iatrogenically immunosuppressed patients. Journal of the American Academy of Dermatology 1998;38:429-37. [DOI: 10.1016/s0190-9622(98)70501-8] [Cited by in Crossref: 49] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
33 Muralidhar S, Veytsmann G, Chandran B, Ablashi D, Doniger J, Rosenthal LJ. Characterization of the human herpesvirus 8 (Kaposi’s sarcoma-associated herpesvirus) oncogene, Kaposin (ORF K12). Journal of Clinical Virology 2000;16:203-13. [DOI: 10.1016/s1386-6532(99)00081-5] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
34 Rosales CM, Mclaughlin MD, Sata T, Katano H, Veno PA, De Las Casas LE, Miranda RN. AIDS Presenting with Cutaneous Kaposi's Sarcoma and Bacillary Angiomatosis in the Bone Marrow Mimicking Kaposi's Sarcoma. AIDS Patient Care and STDs 2002;16:573-7. [DOI: 10.1089/108729102761882107] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
35 Pari GS, AuCoin D, Colletti K, Cei SA, Kirchoff V, Wong SW. Identification of the rhesus macaque rhadinovirus lytic origin of DNA replication. J Virol 2001;75:11401-7. [PMID: 11689621 DOI: 10.1128/JVI.75.23.11401-11407.2001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
36 Lee HR, Lee S, Chaudhary PM, Gill P, Jung JU. Immune evasion by Kaposi's sarcoma-associated herpesvirus. Future Microbiol 2010;5:1349-65. [PMID: 20860481 DOI: 10.2217/fmb.10.105] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 3.7] [Reference Citation Analysis]
37 Pau CP, Lam LL, Spira TJ, Black JB, Stewart JA, Pellett PE, Respess RA. Mapping and serodiagnostic application of a dominant epitope within the human herpesvirus 8 ORF 65-encoded protein. J Clin Microbiol 1998;36:1574-7. [PMID: 9620379 DOI: 10.1128/JCM.36.6.1574-1577.1998] [Cited by in Crossref: 48] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
38 Boshoff C, Weiss R. Kaposi's Sarcoma-Associated Herpesvirus. Elsevier; 1998. pp. 57-87. [DOI: 10.1016/s0065-230x(08)60739-3] [Cited by in Crossref: 127] [Cited by in F6Publishing: 44] [Article Influence: 5.3] [Reference Citation Analysis]
39 Sharma-Walia N, Raghu H, Sadagopan S, Sivakumar R, Veettil MV, Naranatt PP, Smith MM, Chandran B. Cyclooxygenase 2 induced by Kaposi's sarcoma-associated herpesvirus early during in vitro infection of target cells plays a role in the maintenance of latent viral gene expression. J Virol 2006;80:6534-52. [PMID: 16775340 DOI: 10.1128/JVI.00231-06] [Cited by in Crossref: 57] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
40 Xiao B, Verma SC, Cai Q, Kaul R, Lu J, Saha A, Robertson ES. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores. J Virol 2010;84:9718-32. [PMID: 20660191 DOI: 10.1128/JVI.00713-10] [Cited by in Crossref: 49] [Cited by in F6Publishing: 40] [Article Influence: 4.1] [Reference Citation Analysis]
41 Lee HR, Kim MH, Lee JS, Liang C, Jung JU. Viral interferon regulatory factors. J Interferon Cytokine Res 2009;29:621-7. [PMID: 19715458 DOI: 10.1089/jir.2009.0067] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 4.3] [Reference Citation Analysis]
42 Sato-Matsumura KC, Matsumura T, Nabeshima M, Katano H, Sata T, Koizumi H. Serological and immunohistochemical detection of human herpesvirus 8 in Kaposi's sarcoma after immunosuppressive therapy for bullous pemphigoid. Br J Dermatol 2001;145:633-7. [PMID: 11703292 DOI: 10.1046/j.1365-2133.2001.04413.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
43 Rimessi P, Bonaccorsi A, Stürzl M, Fabris M, Brocca-Cofano E, Caputo A, Melucci-Vigo G, Falchi M, Cafaro A, Cassai E, Ensoli B, Monini P. Transcription pattern of human herpesvirus 8 open reading frame K3 in primary effusion lymphoma and Kaposi's sarcoma. J Virol 2001;75:7161-74. [PMID: 11435597 DOI: 10.1128/JVI.75.15.7161-7174.2001] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
44 Wang YC, Zhang Q, Montalvo EA. Purification of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) and analyses of the structural proteins. J Virol Methods 1998;73:219-28. [PMID: 9766893 DOI: 10.1016/s0166-0934(98)00068-8] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
45 Ellison TJ, Izumiya Y, Izumiya C, Luciw PA, Kung HJ. A comprehensive analysis of recruitment and transactivation potential of K-Rta and K-bZIP during reactivation of Kaposi's sarcoma-associated herpesvirus. Virology 2009;387:76-88. [PMID: 19269659 DOI: 10.1016/j.virol.2009.02.016] [Cited by in Crossref: 39] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
46 Boshoff C, Weiss RA. Introduction. Seminars in Cancer Biology 1999;9:149-50. [DOI: 10.1006/scbi.1999.0120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
47 Izumiya Y, Lin SF, Ellison TJ, Levy AM, Mayeur GL, Izumiya C, Kung HJ. Cell cycle regulation by Kaposi's sarcoma-associated herpesvirus K-bZIP: direct interaction with cyclin-CDK2 and induction of G1 growth arrest. J Virol 2003;77:9652-61. [PMID: 12915577 DOI: 10.1128/jvi.77.17.9652-9661.2003] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
48 Kellam P, Bourboulia D, Dupin N, Shotton C, Fisher C, Talbot S, Boshoff C, Weiss RA. Characterization of Monoclonal Antibodies Raised against the Latent Nuclear Antigen of Human Herpesvirus 8. J Virol 1999;73:5149-55. [DOI: 10.1128/jvi.73.6.5149-5155.1999] [Cited by in Crossref: 65] [Cited by in F6Publishing: 30] [Article Influence: 2.8] [Reference Citation Analysis]
49 Liao W, Tang Y, Lin SF, Kung HJ, Giam CZ. K-bZIP of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 (KSHV/HHV-8) binds KSHV/HHV-8 Rta and represses Rta-mediated transactivation. J Virol 2003;77:3809-15. [PMID: 12610155 DOI: 10.1128/jvi.77.6.3809-3815.2003] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 2.7] [Reference Citation Analysis]
50 Lacoste V, Judde JG, Bestett G, Cadranel J, Antoine M, Valensi F, Delabesse E, Macintyre E, Gessain A. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses. Leuk Lymphoma 2000;38:401-9. [PMID: 10830748 DOI: 10.3109/10428190009087032] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
51 Strahan RC, Hiura KS, Verma ASC. Quantifying Symmetrically Methylated H4R3 on the Kaposi's Sarcoma-associated Herpesvirus (KSHV) Genome by ChIP-Seq. Bio Protoc 2018;8:e2781. [PMID: 34179294 DOI: 10.21769/BioProtoc.2781] [Reference Citation Analysis]
52 Pica F, Volpi A, Serafino A, Fraschetti M, Franzese O, Garaci E. Autocrine nerve growth factor is essential for cell survival and viral maturation in HHV-8–infected primary effusion lymphoma cells. Blood 2000;95:2905-12. [DOI: 10.1182/blood.v95.9.2905.009k33_2905_2912] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
53 Bagga S, Bouchard MJ. Cell cycle regulation during viral infection. Methods Mol Biol 2014;1170:165-227. [PMID: 24906315 DOI: 10.1007/978-1-4939-0888-2_10] [Cited by in Crossref: 69] [Cited by in F6Publishing: 59] [Article Influence: 9.9] [Reference Citation Analysis]
54 Lang SM, Bynoe MO, Karki R, Tartell MA, Means RE. Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins down regulate both DC-SIGN and DC-SIGNR. PLoS One 2013;8:e58056. [PMID: 23460925 DOI: 10.1371/journal.pone.0058056] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
55 Hayward GS. Human herpesvirus 8 latent-state gene expression and apoptosis in Kaposi's sarcoma lesions. J Natl Cancer Inst 1999;91:1705-7. [PMID: 10528012 DOI: 10.1093/jnci/91.20.1705] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
56 Nishimura M, Watanabe T, Yagi S, Yamanaka T, Fujimuro M. Kaposi's sarcoma-associated herpesvirus ORF34 is essential for late gene expression and virus production. Sci Rep 2017;7:329. [PMID: 28336944 DOI: 10.1038/s41598-017-00401-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 6.2] [Reference Citation Analysis]
57 Gwack Y, Hwang S, Byun H, Lim C, Kim JW, Choi EJ, Choe J. Kaposi's sarcoma-associated herpesvirus open reading frame 50 represses p53-induced transcriptional activity and apoptosis. J Virol 2001;75:6245-8. [PMID: 11390631 DOI: 10.1128/JVI.75.13.6245-6248.2001] [Cited by in Crossref: 31] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
58 Reddy SM, Cox E, Iofin I, Soong W, Cohen JI. Varicella-zoster virus (VZV) ORF32 encodes a phosphoprotein that is posttranslationally modified by the VZV ORF47 protein kinase. J Virol 1998;72:8083-8. [PMID: 9733848 DOI: 10.1128/JVI.72.10.8083-8088.1998] [Cited by in Crossref: 28] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
59 Choi YB, Cousins E, Nicholas J. Novel Functions and Virus-Host Interactions Implicated in Pathogenesis and Replication of Human Herpesvirus 8. Recent Results Cancer Res 2021;217:245-301. [PMID: 33200369 DOI: 10.1007/978-3-030-57362-1_11] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
60 Veeranna RP, Haque M, Davis DA, Yang M, Yarchoan R. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induction by hypoxia and hypoxia-inducible factors. J Virol 2012;86:1097-108. [PMID: 22090111 DOI: 10.1128/JVI.05167-11] [Cited by in Crossref: 30] [Cited by in F6Publishing: 22] [Article Influence: 2.7] [Reference Citation Analysis]
61 Myoung J, Ganem D. Infection of lymphoblastoid cell lines by Kaposi's sarcoma-associated herpesvirus: critical role of cell-associated virus. J Virol 2011;85:9767-77. [PMID: 21795352 DOI: 10.1128/JVI.05136-11] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
62 Watanabe T, Sugaya M, Atkins AM, Aquilino EA, Yang A, Borris DL, Brady J, Blauvelt A. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen prolongs the life span of primary human umbilical vein endothelial cells. J Virol 2003;77:6188-96. [PMID: 12743275 DOI: 10.1128/jvi.77.11.6188-6196.2003] [Cited by in Crossref: 62] [Cited by in F6Publishing: 45] [Article Influence: 3.3] [Reference Citation Analysis]
63 Helweg-larsen J, Benfield TL, Lundgren JD. Opportunistic Infections. In: Schuitemaker H, Miedema F, editors. AIDS Pathogenesis. Dordrecht: Springer Netherlands; 2000. pp. 155-76. [DOI: 10.1007/978-94-017-0685-8_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.0] [Reference Citation Analysis]
64 Medveczky MM, Horvath E, Lund T, Medveczky PG. In vitro antiviral drug sensitivity of the Kaposi‘s sarcoma-associated herpesvirus. AIDS. 1997;11:1327-1332. [PMID: 9302441 DOI: 10.1097/00002030-199711000-00006] [Cited by in Crossref: 112] [Cited by in F6Publishing: 103] [Article Influence: 4.5] [Reference Citation Analysis]
65 Schulz TF, Moore PS. Response from Schulz and Moore. Trends in Microbiology 1999;7:269-70. [DOI: 10.1016/s0966-842x(99)01527-9] [Cited by in Crossref: 1] [Article Influence: 0.0] [Reference Citation Analysis]
66 Tadagaki K, Nakano K, Yamanishi K. Human herpesvirus 7 open reading frames U12 and U51 encode functional beta-chemokine receptors. J Virol 2005;79:7068-76. [PMID: 15890946 DOI: 10.1128/JVI.79.11.7068-7076.2005] [Cited by in Crossref: 33] [Cited by in F6Publishing: 13] [Article Influence: 1.9] [Reference Citation Analysis]
67 Mori Y, Nishimoto N, Ohno M, Inagi R, Dhepakson P, Amou K, Yoshizaki K, Yamanishi K. Human herpesvirus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J Med Virol 2000;61:332-5. [DOI: 10.1002/1096-9071(200007)61:3<332::aid-jmv8>3.0.co;2-3] [Cited by in Crossref: 52] [Cited by in F6Publishing: 25] [Article Influence: 2.4] [Reference Citation Analysis]
68 Lu J, Verma SC, Cai Q, Robertson ES. The single RBP-Jkappa site within the LANA promoter is crucial for establishing Kaposi's sarcoma-associated herpesvirus latency during primary infection. J Virol 2011;85:6148-61. [PMID: 21507979 DOI: 10.1128/JVI.02608-10] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
69 Sato K, Gee P, Koyanagi Y. Vpu and BST2: Still Not There Yet? Front Microbiol 2012;3:131. [PMID: 22509177 DOI: 10.3389/fmicb.2012.00131] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
70 Feuillard J, Aubin J, Poirel L, Davi F, Kujas M, Rousselet M, Angonin R, Raphaël M, Agut H. Detection rate and intratumoral virus load of human herpesvirus-8 in immunodeficiency-related B-cell lymphoid malignancies. J Med Virol 1997;53:277-81. [DOI: 10.1002/(sici)1096-9071(199711)53:3<277::aid-jmv17>3.0.co;2-e] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
71 Rosenwirth B, Kondova I, Niphuis H, Greenwood EJ, Schmidt F, Verschoor EJ, Wittmann S, Heeney JL, Bogers WM, Fickenscher H, Koopman G. Herpesvirus saimiri infection of rhesus macaques: a model for acute rhadinovirus-induced t-cell transformation and oncogenesis. J Med Virol 2011;83:1938-50. [PMID: 21915869 DOI: 10.1002/jmv.22197] [Cited by in Crossref: 2] [Article Influence: 0.2] [Reference Citation Analysis]
72 Reiss C, Niedobitek G, Hör S, Lisner R, Friedrich U, Bodemer W, Biesinger B. Peripheral T-cell lymphoma in herpesvirus saimiri-infected tamarins: tumor cell lines reveal subgroup-specific differences. Virology 2002;294:31-46. [PMID: 11886263 DOI: 10.1006/viro.2001.1304] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
73 Gérard L, Agbalika F, Sheldon J, Maillard A, Schulz TF, Oksenhendler E. No increased human herpesvirus 8 seroprevalence in patients with HIV-associated non-Hodgkin's lymphoma. J Acquir Immune Defic Syndr 2001;26:182-4. [PMID: 11242187 DOI: 10.1097/00042560-200102010-00013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 0.0] [Reference Citation Analysis]
74 Wu L, Lo P, Yu X, Stoops JK, Forghani B, Zhou ZH. Three-dimensional structure of the human herpesvirus 8 capsid. J Virol 2000;74:9646-54. [PMID: 11000237 DOI: 10.1128/jvi.74.20.9646-9654.2000] [Cited by in Crossref: 49] [Cited by in F6Publishing: 28] [Article Influence: 2.2] [Reference Citation Analysis]
75 Lim C, Sohn H, Gwack Y, Choe J. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) binds ATF4/CREB2 and inhibits its transcriptional activation activity. J Gen Virol 2000;81:2645-52. [PMID: 11038375 DOI: 10.1099/0022-1317-81-11-2645] [Cited by in Crossref: 99] [Cited by in F6Publishing: 96] [Article Influence: 4.7] [Reference Citation Analysis]
76 Tornesello ML, Annunziata C, Tornesello AL, Buonaguro L, Buonaguro FM. Human Oncoviruses and p53 Tumor Suppressor Pathway Deregulation at the Origin of Human Cancers. Cancers (Basel) 2018;10:E213. [PMID: 29932446 DOI: 10.3390/cancers10070213] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 7.8] [Reference Citation Analysis]
77 Fukumoto H, Kanno T, Hasegawa H, Katano H. Pathology of Kaposi's Sarcoma-Associated Herpesvirus Infection. Front Microbiol 2011;2:175. [PMID: 21904536 DOI: 10.3389/fmicb.2011.00175] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
78 Kirshner JR, Staskus K, Haase A, Lagunoff M, Ganem D. Expression of the open reading frame 74 (G-protein-coupled receptor) gene of Kaposi's sarcoma (KS)-associated herpesvirus: implications for KS pathogenesis. J Virol 1999;73:6006-14. [PMID: 10364352 DOI: 10.1128/JVI.73.7.6006-6014.1999] [Cited by in Crossref: 117] [Cited by in F6Publishing: 64] [Article Influence: 5.1] [Reference Citation Analysis]
79 Ensoli B, Stürzl M. Kaposi’s sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 1998;9:63-83. [PMID: 9720757 DOI: 10.1016/s1359-6101(97)00037-3] [Cited by in Crossref: 135] [Cited by in F6Publishing: 71] [Article Influence: 5.9] [Reference Citation Analysis]
80 Talbot SJ, Weiss RA, Kellam P, Boshoff C. Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line. Virology 1999;257:84-94. [PMID: 10208923 DOI: 10.1006/viro.1999.9672] [Cited by in Crossref: 129] [Cited by in F6Publishing: 122] [Article Influence: 5.6] [Reference Citation Analysis]
81 Linderoth J, Rambech E, Dictor M. Dominant human herpesvirus type 8 RNA transcripts in classical and AIDS-related Kaposi's sarcoma. J Pathol 1999;187:582-7. [PMID: 10398125 DOI: 10.1002/(SICI)1096-9896(199904)187:5<582::AID-PATH285>3.0.CO;2-R] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
82 Wang HW, Sharp TV, Koumi A, Koentges G, Boshoff C. Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J. 2002;21:2602-2615. [PMID: 12032073 DOI: 10.1093/emboj/21.11.2602] [Cited by in Crossref: 123] [Cited by in F6Publishing: 116] [Article Influence: 6.2] [Reference Citation Analysis]
83 Duboise M, Guo J, Czajak S, Lee H, Veazey R, Desrosiers RC, Jung JU. A role for herpesvirus saimiri orf14 in transformation and persistent infection. J Virol 1998;72:6770-6. [PMID: 9658125 DOI: 10.1128/JVI.72.8.6770-6776.1998] [Cited by in Crossref: 30] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
84 Schwartz JA, Brittle EE, Reynolds AE, Enquist LW, Silverstein SJ. UL54-null pseudorabies virus is attenuated in mice but productively infects cells in culture. J Virol 2006;80:769-84. [PMID: 16378979 DOI: 10.1128/JVI.80.2.769-784.2006] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
85 Lee BS, Connole M, Tang Z, Harris NL, Jung JU. Structural analysis of the Kaposi's sarcoma-associated herpesvirus K1 protein. J Virol 2003;77:8072-86. [PMID: 12829846 DOI: 10.1128/jvi.77.14.8072-8086.2003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 2.2] [Reference Citation Analysis]
86 Li Q, Pan D, Zhang J, Yang F. Identification of the thymidylate synthase within the genome of white spot syndrome virus. Journal of General Virology 2004;85:2035-44. [DOI: 10.1099/vir.0.80048-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 1.3] [Reference Citation Analysis]
87 Song MJ, Li X, Brown HJ, Sun R. Characterization of interactions between RTA and the promoter of polyadenylated nuclear RNA in Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol 2002;76:5000-13. [PMID: 11967316 DOI: 10.1128/jvi.76.10.5000-5013.2002] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 4.7] [Reference Citation Analysis]
88 Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol 1997;71:4193-8. [PMID: 9151805 DOI: 10.1128/JVI.71.6.4193-4198.1997] [Cited by in Crossref: 216] [Cited by in F6Publishing: 101] [Article Influence: 8.6] [Reference Citation Analysis]
89 McAllister SC, Moses AV. Endothelial cell- and lymphocyte-based in vitro systems for understanding KSHV biology. Curr Top Microbiol Immunol 2007;312:211-44. [PMID: 17089799 DOI: 10.1007/978-3-540-34344-8_8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 15] [Article Influence: 0.2] [Reference Citation Analysis]
90 Subramanian R, D'Auvergne O, Kong H, Kousoulas KG. The cytoplasmic terminus of Kaposi's sarcoma-associated herpesvirus glycoprotein B is not essential for virion egress and infectivity. J Virol 2008;82:7144-54. [PMID: 18480449 DOI: 10.1128/JVI.00617-08] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
91 Samols MA, Hu J, Skalsky RL, Renne R. Cloning and identification of a microRNA cluster within the latency-associated region of Kaposi's sarcoma-associated herpesvirus. J Virol 2005;79:9301-5. [PMID: 15994824 DOI: 10.1128/JVI.79.14.9301-9305.2005] [Cited by in Crossref: 289] [Cited by in F6Publishing: 227] [Article Influence: 17.0] [Reference Citation Analysis]
92 Schultz ER, Rankin GW Jr, Blanc MP, Raden BW, Tsai CC, Rose TM. Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus. J Virol 2000;74:4919-28. [PMID: 10775636 DOI: 10.1128/jvi.74.10.4919-4928.2000] [Cited by in Crossref: 61] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
93 Schulz TF. Epidemiology of Kaposi’s Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. Elsevier; 1999. pp. 121-60. [DOI: 10.1016/s0065-230x(08)60775-7] [Cited by in Crossref: 85] [Cited by in F6Publishing: 28] [Article Influence: 3.7] [Reference Citation Analysis]
94 Murakami Y, Yamagoe S, Noguchi K, Takebe Y, Takahashi N, Uehara Y, Fukazawa H. Ets-1-dependent expression of vascular endothelial growth factor receptors is activated by latency-associated nuclear antigen of Kaposi’s sarcoma-associated herpesvirus through interaction with Daxx. J Biol Chem. 2006;281:28113-28121. [PMID: 16861237 DOI: 10.1074/jbc.m602026200] [Cited by in Crossref: 44] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
95 Nascimento MC, de Souza VA, Sumita LM, Freire W, Weiss HA, Sabino EC, Franceschi S, Pannuti CS, Mayaud P. Prevalence of, and risk factors for Kaposi's sarcoma-associated herpesvirus infection among blood donors in Brazil: A multi-center serosurvey. J Med Virol 2008;80:1202-10. [DOI: 10.1002/jmv.21188] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
96 Hikita SI, Yanagi Y, Ohno S. Murine gammaherpesvirus 68 ORF35 is required for efficient lytic replication and latency. J Gen Virol 2015;96:3624-34. [PMID: 26459827 DOI: 10.1099/jgv.0.000310] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
97 Nealon K, Newcomb WW, Pray TR, Craik CS, Brown JC, Kedes DH. Lytic replication of Kaposi's sarcoma-associated herpesvirus results in the formation of multiple capsid species: isolation and molecular characterization of A, B, and C capsids from a gammaherpesvirus. J Virol 2001;75:2866-78. [PMID: 11222712 DOI: 10.1128/JVI.75.6.2866-2878.2001] [Cited by in Crossref: 64] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
98 Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi's Sarcoma-associated Herpesvirus-encoded Cytokine Homolog (vIL-6) Activates Signaling through the Shared gp130 Receptor Subunit. Journal of Biological Chemistry 1997;272:19625-31. [DOI: 10.1074/jbc.272.31.19625] [Cited by in Crossref: 211] [Cited by in F6Publishing: 195] [Article Influence: 8.4] [Reference Citation Analysis]
99 Whelan P, Scadden DT. New developments in the etiopathogenesis and treatment of HIV-related Kaposi's sarcoma. Clin Dermatol 2000;18:469-77. [PMID: 11024314 DOI: 10.1016/s0738-081x(99)00142-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
100 Sharma-Walia N, Krishnan HH, Naranatt PP, Zeng L, Smith MS, Chandran B. ERK1/2 and MEK1/2 induced by Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) early during infection of target cells are essential for expression of viral genes and for establishment of infection. J Virol 2005;79:10308-29. [PMID: 16051824 DOI: 10.1128/JVI.79.16.10308-10329.2005] [Cited by in Crossref: 133] [Cited by in F6Publishing: 103] [Article Influence: 7.8] [Reference Citation Analysis]
101 Blake N. Immune evasion by gammaherpesvirus genome maintenance proteins. J Gen Virol 2010;91:829-46. [PMID: 20089802 DOI: 10.1099/vir.0.018242-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 2.1] [Reference Citation Analysis]
102 Choi J, Means RE, Damania B, Jung JU. Molecular piracy of Kaposi's sarcoma associated herpesvirus. Cytokine Growth Factor Rev 2001;12:245-57. [PMID: 11325605 DOI: 10.1016/s1359-6101(00)00029-0] [Cited by in Crossref: 36] [Cited by in F6Publishing: 13] [Article Influence: 1.7] [Reference Citation Analysis]
103 Damania B, Li M, Choi JK, Alexander L, Jung JU, Desrosiers RC. Identification of the R1 oncogene and its protein product from the rhadinovirus of rhesus monkeys. J Virol 1999;73:5123-31. [PMID: 10233975 DOI: 10.1128/JVI.73.6.5123-5131.1999] [Cited by in Crossref: 42] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
104 Zong J, Ciufo DM, Viscidi R, Alagiozoglou L, Tyring S, Rady P, Orenstein J, Boto W, Kalumbuja H, Romano N, Melbye M, Kang GH, Boshoff C, Hayward GS. Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. Journal of Clinical Virology 2002;23:119-48. [DOI: 10.1016/s1386-6532(01)00205-0] [Cited by in Crossref: 81] [Cited by in F6Publishing: 20] [Article Influence: 4.1] [Reference Citation Analysis]
105 Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol Cell Biol 1999;19:959-66. [PMID: 9891032 DOI: 10.1128/MCB.19.2.959] [Cited by in Crossref: 220] [Cited by in F6Publishing: 105] [Article Influence: 9.6] [Reference Citation Analysis]
106 Gupta AK, Ruvolo V, Patterson C, Swaminathan S. The human herpesvirus 8 homolog of Epstein-Barr virus SM protein (KS-SM) is a posttranscriptional activator of gene expression. J Virol 2000;74:1038-44. [PMID: 10623771 DOI: 10.1128/jvi.74.2.1038-1044.2000] [Cited by in Crossref: 46] [Cited by in F6Publishing: 32] [Article Influence: 2.1] [Reference Citation Analysis]
107 Dubey AR, Jagtap YA, Kumar P, Patwa SM, Kinger S, Kumar A, Singh S, Prasad A, Jana NR, Mishra A. Biochemical strategies of E3 ubiquitin ligases target viruses in critical diseases. J Cell Biochem 2021. [PMID: 34520596 DOI: 10.1002/jcb.30143] [Reference Citation Analysis]
108 Hayajneh WA, Contopoulos-Ioannidis DG, Lesperance MM, Venegas AM, Colberg-Poley AM. The carboxyl terminus of the human cytomegalovirus UL37 immediate-early glycoprotein is conserved in primary strains and is important for transactivation. J Gen Virol 2001;82:1569-79. [PMID: 11413367 DOI: 10.1099/0022-1317-82-7-1569] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.8] [Reference Citation Analysis]
109 Atula T, Grénman R, Klemi P, Syrjänen S. Human papillomavirus, Epstein–Barr virus, human herpesvirus 8 and human cytomegalovirus involvement in salivary gland tumours. Oral Oncology 1998;34:391-5. [DOI: 10.1016/s1368-8375(98)00023-2] [Cited by in Crossref: 34] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
110 Qi J, Han C, Gong D, Liu P, Zhou S, Deng H. Murine Gammaherpesvirus 68 ORF48 Is an RTA-Responsive Gene Product and Functions in both Viral Lytic Replication and Latency during In Vivo Infection. J Virol 2015;89:5788-800. [PMID: 25762743 DOI: 10.1128/JVI.00406-15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
111 Saji C, Higashi C, Niinaka Y, Yamada K, Noguchi K, Fujimuro M. Proteasome inhibitors induce apoptosis and reduce viral replication in primary effusion lymphoma cells. Biochem Biophys Res Commun 2011;415:573-8. [PMID: 22074820 DOI: 10.1016/j.bbrc.2011.10.107] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
112 Lu F, Zhou J, Wiedmer A, Madden K, Yuan Y, Lieberman PM. Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol 2003;77:11425-35. [PMID: 14557628 DOI: 10.1128/jvi.77.21.11425-11435.2003] [Cited by in Crossref: 128] [Cited by in F6Publishing: 95] [Article Influence: 6.7] [Reference Citation Analysis]
113 Kieff E. Current Perspectives on the Molecular Pathogenesis of Virus-Induced Cancers in Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome. JNCI Monographs 1998;1998:7-14. [DOI: 10.1093/oxfordjournals.jncimonographs.a024177] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 0.6] [Reference Citation Analysis]
114 Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ. HIV-associated multicentric Castleman's disease. Am J Hematol 2008;83:498-503. [PMID: 18260115 DOI: 10.1002/ajh.21137] [Cited by in Crossref: 59] [Cited by in F6Publishing: 48] [Article Influence: 4.2] [Reference Citation Analysis]
115 Tamm M, Reichenberger F, McGandy CE, Stalder A, Tietz A, Dalquen P, Perruchoud AP, Cathomas G. Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage. Am J Respir Crit Care Med 1998;157:458-63. [PMID: 9476858 DOI: 10.1164/ajrccm.157.2.9707068] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.1] [Reference Citation Analysis]
116 Euvrard S, Kanitakis J, Claudy A. Neoplastic Skin Diseases in Organ Transplant Recipients: . American Journal of Cancer 2002;1:109-20. [DOI: 10.2165/00024669-200201020-00004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
117 Ceran F, Aydin Y, Ozçakar L, Han U, Yildiz M. Primary effusion lymphoma: an untrivial differential diagnosis for ascites. Yonsei Med J 2009;50:862-4. [PMID: 20046433 DOI: 10.3349/ymj.2009.50.6.862] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
118 Su M, Mei Y, Sinha S. Role of the Crosstalk between Autophagy and Apoptosis in Cancer. J Oncol 2013;2013:102735. [PMID: 23840208 DOI: 10.1155/2013/102735] [Cited by in Crossref: 112] [Cited by in F6Publishing: 123] [Article Influence: 12.4] [Reference Citation Analysis]
119 Dittmer DP, Damania B. Kaposi's Sarcoma-Associated Herpesvirus (KSHV)-Associated Disease in the AIDS Patient: An Update. Cancer Treat Res 2019;177:63-80. [PMID: 30523621 DOI: 10.1007/978-3-030-03502-0_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
120 Means RE, Choi JK, Nakamura H, Chung YH, Ishido S, Jung JU. Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus. Curr Top Microbiol Immunol 2002;269:187-201. [PMID: 12224509 DOI: 10.1007/978-3-642-59421-2_12] [Cited by in Crossref: 6] [Cited by in F6Publishing: 18] [Article Influence: 0.3] [Reference Citation Analysis]
121 Knowles DM. Biology of Non-Hodgkin’s Lymphoma. In: Sparano JA, editor. HIV & HTLV-I Associated Malignancies. Boston: Springer US; 2001. pp. 149-200. [DOI: 10.1007/978-1-4615-1601-9_6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
122 Iscovich J, Boffetta P, Franceschi S, Azizi E, Sarid R. Classic Kaposi sarcoma: Epidemiology and risk factors. Cancer 2000;88:500-17. [DOI: 10.1002/(sici)1097-0142(20000201)88:3<500::aid-cncr3>3.0.co;2-9] [Cited by in Crossref: 143] [Article Influence: 6.5] [Reference Citation Analysis]
123 Gwack Y, Baek HJ, Nakamura H, Lee SH, Meisterernst M, Roeder RG, Jung JU. Principal role of TRAP/mediator and SWI/SNF complexes in Kaposi's sarcoma-associated herpesvirus RTA-mediated lytic reactivation. Mol Cell Biol 2003;23:2055-67. [PMID: 12612078 DOI: 10.1128/MCB.23.6.2055-2067.2003] [Cited by in Crossref: 82] [Cited by in F6Publishing: 64] [Article Influence: 4.3] [Reference Citation Analysis]
124 Fakhari FD, Dittmer DP. Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol 2002;76:6213-23. [PMID: 12021355 DOI: 10.1128/jvi.76.12.6213-6223.2002] [Cited by in Crossref: 162] [Cited by in F6Publishing: 126] [Article Influence: 8.1] [Reference Citation Analysis]
125 Wang SS, Chang PJ, Chen LW, Chen LY, Hung CH, Liou JY, Yen JB. Positive and negative regulation in the promoter of the ORF46 gene of Kaposi's sarcoma-associated herpesvirus. Virus Res 2012;165:157-69. [PMID: 22366521 DOI: 10.1016/j.virusres.2012.02.010] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
126 Carbone A, Cesarman E, Gloghini A, Drexler HG. Understanding pathogenetic aspects and clinical presentation of primary effusion lymphoma through its derived cell lines. AIDS 2010;24:479-90. [PMID: 20051807 DOI: 10.1097/QAD.0b013e3283365395] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 3.7] [Reference Citation Analysis]
127 Wang XP, Zhang YJ, Deng JH, Pan HY, Zhou FC, Montalvo EA, Gao SJ. Characterization of the promoter region of the viral interferon regulatory factor encoded by Kaposi's sarcoma-associated herpesvirus. Oncogene 2001;20:523-30. [PMID: 11313983 DOI: 10.1038/sj.onc.1204115] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 0.7] [Reference Citation Analysis]
128 Gage JR, Breen EC, Echeverri A, Magpantay L, Kishimoto T, Miles S, Martínez-maza O. Human herpesvirus 8-encoded interleukin 6 activates HIV-1 in the U1 monocytic cell line: . AIDS 1999;13:1851-5. [DOI: 10.1097/00002030-199910010-00006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
129 Sharma NR, Majerciak V, Kruhlak MJ, Zheng ZM. KSHV inhibits stress granule formation by viral ORF57 blocking PKR activation. PLoS Pathog 2017;13:e1006677. [PMID: 29084250 DOI: 10.1371/journal.ppat.1006677] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
130 Katano H, Iwasaki T, Baba N, Terai M, Mori S, Iwamoto A, Kurata T, Sata T. Identification of antigenic proteins encoded by human herpesvirus 8 and seroprevalence in the general population and among patients with and without Kaposi's sarcoma. J Virol 2000;74:3478-85. [PMID: 10729121 DOI: 10.1128/jvi.74.8.3478-3485.2000] [Cited by in Crossref: 69] [Cited by in F6Publishing: 23] [Article Influence: 3.1] [Reference Citation Analysis]
131 Li H, Komatsu T, Dezube BJ, Kaye KM. The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol 2002;76:11880-8. [PMID: 12414930 DOI: 10.1128/jvi.76.23.11880-11888.2002] [Cited by in Crossref: 53] [Cited by in F6Publishing: 36] [Article Influence: 2.7] [Reference Citation Analysis]
132 Bruce AG, Bakke AM, Bielefeldt-Ohmann H, Ryan JT, Thouless ME, Tsai CC, Rose TM. High levels of retroperitoneal fibromatosis (RF)-associated herpesvirus in RF lesions in macaques are associated with ORF73 LANA expression in spindleoid tumour cells. J Gen Virol 2006;87:3529-38. [PMID: 17098967 DOI: 10.1099/vir.0.82339-0] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
133 Kirsch P, Jakob V, Oberhausen K, Stein SC, Cucarro I, Schulz TF, Empting M. Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. J Med Chem 2019;62:3924-39. [PMID: 30888817 DOI: 10.1021/acs.jmedchem.8b01827] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 5.3] [Reference Citation Analysis]
134 Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N, Koeffler HP. Mechanisms of Growth Control of Kaposi's Sarcoma–Associated Herpes Virus–Associated Primary Effusion Lymphoma Cells. Blood 1998;91:2475-81. [DOI: 10.1182/blood.v91.7.2475.2475_2475_2481] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
135 Pires de Miranda M, Quendera AP, McVey CE, Kaye KM, Simas JP. In Vivo Persistence of Chimeric Virus after Substitution of the Kaposi's Sarcoma-Associated Herpesvirus LANA DNA Binding Domain with That of Murid Herpesvirus 4. J Virol 2018;92:e01251-18. [PMID: 30111565 DOI: 10.1128/JVI.01251-18] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
136 Piguet V. Receptor modulation in viral replication: HIV, HSV, HHV-8 and HPV: same goal, different techniques to interfere with MHC-I antigen presentation. Curr Top Microbiol Immunol 2005;285:199-217. [PMID: 15609505 DOI: 10.1007/3-540-26764-6_7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.4] [Reference Citation Analysis]
137 Kapadia SB, Levine B, Speck SH, Virgin HW 4th. Critical role of complement and viral evasion of complement in acute, persistent, and latent gamma-herpesvirus infection. Immunity 2002;17:143-55. [PMID: 12196286 DOI: 10.1016/s1074-7613(02)00369-2] [Cited by in Crossref: 72] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
138 Haggerty SM, Schleiss MR. A novel CC-chemokine homolog encoded by guinea pig cytomegalovirus. Virus Genes 2002;25:271-9. [PMID: 12881638 DOI: 10.1023/a:1020923924471] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
139 Ackermann M. Pathogenesis of gammaherpesvirus infections. Vet Microbiol 2006;113:211-22. [PMID: 16332416 DOI: 10.1016/j.vetmic.2005.11.008] [Cited by in Crossref: 78] [Cited by in F6Publishing: 69] [Article Influence: 4.6] [Reference Citation Analysis]
140 Lin R, Heylbroeck C, Pitha PM, Hiscott J. Virus-dependent phosphorylation of the IRF-3 transcription factor regulates nuclear translocation, transactivation potential, and proteasome-mediated degradation. Mol Cell Biol 1998;18:2986-96. [PMID: 9566918 DOI: 10.1128/MCB.18.5.2986] [Cited by in Crossref: 682] [Cited by in F6Publishing: 381] [Article Influence: 28.4] [Reference Citation Analysis]
141 Nishimura K, Ueda K, Sakakibara S, Do E, Ohsaki E, Okuno T, Yamanishi K. A viral transcriptional activator of Kaposi's sarcoma-associated herpesvirus (KSHV) induces apoptosis, which is blocked in KSHV-infected cells. Virology 2003;316:64-74. [PMID: 14599791 DOI: 10.1016/s0042-6822(03)00582-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
142 El-Mokhtar MA, Bauer A, Madela J, Voigt S. Cellular distribution of CD200 receptor in rats and its interaction with cytomegalovirus e127 protein. Med Microbiol Immunol 2018;207:307-18. [PMID: 30032349 DOI: 10.1007/s00430-018-0552-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
143 Polson AG, Huang L, Lukac DM, Blethrow JD, Morgan DO, Burlingame AL, Ganem D. Kaposi's sarcoma-associated herpesvirus K-bZIP protein is phosphorylated by cyclin-dependent kinases. J Virol 2001;75:3175-84. [PMID: 11238844 DOI: 10.1128/JVI.75.7.3175-3184.2001] [Cited by in Crossref: 57] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
144 Prasad A, Lu M, Lukac DM, Zeichner SL. An alternative Kaposi's sarcoma-associated herpesvirus replication program triggered by host cell apoptosis. J Virol 2012;86:4404-19. [PMID: 22345480 DOI: 10.1128/JVI.06617-11] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
145 Razin SV, Ioudinkova ES, Trifonov EN, Scherrer K. Non-clonability correlates with genomic instability: a case study of a unique DNA region. J Mol Biol 2001;307:481-6. [PMID: 11254376 DOI: 10.1006/jmbi.2000.4372] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
146 Roychoudhury S, Mukherjee D. A detailed comparative analysis on the overall codon usage pattern in herpesviruses. Virus Research 2010;148:31-43. [DOI: 10.1016/j.virusres.2009.11.018] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 3.3] [Reference Citation Analysis]
147 Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF. The 222- to 234-kilodalton latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol 1997;71:5915-21. [PMID: 9223481 DOI: 10.1128/JVI.71.8.5915-5921.1997] [Cited by in Crossref: 352] [Cited by in F6Publishing: 190] [Article Influence: 14.1] [Reference Citation Analysis]
148 Thakur NN, El-Gogo S, Steer B, Freimüller K, Waha A, Adler H. A gammaherpesviral internal repeat contributes to latency amplification. PLoS One 2007;2:e733. [PMID: 17710133 DOI: 10.1371/journal.pone.0000733] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
149 Roshan R, Labo N, Trivett M, Miley W, Marshall V, Coren L, Cornejo Castro EM, Perez H, Holdridge B, Davis E, Matus-Nicodemos R, Ayala VI, Sowder R 2nd, Wyvill KM, Aleman K, Fennessey C, Lifson J, Polizzotto MN, Douek D, Keele B, Uldrick TS, Yarchoan R, Ohlen C, Ott D, Whitby D. T-cell responses to KSHV infection: a systematic approach. Oncotarget 2017;8:109402-16. [PMID: 29312617 DOI: 10.18632/oncotarget.22683] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
150 Greenspan G, Geiger D, Gotch F, Bower M, Patterson S, Nelson M, Gazzard B, Stebbing J. Model-Based Inference of Recombination Hotspots in a Highly, Variable Oncogene. J Mol Evol 2004;58:239-51. [DOI: 10.1007/s00239-003-2543-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
151 Lin CW, Tu PF, Hsiao NW, Chang CY, Wan L, Lin YT, Chang HW. Identification of a novel septin 4 protein binding to human herpesvirus 8 kaposin A protein using a phage display cDNA library. J Virol Methods 2007;143:65-72. [PMID: 17383018 DOI: 10.1016/j.jviromet.2007.02.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
152 Müller K, Tidona CA, Bahr U, Darai G. Identification of a thymidylate synthase gene within the genome of Chilo iridescent virus. Virus Genes 1998;17:243-58. [PMID: 9926400 DOI: 10.1023/a:1008017820941] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
153 Koch S, Damas M, Freise A, Hage E, Dhingra A, Rückert J, Gallo A, Kremmer E, Tegge W, Brönstrup M, Brune W, Schulz TF. Kaposi's sarcoma-associated herpesvirus vIRF2 protein utilizes an IFN-dependent pathway to regulate viral early gene expression. PLoS Pathog 2019;15:e1007743. [PMID: 31059555 DOI: 10.1371/journal.ppat.1007743] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
154 Estep RD, Hansen SG, Rogers KS, Axthelm MK, Wong SW. Genomic characterization of Japanese macaque rhadinovirus, a novel herpesvirus isolated from a nonhuman primate with a spontaneous inflammatory demyelinating disease. J Virol 2013;87:512-23. [PMID: 23097433 DOI: 10.1128/JVI.02194-12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
155 Yanai H, Negishi H, Taniguchi T. The IRF family of transcription factors: Inception, impact and implications in oncogenesis. Oncoimmunology 2012;1:1376-86. [PMID: 23243601 DOI: 10.4161/onci.22475] [Cited by in Crossref: 125] [Cited by in F6Publishing: 111] [Article Influence: 125.0] [Reference Citation Analysis]
156 Kang H, Lieberman PM. Cell cycle control of Kaposi's sarcoma-associated herpesvirus latency transcription by CTCF-cohesin interactions. J Virol 2009;83:6199-210. [PMID: 19369356 DOI: 10.1128/JVI.00052-09] [Cited by in Crossref: 35] [Cited by in F6Publishing: 32] [Article Influence: 2.7] [Reference Citation Analysis]
157 Mack AA, Sugden B. EBV is necessary for proliferation of dually infected primary effusion lymphoma cells. Cancer Res 2008;68:6963-8. [PMID: 18757410 DOI: 10.1158/0008-5472.CAN-08-0627] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.7] [Reference Citation Analysis]
158 Dhingra A, Ganzenmueller T, Hage E, Suárez NM, Mätz-Rensing K, Widmer D, Pöhlmann S, Davison AJ, Schulz TF, Kaul A. Novel Virus Related to Kaposi's Sarcoma-Associated Herpesvirus from Colobus Monkey. Emerg Infect Dis 2019;25:1548-51. [PMID: 31310220 DOI: 10.3201/eid2508.181802] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
159 Gruffat H, Sergeant A, Manet E. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma. Microbes and Infection 2000;2:671-80. [DOI: 10.1016/s1286-4579(00)00358-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
160 Lange P, Damania B. Kaposi Sarcoma-Associated Herpesvirus (KSHV). Trends Microbiol 2020;28:236-7. [PMID: 31759828 DOI: 10.1016/j.tim.2019.10.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
161 Vega F, Miranda RN, Medeiros LJ. KSHV/HHV8-positive large B-cell lymphomas and associated diseases: a heterogeneous group of lymphoproliferative processes with significant clinicopathological overlap. Mod Pathol 2020;33:18-28. [PMID: 31527708 DOI: 10.1038/s41379-019-0365-y] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
162 Zong JC, Ciufo DM, Alcendor DJ, Wan X, Nicholas J, Browning PJ, Rady PL, Tyring SK, Orenstein JM, Rabkin CS, Su IJ, Powell KF, Croxson M, Foreman KE, Nickoloff BJ, Alkan S, Hayward GS. High-level variability in the ORF-K1 membrane protein gene at the left end of the Kaposi's sarcoma-associated herpesvirus genome defines four major virus subtypes and multiple variants or clades in different human populations. J Virol 1999;73:4156-70. [PMID: 10196312 DOI: 10.1128/JVI.73.5.4156-4170.1999] [Cited by in Crossref: 187] [Cited by in F6Publishing: 72] [Article Influence: 8.1] [Reference Citation Analysis]
163 Wong EL, Damania B. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus K15 gene. J Virol 2006;80:1385-92. [PMID: 16415016 DOI: 10.1128/JVI.80.3.1385-1392.2006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
164 Lachmann PJ, Davies A. Complement and immunity to viruses. Immunol Rev 1997;159:69-77. [PMID: 9416503 DOI: 10.1111/j.1600-065x.1997.tb01007.x] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
165 Bellos F, Goldschmidt H, Dörner M, Ho A, Moos M. Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNA. Annals of Oncology 1999;10:323-8. [DOI: 10.1023/a:1008320717531] [Cited by in Crossref: 10] [Article Influence: 0.4] [Reference Citation Analysis]
166 Jeong JH, Orvis J, Kim JW, Mcmurtrey CP, Renne R, Dittmer DP. Regulation and Autoregulation of the Promoter for the Latency-associated Nuclear Antigen of Kaposi's Sarcoma-associated Herpesvirus. Journal of Biological Chemistry 2004;279:16822-31. [DOI: 10.1074/jbc.m312801200] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 2.6] [Reference Citation Analysis]
167 Dittmer D, Kedes DH. Do viral chemokines modulate Kaposi's sarcoma? Bioessays 1998;20:367-70. [DOI: 10.1002/(sici)1521-1878(199805)20:5<367::aid-bies3>3.0.co;2-l] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
168 Baresova P, Pitha PM, Lubyova B. Distinct roles of Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factors in inflammatory response and cancer. J Virol 2013;87:9398-410. [PMID: 23785197 DOI: 10.1128/JVI.03315-12] [Cited by in Crossref: 34] [Cited by in F6Publishing: 28] [Article Influence: 3.8] [Reference Citation Analysis]
169 Delecluse HJ, Kost M, Feederle R, Wilson L, Hammerschmidt W. Spontaneous activation of the lytic cycle in cells infected with a recombinant Kaposi's sarcoma-associated virus. J Virol 2001;75:2921-8. [PMID: 11222717 DOI: 10.1128/JVI.75.6.2921-2928.2001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
170 Liang Y, Ganem D. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA. J Virol 2004;78:6818-26. [PMID: 15194757 DOI: 10.1128/JVI.78.13.6818-6826.2004] [Cited by in Crossref: 69] [Cited by in F6Publishing: 44] [Article Influence: 3.8] [Reference Citation Analysis]
171 Burnside KL, Ryan JT, Bielefeldt-ohmann H, Gregory Bruce A, Thouless ME, Tsai C, Rose TM. RFHVMn ORF73 is structurally related to the KSHV ORF73 latency-associated nuclear antigen (LANA) and is expressed in retroperitoneal fibromatosis (RF) tumor cells. Virology 2006;354:103-15. [DOI: 10.1016/j.virol.2006.06.022] [Cited by in Crossref: 26] [Cited by in F6Publishing: 24] [Article Influence: 1.6] [Reference Citation Analysis]
172 Strahan R, Uppal T, Verma SC. Next-Generation Sequencing in the Understanding of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Biology. Viruses 2016;8:92. [PMID: 27043613 DOI: 10.3390/v8040092] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
173 Hu J, Renne R. Characterization of the minimal replicator of Kaposi's sarcoma-associated herpesvirus latent origin. J Virol 2005;79:2637-42. [PMID: 15681465 DOI: 10.1128/JVI.79.4.2637-2642.2005] [Cited by in Crossref: 58] [Cited by in F6Publishing: 48] [Article Influence: 3.4] [Reference Citation Analysis]
174 Canham M, Talbot SJ. A naturally occurring C-terminal truncated isoform of the latent nuclear antigen of Kaposi's sarcoma-associated herpesvirus does not associate with viral episomal DNA. J Gen Virol 2004;85:1363-9. [PMID: 15166417 DOI: 10.1099/vir.0.79802-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
175 Baresova P, Musilova J, Pitha PM, Lubyova B. p53 tumor suppressor protein stability and transcriptional activity are targeted by Kaposi's sarcoma-associated herpesvirus-encoded viral interferon regulatory factor 3. Mol Cell Biol 2014;34:386-99. [PMID: 24248600 DOI: 10.1128/MCB.01011-13] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
176 Wang QJ, Huang XL, Rappocciolo G, Jenkins FJ, Hildebrand WH, Fan Z, Thomas EK, Rinaldo CR Jr. Identification of an HLA A*0201-restricted CD8(+) T-cell epitope for the glycoprotein B homolog of human herpesvirus 8. Blood 2002;99:3360-6. [PMID: 11964304 DOI: 10.1182/blood.v99.9.3360] [Cited by in Crossref: 41] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
177 Cohen A, Wolf DG, Guttman-Yassky E, Sarid R. Kaposi's sarcoma-associated herpesvirus: clinical, diagnostic, and epidemiological aspects. Crit Rev Clin Lab Sci 2005;42:101-53. [PMID: 15941082 DOI: 10.1080/10408360590913524] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 1.8] [Reference Citation Analysis]
178 Jeong JH, Hines-Boykin R, Ash JD, Dittmer DP. Tissue specificity of the Kaposi's sarcoma-associated herpesvirus latent nuclear antigen (LANA/orf73) promoter in transgenic mice. J Virol 2002;76:11024-32. [PMID: 12368345 DOI: 10.1128/jvi.76.21.11024-11032.2002] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
179 Faure A, Hayes M, Sugden B. How Kaposi's sarcoma-associated herpesvirus stably transforms peripheral B cells towards lymphomagenesis. Proc Natl Acad Sci U S A 2019;116:16519-28. [PMID: 31363046 DOI: 10.1073/pnas.1905025116] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
180 Hamden KE, Bryan BA, Ford PW, Xie C, Li Y, Akula SM. Spectroscopic analysis of Kaposi's sarcoma-associated herpesvirus infected cells by Raman tweezers. Journal of Virological Methods 2005;129:145-51. [DOI: 10.1016/j.jviromet.2005.05.018] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
181 Li Q, Means R, Lang S, Jung JU. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. J Virol 2007;81:2117-27. [PMID: 17166914 DOI: 10.1128/JVI.01961-06] [Cited by in Crossref: 73] [Cited by in F6Publishing: 59] [Article Influence: 4.6] [Reference Citation Analysis]
182 Shigemi Z, Manabe K, Hara N, Baba Y, Hosokawa K, Kagawa H, Watanabe T, Fujimuro M. Methylseleninic acid and sodium selenite induce severe ER stress and subsequent apoptosis through UPR activation in PEL cells. Chem Biol Interact 2017;266:28-37. [PMID: 28161410 DOI: 10.1016/j.cbi.2017.01.027] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
183 Curtiss P, Strazzulla LC, Friedman-Kien AE. An Update on Kaposi's Sarcoma: Epidemiology, Pathogenesis and Treatment. Dermatol Ther (Heidelb) 2016;6:465-70. [PMID: 27804093 DOI: 10.1007/s13555-016-0152-3] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 5.5] [Reference Citation Analysis]
184 Olsen SJ, Moore PS. Kaposi’s Sarcoma-Associated Herpesvirus (KSHV/HHV8) and the Etiology of KS. In: Medveczky PG, Friedman H, Bendinelli M, editors. Herpesviruses and Immunity. Boston: Kluwer Academic Publishers; 2002. pp. 115-47. [DOI: 10.1007/0-306-46808-5_5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
185 Arvanitakis L, Geras-raaka E, Gershengorn MC. Constitutively Signaling G-Protein-Coupled Receptors and Human Disease. Trends in Endocrinology & Metabolism 1998;9:27-31. [DOI: 10.1016/s1043-2760(98)00007-1] [Cited by in Crossref: 29] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
186 Mullick J, Kadam A, Sahu A. Herpes and pox viral complement control proteins: 'the mask of self'. Trends Immunol 2003;24:500-7. [PMID: 12967674 DOI: 10.1016/s1471-4906(03)00207-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
187 Radkov SA, Kellam P, Boshoff C. The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells. Nat Med 2000;6:1121-7. [PMID: 11017143 DOI: 10.1038/80459] [Cited by in Crossref: 365] [Cited by in F6Publishing: 347] [Article Influence: 16.6] [Reference Citation Analysis]
188 McGeoch DJ, Davison AJ. The descent of human herpesvirus 8. Semin Cancer Biol 1999;9:201-9. [PMID: 10343071 DOI: 10.1006/scbi.1999.0093] [Cited by in Crossref: 40] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
189 Tang T, Owen JD, Du J, Walker CL, Richmond A. Molecular cloning and characterization of a mouse gene with homology to the Duffy-antigen receptor for chemokines. DNA Seq 1998;9:129-43. [PMID: 10520743 DOI: 10.3109/10425179809072188] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.3] [Reference Citation Analysis]
190 Levy JA. Three new human herpesviruses (HHV6, 7, and 8). The Lancet 1997;349:558-63. [DOI: 10.1016/s0140-6736(97)80119-5] [Cited by in Crossref: 94] [Cited by in F6Publishing: 16] [Article Influence: 3.8] [Reference Citation Analysis]
191 Cannon M, Cesarman E, Boshoff C. KSHV G protein-coupled receptor inhibits lytic gene transcription in primary-effusion lymphoma cells via p21-mediated inhibition of Cdk2. Blood 2006;107:277-84. [PMID: 16150942 DOI: 10.1182/blood-2005-06-2350] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 1.9] [Reference Citation Analysis]
192 Sjak-shie NN, Vescio RA, Berenson JR. THE ROLE OF HUMAN HERPESVIRUS-8 IN THE PATHOGENESIS OF MULTIPLE MYELOMA. Hematology/Oncology Clinics of North America 1999;13:1159-67. [DOI: 10.1016/s0889-8588(05)70118-0] [Cited by in Crossref: 11] [Article Influence: 0.5] [Reference Citation Analysis]
193 Majerciak V, Ni T, Yang W, Meng B, Zhu J, Zheng ZM. A viral genome landscape of RNA polyadenylation from KSHV latent to lytic infection. PLoS Pathog 2013;9:e1003749. [PMID: 24244170 DOI: 10.1371/journal.ppat.1003749] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 4.2] [Reference Citation Analysis]
194 Guo F, Xing L. RNA helicase A as co-factor for DNA viruses during replication. Virus Res 2021;291:198206. [PMID: 33132162 DOI: 10.1016/j.virusres.2020.198206] [Reference Citation Analysis]
195 Chang M, Brown HJ, Collado-Hidalgo A, Arevalo JM, Galic Z, Symensma TL, Tanaka L, Deng H, Zack JA, Sun R, Cole SW. beta-Adrenoreceptors reactivate Kaposi's sarcoma-associated herpesvirus lytic replication via PKA-dependent control of viral RTA. J Virol 2005;79:13538-47. [PMID: 16227274 DOI: 10.1128/JVI.79.21.13538-13547.2005] [Cited by in Crossref: 37] [Cited by in F6Publishing: 25] [Article Influence: 2.2] [Reference Citation Analysis]
196 Massimelli MJ, Kang JG, Majerciak V, Le SY, Liewehr DJ, Steinberg SM, Zheng ZM. Stability of a long noncoding viral RNA depends on a 9-nt core element at the RNA 5' end to interact with viral ORF57 and cellular PABPC1. Int J Biol Sci 2011;7:1145-60. [PMID: 22043172 DOI: 10.7150/ijbs.7.1145] [Cited by in Crossref: 51] [Cited by in F6Publishing: 51] [Article Influence: 4.6] [Reference Citation Analysis]
197 Gangappa S, van Dyk LF, Jewett TJ, Speck SH, Virgin HW 4th. Identification of the in vivo role of a viral bcl-2. J Exp Med 2002;195:931-40. [PMID: 11927636 DOI: 10.1084/jem.20011825] [Cited by in Crossref: 100] [Cited by in F6Publishing: 89] [Article Influence: 5.0] [Reference Citation Analysis]
198 Majerciak V, Yamanegi K, Allemand E, Kruhlak M, Krainer AR, Zheng ZM. Kaposi's sarcoma-associated herpesvirus ORF57 functions as a viral splicing factor and promotes expression of intron-containing viral lytic genes in spliceosome-mediated RNA splicing. J Virol 2008;82:2792-801. [PMID: 18184716 DOI: 10.1128/JVI.01856-07] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 3.9] [Reference Citation Analysis]
199 Sarid R, Klepfish A, Schattner A. Virology, Pathogenetic Mechanisms, and Associated Diseases of Kaposi Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). Mayo Clinic Proceedings 2002;77:941-9. [DOI: 10.1016/s0025-6196(11)62261-1] [Cited by in Crossref: 44] [Article Influence: 2.2] [Reference Citation Analysis]
200 Hu Z, Usherwood EJ. Immune escape of γ-herpesviruses from adaptive immunity. Rev Med Virol 2014;24:365-78. [PMID: 24733560 DOI: 10.1002/rmv.1791] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
201 Haque M, Chen J, Ueda K, Mori Y, Nakano K, Hirata Y, Kanamori S, Uchiyama Y, Inagi R, Okuno T, Yamanishi K. Identification and analysis of the K5 gene of Kaposi's sarcoma-associated herpesvirus. J Virol 2000;74:2867-75. [PMID: 10684303 DOI: 10.1128/jvi.74.6.2867-2875.2000] [Cited by in Crossref: 63] [Cited by in F6Publishing: 37] [Article Influence: 2.9] [Reference Citation Analysis]
202 Tomkowicz B, Singh SP, Cartas M, Srinivasan A. Human Herpesvirus-8 Encoded Kaposin: Subcellular Localization Using Immunofluorescence and Biochemical Approaches. DNA and Cell Biology 2002;21:151-62. [DOI: 10.1089/10445490252925413] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
203 Zhu L, Wang R, Sweat A, Goldstein E, Horvat R, Chandran B. Comparison of Human Sera Reactivities in Immunoblots with Recombinant Human Herpesvirus (HHV)-8 Proteins Associated with the Latent (ORF73) and Lytic (ORFs 65, K8.1A, and K8.1B) Replicative Cycles and in Immunofluorescence Assays with HHV-8-Infected BCBL-1 Cells. Virology 1999;256:381-92. [DOI: 10.1006/viro.1999.9674] [Cited by in Crossref: 60] [Cited by in F6Publishing: 59] [Article Influence: 2.6] [Reference Citation Analysis]
204 Burdick AE, Carmichael C, Rady PL, Tyring SK, Badiavas E. Resolution of Kaposi’s sarcoma associated with undetectable level of human herpesvirus 8 DNA in a patient with AIDS after protease inhibitor therapy. Journal of the American Academy of Dermatology 1997;37:648-9. [DOI: 10.1016/s0190-9622(97)70188-9] [Cited by in Crossref: 32] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
205 Nicholas J. Human herpesvirus-8-encoded signalling ligands and receptors. J Biomed Sci 2003;10:475-89. [PMID: 12928588 DOI: 10.1007/BF02256109] [Cited by in Crossref: 17] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
206 Flowers CC, Flowers SP, Nabel GJ. Kaposi’s Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor Confers Resistance to the Antiproliferative Effect of Interferon-α. Mol Med 1998;4:402-12. [DOI: 10.1007/bf03401747] [Cited by in Crossref: 39] [Article Influence: 1.6] [Reference Citation Analysis]
207 Bibert S, Wójtowicz A, Taffé P, Tarr PE, Bernasconi E, Furrer H, Günthard HF, Hoffmann M, Kaiser L, Osthoff M, Fellay J, Cavassini M, Bochud PY; Swiss HIV Cohort Study. Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma. AIDS 2018;32:2759-65. [PMID: 30234607 DOI: 10.1097/QAD.0000000000002004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
208 Shiratori I, Yamaguchi M, Suzukawa M, Yamamoto K, Lanier LL, Saito T, Arase H. Down-Regulation of Basophil Function by Human CD200 and Human Herpesvirus-8 CD200. J Immunol 2005;175:4441-9. [DOI: 10.4049/jimmunol.175.7.4441] [Cited by in Crossref: 68] [Cited by in F6Publishing: 69] [Article Influence: 4.0] [Reference Citation Analysis]
209 Roback JD. Human Herpesvirus Infections. Blood Banking and Transfusion Medicine. Elsevier; 2007. pp. 618-38. [DOI: 10.1016/b978-0-443-06981-9.50051-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
210 Lee BS, Lee SH, Feng P, Chang H, Cho NH, Jung JU. Characterization of the Kaposi's sarcoma-associated herpesvirus K1 signalosome. J Virol 2005;79:12173-84. [PMID: 16160144 DOI: 10.1128/JVI.79.19.12173-12184.2005] [Cited by in Crossref: 59] [Cited by in F6Publishing: 41] [Article Influence: 3.5] [Reference Citation Analysis]
211 Borie R, Cadranel J, Galicier L, Couderc LJ. [Pulmonary involvement due to HHV-8 virus during the course of HIV infection]. Rev Mal Respir 2012;29:1209-23. [PMID: 23228679 DOI: 10.1016/j.rmr.2012.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
212 Visalli RJ, Schwartz AM, Patel S, Visalli MA. Identification of the Epstein Barr Virus portal. Virology 2019;529:152-9. [PMID: 30710799 DOI: 10.1016/j.virol.2019.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
213 Moore PS, Chang Y. The conundrum of causality in tumor virology: the cases of KSHV and MCV. Semin Cancer Biol 2014;26:4-12. [PMID: 24304907 DOI: 10.1016/j.semcancer.2013.11.001] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 2.9] [Reference Citation Analysis]
214 Brander C, Raje N, O'connor PG, Davies F, Davis J, Chauhan D, Hideshima T, Martin J, Osmond D, Kedes DH, Walker BD, Scadden DT, Anderson KC. Absence of biologically important Kaposi sarcoma–associated herpesvirus gene products and virus-specific cellular immune responses in multiple myeloma. Blood 2002;100:698-700. [DOI: 10.1182/blood.v100.2.698] [Cited by in Crossref: 21] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
215 Pyaram K, Kieslich CA, Yadav VN, Morikis D, Sahu A. Influence of electrostatics on the complement regulatory functions of Kaposica, the complement inhibitor of Kaposi's sarcoma-associated herpesvirus. J Immunol 2010;184:1956-67. [PMID: 20089702 DOI: 10.4049/jimmunol.0903261] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
216 Campbell M, Yang WS, Yeh WW, Kao CH, Chang PC. Epigenetic Regulation of Kaposi's Sarcoma-Associated Herpesvirus Latency. Front Microbiol 2020;11:850. [PMID: 32508765 DOI: 10.3389/fmicb.2020.00850] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
217 Moriguchi M, Watanabe T, Kadota A, Fujimuro M. Capsaicin Induces Apoptosis in KSHV-Positive Primary Effusion Lymphoma by Suppressing ERK and p38 MAPK Signaling and IL-6 Expression. Front Oncol 2019;9:83. [PMID: 30838176 DOI: 10.3389/fonc.2019.00083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
218 Viallard JF, Lacombe F, Belloc F, Pellegrin JL, Reiffers J. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology]. Cancer Radiother. 2001;5:109-129. [PMID: 11355576 DOI: 10.1016/s1278-3218(01)00087-7] [Cited by in Crossref: 57] [Cited by in F6Publishing: 19] [Article Influence: 2.7] [Reference Citation Analysis]
219 Lazăr DC, Avram MF, Romoșan I, Văcariu V, Goldiș A, Cornianu M. Malignant hepatic vascular tumors in adults: Characteristics, diagnostic difficulties and current management. World J Clin Oncol 2019; 10(3): 110-135 [PMID: 30949442 DOI: 10.5306/wjco.v10.i3.110] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
220 Geras-raaka E, Varma A, Clark-lewis I, Gershengorn MC. Kaposi's Sarcoma-Associated Herpesvirus (KSHV) Chemokine vMIP-II and Human SDF-1α Inhibit Signaling by KSHV G Protein-Coupled Receptor. Biochemical and Biophysical Research Communications 1998;253:725-7. [DOI: 10.1006/bbrc.1998.9557] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 2.4] [Reference Citation Analysis]
221 Murphy PM. Pirated genes in Kaposi's sarcoma. Nature 1997;385:296-9. [DOI: 10.1038/385296a0] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
222 Schulz TF, Chang Y, Moore PS. Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8). In: Mccance DJ, editor. Human Tumor Viruses. Washington: ASM Press; 1998. pp. 87-134. [DOI: 10.1128/9781555818289.ch3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 2] [Article Influence: 2.3] [Reference Citation Analysis]
223 Davison AJ, Clements JB. Herpesviruses: General Properties. In: Mahy BW, Meulen VT, Borriello SP, Murray PR, Funke G, Kaufmann SH, Steward MW, Merz WG, Hay RJ, Cox F, Wakelin D, Gillespie SH, Despommier DD, editors. Topley & Wilson's Microbiology and Microbial Infections. Chichester: John Wiley & Sons, Ltd; 2010. [DOI: 10.1002/9780470688618.taw0231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
224 Dresang LR, Teuton JR, Feng H, Jacobs JM, Camp DG 2nd, Purvine SO, Gritsenko MA, Li Z, Smith RD, Sugden B, Moore PS, Chang Y. Coupled transcriptome and proteome analysis of human lymphotropic tumor viruses: insights on the detection and discovery of viral genes. BMC Genomics 2011;12:625. [PMID: 22185355 DOI: 10.1186/1471-2164-12-625] [Cited by in Crossref: 41] [Cited by in F6Publishing: 39] [Article Influence: 3.7] [Reference Citation Analysis]
225 Wells TN, Schwartz TW. Plagiarism of the host immune system: lessons about chemokine immunology from viruses. Curr Opin Biotechnol 1997;8:741-8. [PMID: 9425666 DOI: 10.1016/s0958-1669(97)80129-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
226 Semmes OJ, Chen L, Sarisky RT, Gao Z, Zhong L, Hayward SD. Mta has properties of an RNA export protein and increases cytoplasmic accumulation of Epstein-Barr virus replication gene mRNA. J Virol 1998;72:9526-34. [PMID: 9811685 DOI: 10.1128/JVI.72.12.9526-9534.1998] [Cited by in Crossref: 56] [Cited by in F6Publishing: 44] [Article Influence: 2.3] [Reference Citation Analysis]
227 Skalsky RL, Samols MA, Plaisance KB, Boss IW, Riva A, Lopez MC, Baker HV, Renne R. Kaposi's sarcoma-associated herpesvirus encodes an ortholog of miR-155. J Virol 2007;81:12836-45. [PMID: 17881434 DOI: 10.1128/JVI.01804-07] [Cited by in Crossref: 338] [Cited by in F6Publishing: 244] [Article Influence: 22.5] [Reference Citation Analysis]
228 Kirshner JR, Lukac DM, Chang J, Ganem D. Kaposi's sarcoma-associated herpesvirus open reading frame 57 encodes a posttranscriptional regulator with multiple distinct activities. J Virol 2000;74:3586-97. [PMID: 10729134 DOI: 10.1128/jvi.74.8.3586-3597.2000] [Cited by in Crossref: 90] [Cited by in F6Publishing: 70] [Article Influence: 4.1] [Reference Citation Analysis]
229 White MK, Pagano JS, Khalili K. Viruses and human cancers: a long road of discovery of molecular paradigms. Clin Microbiol Rev. 2014;27:463-481. [PMID: 24982317 DOI: 10.1128/cmr.00124-13] [Cited by in Crossref: 93] [Cited by in F6Publishing: 43] [Article Influence: 13.3] [Reference Citation Analysis]
230 Davison AJ. Herpesvirus systematics. Vet Microbiol 2010;143:52-69. [PMID: 20346601 DOI: 10.1016/j.vetmic.2010.02.014] [Cited by in Crossref: 209] [Cited by in F6Publishing: 168] [Article Influence: 17.4] [Reference Citation Analysis]
231 Chen W, Huang Q, Zuppan CW, Rowsell EH, Cao JD, Weiss LM, Wang J. Complete absence of KSHV/HHV-8 in posttransplant lymphoproliferative disorders: an immunohistochemical and molecular study of 52 cases. Am J Clin Pathol. 2009;131:632-639. [PMID: 19369621 DOI: 10.1309/ajcp2t4iiizkbhmi] [Cited by in Crossref: 12] [Cited by in F6Publishing: 3] [Article Influence: 0.9] [Reference Citation Analysis]
232 Borah S, Verma SC, Robertson ES. ORF73 of herpesvirus saimiri, a viral homolog of Kaposi's sarcoma-associated herpesvirus, modulates the two cellular tumor suppressor proteins p53 and pRb. J Virol 2004;78:10336-47. [PMID: 15367600 DOI: 10.1128/JVI.78.19.10336-10347.2004] [Cited by in Crossref: 31] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
233 Neipel F, Albrecht J, Fleckenstein B. Human Herpesvirus 8: Is it a Tumor Virus? Proc Assoc Am Phys 1999;111:594-601. [DOI: 10.1046/j.1525-1381.1999.99250.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.4] [Reference Citation Analysis]
234 Saveliev A, Zhu F, Yuan Y. Transcription mapping and expression patterns of genes in the major immediate-early region of Kaposi's sarcoma-associated herpesvirus. Virology 2002;299:301-14. [PMID: 12202233 DOI: 10.1006/viro.2002.1561] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 1.8] [Reference Citation Analysis]
235 Rosenkilde MM, Waldhoer M, Lüttichau HR, Schwartz TW. Virally encoded 7TM receptors. Oncogene 2001;20:1582-93. [DOI: 10.1038/sj.onc.1204191] [Cited by in Crossref: 73] [Cited by in F6Publishing: 70] [Article Influence: 3.5] [Reference Citation Analysis]
236 Damania B, Choi JK, Jung JU. Signaling activities of gammaherpesvirus membrane proteins. J Virol 2000;74:1593-601. [PMID: 10644328 DOI: 10.1128/jvi.74.4.1593-1601.2000] [Cited by in Crossref: 44] [Cited by in F6Publishing: 26] [Article Influence: 2.0] [Reference Citation Analysis]
237 Choi J, Lee B, Shim SN, Li M, Jung JU. Identification of the Novel K15 Gene at the Rightmost End of the Kaposi's Sarcoma-Associated Herpesvirus Genome. J Virol 2000;74:436-46. [DOI: 10.1128/jvi.74.1.436-446.2000] [Cited by in Crossref: 85] [Article Influence: 3.9] [Reference Citation Analysis]
238 Gérard L, Agbalika F, Sheldon J, Maillard A, Schulz TF, Oksenhendler E. No Increased Human Herpesvirus 8 Seroprevalence in Patients With HIV-Associated Non-Hodgkin's Lymphoma: . JAIDS Journal of Acquired Immune Deficiency Syndromes 2001;26:182-4. [DOI: 10.1097/00126334-200102010-00013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
239 Voigt S, Sandford GR, Hayward GS, Burns WH. The English strain of rat cytomegalovirus (CMV) contains a novel captured CD200 (vOX2) gene and a spliced CC chemokine upstream from the major immediate-early region: further evidence for a separate evolutionary lineage from that of rat CMV Maastricht. Journal of General Virology 2005;86:263-74. [DOI: 10.1099/vir.0.80539-0] [Cited by in Crossref: 33] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
240 Ballestas ME, Kaye KM. The latency-associated nuclear antigen, a multifunctional protein central to Kaposi's sarcoma-associated herpesvirus latency. Future Microbiol 2011;6:1399-413. [PMID: 22122438 DOI: 10.2217/fmb.11.137] [Cited by in Crossref: 64] [Cited by in F6Publishing: 58] [Article Influence: 6.4] [Reference Citation Analysis]
241 Ablashi DV, Chatlynne LG, Whitman JE Jr, Cesarman E. Spectrum of Kaposi's sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 2002;15:439-64. [PMID: 12097251 DOI: 10.1128/CMR.15.3.439-464.2002] [Cited by in Crossref: 199] [Cited by in F6Publishing: 68] [Article Influence: 10.0] [Reference Citation Analysis]
242 van Senten JR, Fan TS, Siderius M, Smit MJ. Viral G protein-coupled receptors as modulators of cancer hallmarks. Pharmacol Res 2020;156:104804. [PMID: 32278040 DOI: 10.1016/j.phrs.2020.104804] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
243 Si H, Verma SC, Robertson ES. Proteomic analysis of the Kaposi's sarcoma-associated herpesvirus terminal repeat element binding proteins. J Virol 2006;80:9017-30. [PMID: 16940514 DOI: 10.1128/JVI.00297-06] [Cited by in Crossref: 36] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
244 Sun R, Tan X, Wang X, Wang X, Yang L, Robertson ES, Lan K. Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues. PLoS Pathog 2017;13:e1006167. [PMID: 28118409 DOI: 10.1371/journal.ppat.1006167] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
245 Chen Y, Ciustea M, Ricciardi RP. Processivity factor of KSHV contains a nuclear localization signal and binding domains for transporting viral DNA polymerase into the nucleus. Virology 2005;340:183-91. [PMID: 16043206 DOI: 10.1016/j.virol.2005.06.017] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 1.9] [Reference Citation Analysis]
246 Hu H, Dong J, Liang D, Gao Z, Bai L, Sun R, Hu H, Zhang H, Dong Y, Lan K. Genome-Wide Mapping of the Binding Sites and Structural Analysis of Kaposi's Sarcoma-Associated Herpesvirus Viral Interferon Regulatory Factor 2 Reveal that It Is a DNA-Binding Transcription Factor. J Virol 2016;90:1158-68. [PMID: 26537687 DOI: 10.1128/JVI.01392-15] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
247 Zhu FX, Cusano T, Yuan Y. Identification of the immediate-early transcripts of Kaposi's sarcoma-associated herpesvirus. J Virol 1999;73:5556-67. [PMID: 10364304 DOI: 10.1128/JVI.73.7.5556-5567.1999] [Cited by in Crossref: 169] [Cited by in F6Publishing: 135] [Article Influence: 7.3] [Reference Citation Analysis]
248 Couty JP, Gershengorn MC. G-protein-coupled receptors encoded by human herpesviruses. Trends Pharmacol Sci 2005;26:405-11. [PMID: 15990176 DOI: 10.1016/j.tips.2005.06.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
249 Cesarman E, Mesri EA. Virus-associated lymphomas. Curr Opin Oncol. 1999;11:322-332. [PMID: 10505767 DOI: 10.1097/00001622-199909000-00002] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
250 Yamanegi K, Tang S, Zheng ZM. Kaposi's sarcoma-associated herpesvirus K8beta is derived from a spliced intermediate of K8 pre-mRNA and antagonizes K8alpha (K-bZIP) to induce p21 and p53 and blocks K8alpha-CDK2 interaction. J Virol 2005;79:14207-21. [PMID: 16254356 DOI: 10.1128/JVI.79.22.14207-14221.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
251 Neipel F, Albrecht J, Fleckenstein B. Human Herpesvirus 8--the First Human Rhadinovirus. JNCI Monographs 1998;1998:73-7. [DOI: 10.1093/oxfordjournals.jncimonographs.a024178] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 1.6] [Reference Citation Analysis]
252 Yakushko Y, Hackmann C, Günther T, Rückert J, Henke M, Koste L, Alkharsah K, Bohne J, Grundhoff A, Schulz TF, Henke-Gendo C. Kaposi's sarcoma-associated herpesvirus bacterial artificial chromosome contains a duplication of a long unique-region fragment within the terminal repeat region. J Virol 2011;85:4612-7. [PMID: 21307197 DOI: 10.1128/JVI.02068-10] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 2.8] [Reference Citation Analysis]
253 Verma SC, Robertson ES. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiology Letters 2003;222:155-63. [DOI: 10.1016/s0378-1097(03)00261-1] [Cited by in Crossref: 81] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
254 Forte E, Raja AN, Shamulailatpam P, Manzano M, Schipma MJ, Casey JL, Gottwein E. MicroRNA-mediated transformation by the Kaposi's sarcoma-associated herpesvirus Kaposin locus. J Virol 2015;89:2333-41. [PMID: 25505059 DOI: 10.1128/JVI.03317-14] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
255 Gottwein E, Cai X, Cullen BR. Expression and function of microRNAs encoded by Kaposi's sarcoma-associated herpesvirus. Cold Spring Harb Symp Quant Biol 2006;71:357-64. [PMID: 17381317 DOI: 10.1101/sqb.2006.71.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
256 Wang QJ, Jenkins FJ, Jacobson LP, Kingsley LA, Day RD, Zhang ZW, Meng YX, Pellett PE, Kousoulas KG, Baghian A, Rinaldo CR Jr. Primary human herpesvirus 8 infection generates a broadly specific CD8(+) T-cell response to viral lytic cycle proteins. Blood 2001;97:2366-73. [PMID: 11290599 DOI: 10.1182/blood.v97.8.2366] [Cited by in Crossref: 69] [Cited by in F6Publishing: 27] [Article Influence: 3.3] [Reference Citation Analysis]
257 Lukac DM, Renne R, Kirshner JR, Ganem D. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein. Virology 1998;252:304-12. [PMID: 9878608 DOI: 10.1006/viro.1998.9486] [Cited by in Crossref: 346] [Cited by in F6Publishing: 342] [Article Influence: 15.0] [Reference Citation Analysis]
258 Carroll PA, Brazeau E, Lagunoff M. Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation. Virology 2004;328:7-18. [PMID: 15380353 DOI: 10.1016/j.virol.2004.07.008] [Cited by in Crossref: 130] [Cited by in F6Publishing: 124] [Article Influence: 7.2] [Reference Citation Analysis]
259 Verma SC, Lan K, Choudhuri T, Cotter MA, Robertson ES. An autonomous replicating element within the KSHV genome. Cell Host Microbe 2007;2:106-18. [PMID: 18005725 DOI: 10.1016/j.chom.2007.07.002] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
260 Deng H, Liang Y, Sun R. Regulation of KSHV lytic gene expression. Curr Top Microbiol Immunol 2007;312:157-83. [PMID: 17089797 DOI: 10.1007/978-3-540-34344-8_6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 46] [Article Influence: 0.8] [Reference Citation Analysis]
261 Davis MA, Stürzl MA, Blasig C, Schreier A, Guo HG, Reitz M, Opalenik SR, Browning PJ. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst 1997;89:1868-74. [PMID: 9414174 DOI: 10.1093/jnci/89.24.1868] [Cited by in Crossref: 107] [Cited by in F6Publishing: 94] [Article Influence: 4.5] [Reference Citation Analysis]
262 Boshoff C, Gao S, Healy LE, Matthews S, Thomas AJ, Coignet L, Warnke RA, Strauchen JA, Matutes E, Kamel OW, Moore PS, Weiss RA, Chang Y. Establishing a KSHV+ Cell Line (BCP-1) From Peripheral Blood and Characterizing Its Growth in Nod/SCID Mice. Blood 1998;91:1671-9. [DOI: 10.1182/blood.v91.5.1671.1671_1671_1679] [Cited by in Crossref: 124] [Article Influence: 5.2] [Reference Citation Analysis]
263 Wong LY, Wilson AC. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen induces a strong bend on binding to terminal repeat DNA. J Virol 2005;79:13829-36. [PMID: 16227305 DOI: 10.1128/JVI.79.21.13829-13836.2005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
264 Lan K, Murakami M, Choudhuri T, Kuppers DA, Robertson ES. Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency. Virology 2006;351:393-403. [PMID: 16701788 DOI: 10.1016/j.virol.2006.03.047] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.6] [Reference Citation Analysis]
265 Myoung J, Ganem D. Active lytic infection of human primary tonsillar B cells by KSHV and its noncytolytic control by activated CD4+ T cells. J Clin Invest 2011;121:1130-40. [PMID: 21339648 DOI: 10.1172/JCI43755] [Cited by in Crossref: 43] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]
266 Watanabe T, Sugimoto A, Hosokawa K, Fujimuro M. Signal Transduction Pathways Associated with KSHV-Related Tumors. Adv Exp Med Biol 2018;1045:321-55. [PMID: 29896674 DOI: 10.1007/978-981-10-7230-7_15] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
267 Labo N, Miley W, Marshall V, Gillette W, Esposito D, Bess M, Turano A, Uldrick T, Polizzotto MN, Wyvill KM, Bagni R, Yarchoan R, Whitby D. Heterogeneity and breadth of host antibody response to KSHV infection demonstrated by systematic analysis of the KSHV proteome. PLoS Pathog 2014;10:e1004046. [PMID: 24675986 DOI: 10.1371/journal.ppat.1004046] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 4.1] [Reference Citation Analysis]
268 Katano H, Sato Y, Kurata T, Mori S, Sata T. Expression and localization of human herpesvirus 8-encoded proteins in primary effusion lymphoma, Kaposi's sarcoma, and multicentric Castleman's disease. Virology 2000;269:335-44. [PMID: 10753712 DOI: 10.1006/viro.2000.0196] [Cited by in Crossref: 176] [Cited by in F6Publishing: 164] [Article Influence: 8.0] [Reference Citation Analysis]
269 Mark L, Spiller OB, Villoutreix BO, Blom AM. Kaposi's sarcoma-associated herpes virus complement control protein: KCP--complement inhibition and more. Mol Immunol 2007;44:11-22. [PMID: 16905191 DOI: 10.1016/j.molimm.2006.06.018] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
270 Toth Z, Brulois K, Jung JU. The chromatin landscape of Kaposi's sarcoma-associated herpesvirus. Viruses 2013;5:1346-73. [PMID: 23698402 DOI: 10.3390/v5051346] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 5.1] [Reference Citation Analysis]
271 Duboise SM, Lee H, Guo J, Choi JK, Czajak S, Simon M, Desrosiers RC, Jung JU. Mutation of the Lck-binding motif of Tip enhances lymphoid cell activation by herpesvirus saimiri. J Virol 1998;72:2607-14. [PMID: 9525577 DOI: 10.1128/JVI.72.4.2607-2614.1998] [Cited by in Crossref: 25] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
272 Blackbourn DJ, Lennette E, Klencke B, Moses A, Chandran B, Weinstein M, Glogau RG, Witte MH, Way DL, Kutzkey T, Herndier B, Levy JA. The restricted cellular host range of human herpesvirus 8. AIDS 2000;14:1123-33. [PMID: 10894276 DOI: 10.1097/00002030-200006160-00009] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 3.4] [Reference Citation Analysis]
273 Wang Y, Li H, Chan MY, Zhu FX, Lukac DM, Yuan Y. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: cis-acting requirements for replication and ori-Lyt-associated RNA transcription. J Virol 2004;78:8615-29. [PMID: 15280471 DOI: 10.1128/JVI.78.16.8615-8629.2004] [Cited by in Crossref: 67] [Cited by in F6Publishing: 58] [Article Influence: 3.7] [Reference Citation Analysis]
274 Park J, Lee MS, Yoo SM, Seo T. A novel protein encoded by Kaposi's sarcoma-associated herpesvirus open reading frame 36 inhibits cell spreading and focal adhesion kinase activation. Intervirology 2007;50:426-32. [PMID: 18182822 DOI: 10.1159/000112949] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
275 Morin G, Robinson BA, Rogers KS, Wong SW. A Rhesus Rhadinovirus Viral Interferon (IFN) Regulatory Factor Is Virion Associated and Inhibits the Early IFN Antiviral Response. J Virol 2015;89:7707-21. [PMID: 25972548 DOI: 10.1128/JVI.01175-15] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
276 Komatsu T, Barbera AJ, Ballestas ME, Kaye KM. The Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen. Viral Immunology 2001;14:311-7. [DOI: 10.1089/08828240152716565] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
277 Schäfer A, Lengenfelder D, Grillhösl C, Wieser C, Fleckenstein B, Ensser A. The latency-associated nuclear antigen homolog of herpesvirus saimiri inhibits lytic virus replication. J Virol 2003;77:5911-25. [PMID: 12719584 DOI: 10.1128/jvi.77.10.5911-5925.2003] [Cited by in Crossref: 34] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
278 Schulz TF, Moore PS. Kaposi’s sarcoma-associated herpesvirus: a new human tumor virus, but how? Trends in Microbiology 1999;7:196-200. [DOI: 10.1016/s0966-842x(99)01495-x] [Cited by in Crossref: 25] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
279 Means RE. Characterization of the Herpesvirus saimiri Orf51 protein. Virology 2004;326:67-78. [PMID: 15262496 DOI: 10.1016/j.virol.2004.05.015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
280 Ueda K, Sakakibara S, Ohsaki E, Yada K. Lack of a mechanism for faithful partition and maintenance of the KSHV genome. Virus Res 2006;122:85-94. [PMID: 16920214 DOI: 10.1016/j.virusres.2006.07.002] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
281 Uppal T, Banerjee S, Sun Z, Verma SC, Robertson ES. KSHV LANA--the master regulator of KSHV latency. Viruses 2014;6:4961-98. [PMID: 25514370 DOI: 10.3390/v6124961] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 10.1] [Reference Citation Analysis]
282 Camarda G, Spinetti G, Bernardini G, Mair C, Davis-Poynter N, Capogrossi MC, Napolitano M. The equine herpesvirus 2 E1 open reading frame encodes a functional chemokine receptor. J Virol 1999;73:9843-8. [PMID: 10559296 DOI: 10.1128/JVI.73.12.9843-9848.1999] [Cited by in Crossref: 22] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
283 Jary A, Veyri M, Gothland A, Leducq V, Calvez V, Marcelin AG. Kaposi's Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi's Sarcoma. Cancers (Basel) 2021;13:6208. [PMID: 34944828 DOI: 10.3390/cancers13246208] [Reference Citation Analysis]
284 Gondivkar SM, Parikh RV, Gadbail AR, Solanke V, Chole R, Mankar M, Balsaraf S. Involvement of viral factors with head and neck cancers. Oral Oncol 2012;48:195-9. [PMID: 22078009 DOI: 10.1016/j.oraloncology.2011.10.007] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
285 Rossetto C, Yamboliev I, Pari GS. Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 K-bZIP modulates latency-associated nuclear protein-mediated suppression of lytic origin-dependent DNA synthesis. J Virol 2009;83:8492-501. [PMID: 19553319 DOI: 10.1128/JVI.00922-09] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
286 Guliani S, Polkinghorne I, Smith GA, Young P, Mattick JS, Mahony TJ. Macropodid herpesvirus 1 encodes genes for both thymidylate synthase and ICP34.5. Virus Genes 2002;24:207-13. [PMID: 12086140 DOI: 10.1023/a:1015396430131] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
287 Kelsen J, Tarp B, Obel N. Absence of human herpes virus 8 in semen from healthy Danish donors. Hum Reprod 1999;14:2274-6. [PMID: 10469694 DOI: 10.1093/humrep/14.9.2274] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.3] [Reference Citation Analysis]
288 Lim C, Seo T, Jung J, Choe J. Identification of a virus trans-acting regulatory element on the latent DNA replication of Kaposi's sarcoma-associated herpesvirus. J Gen Virol 2004;85:843-55. [PMID: 15039527 DOI: 10.1099/vir.0.19510-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
289 Molin WT, Yaguchi A, Blenner M, Saski CA. The EccDNA Replicon: A Heritable, Extranuclear Vehicle That Enables Gene Amplification and Glyphosate Resistance in Amaranthus palmeri. Plant Cell 2020;32:2132-40. [PMID: 32327538 DOI: 10.1105/tpc.20.00099] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
290 Wen KW, Damania B. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett 2010;289:140-50. [PMID: 19651473 DOI: 10.1016/j.canlet.2009.07.004] [Cited by in Crossref: 134] [Cited by in F6Publishing: 123] [Article Influence: 10.3] [Reference Citation Analysis]
291 Chmielewicz B, Goltz M, Franz T, Bauer C, Brema S, Ellerbrok H, Beckmann S, Rziha HJ, Lahrmann KH, Romero C, Ehlers B. A novel porcine gammaherpesvirus. Virology 2003;308:317-29. [PMID: 12706081 DOI: 10.1016/s0042-6822(03)00006-0] [Cited by in Crossref: 49] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
292 Ward PL, Roizman B. Evasion and Obstruction. In: Medveczky PG, Friedman H, Bendinelli M, editors. Herpesviruses and Immunity. Boston: Kluwer Academic Publishers; 2002. pp. 1-32. [DOI: 10.1007/0-306-46808-5_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
293 Lopušná K, Benkóczka T, Lupták J, Matúšková R, Lukáčiková Ľ, Ovečková I, Režuchová I. Murine gammaherpesvirus targets type I IFN receptor but not type III IFN receptor early in infection. Cytokine 2016;83:158-70. [PMID: 27152708 DOI: 10.1016/j.cyto.2016.04.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
294 Wakenshaw L, Walters MS, Whitehouse A. The Herpesvirus saimiri replication and transcription activator acts synergistically with CCAAT enhancer binding protein alpha to activate the DNA polymerase promoter. J Virol 2005;79:13548-60. [PMID: 16227275 DOI: 10.1128/JVI.79.21.13548-13560.2005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
295 Grant MJ, Loftus MS, Stoja AP, Kedes DH, Smith MM. Superresolution microscopy reveals structural mechanisms driving the nanoarchitecture of a viral chromatin tether. Proc Natl Acad Sci U S A 2018;115:4992-7. [PMID: 29610353 DOI: 10.1073/pnas.1721638115] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
296 Casarosa P, Bakker RA, Verzijl D, Navis M, Timmerman H, Leurs R, Smit MJ. Constitutive Signaling of the Human Cytomegalovirus-encoded Chemokine Receptor US28. Journal of Biological Chemistry 2001;276:1133-7. [DOI: 10.1074/jbc.m008965200] [Cited by in Crossref: 176] [Cited by in F6Publishing: 78] [Article Influence: 8.4] [Reference Citation Analysis]
297 Huber MT, Compton T. The Human Cytomegalovirus UL74 Gene Encodes the Third Component of the Glycoprotein H-Glycoprotein L-Containing Envelope Complex. J Virol 1998;72:8191-7. [DOI: 10.1128/jvi.72.10.8191-8197.1998] [Cited by in Crossref: 127] [Cited by in F6Publishing: 92] [Article Influence: 5.3] [Reference Citation Analysis]
298 Lin S, Robinson DR, Oh J, Jung JU, Luciw PA, Kung H. Identification of the bZIP and Rta Homologues in the Genome of Rhesus Monkey Rhadinovirus. Virology 2002;298:181-8. [DOI: 10.1006/viro.2002.1490] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
299 Bubman D, Cesarman E. Pathogenesis of Kaposi's sarcoma. Hematology/Oncology Clinics of North America 2003;17:717-45. [DOI: 10.1016/s0889-8588(03)00044-3] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
300 Carbone M, Barbanti-brodano G. Viral Carcinogenesis. In: Chang AE, Hayes DF, Pass HI, Stone RM, Ganz PA, Kinsella TJ, Schiller JH, Strecher VJ, editors. Oncology. New York: Springer; 2006. pp. 214-32. [DOI: 10.1007/0-387-31056-8_17] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
301 Bowser BS, DeWire SM, Damania B. Transcriptional regulation of the K1 gene product of Kaposi's sarcoma-associated herpesvirus. J Virol 2002;76:12574-83. [PMID: 12438583 DOI: 10.1128/jvi.76.24.12574-12583.2002] [Cited by in Crossref: 40] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
302 Hall KT, Giles MS, Goodwin DJ, Calderwood MA, Carr IM, Stevenson AJ, Markham AF, Whitehouse A. Analysis of gene expression in a human cell line stably transduced with herpesvirus saimiri. J Virol 2000;74:7331-7. [PMID: 10906186 DOI: 10.1128/jvi.74.16.7331-7337.2000] [Cited by in Crossref: 26] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
303 Martínez-maza O, Widney D, van der Meijden M, Knox R, Echeverri A, Breen EC, Magpantay L, Miles SA. Immune Dysfunction and the Pathogenesis of AIDS-associated non-Hodgkin's Lymphoma. Mem Inst Oswaldo Cruz 1998;93:373-81. [DOI: 10.1590/s0074-02761998000300019] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
304 Krishnan HH, Naranatt PP, Smith MS, Zeng L, Bloomer C, Chandran B. Concurrent expression of latent and a limited number of lytic genes with immune modulation and antiapoptotic function by Kaposi’s sarcoma-associated herpesvirus early during infection of primary endothelial and fibroblast cells and subsequent decline of lytic gene expression. J Virol. 2004;78:3601-3620. [PMID: 15016882 DOI: 10.1128/jvi.78.7.3601-3620.2004] [Cited by in Crossref: 253] [Cited by in F6Publishing: 204] [Article Influence: 14.1] [Reference Citation Analysis]
305 Chen L, Lagunoff M. The KSHV viral interleukin-6 is not essential for latency or lytic replication in BJAB cells. Virology 2007;359:425-35. [PMID: 17074378 DOI: 10.1016/j.virol.2006.09.044] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.8] [Reference Citation Analysis]
306 Staskus KA, Sun R, Miller G, Racz P, Jaslowski A, Metroka C, Brett-smith H, Haase AT. Cellular Tropism and Viral Interleukin-6 Expression Distinguish Human Herpesvirus 8 Involvement in Kaposi’s Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman’s Disease. J Virol 1999;73:4181-7. [DOI: 10.1128/jvi.73.5.4181-4187.1999] [Cited by in Crossref: 173] [Cited by in F6Publishing: 83] [Article Influence: 7.5] [Reference Citation Analysis]
307 Staudt MR, Dittmer DP. Promoter switching allows simultaneous transcription of LANA and K14/vGPCR of Kaposi's sarcoma-associated herpesvirus. Virology 2006;350:192-205. [DOI: 10.1016/j.virol.2006.03.006] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.1] [Reference Citation Analysis]
308 Unal A, Pray TR, Lagunoff M, Pennington MW, Ganem D, Craik CS. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8). J Virol 1997;71:7030-8. [DOI: 10.1128/jvi.71.9.7030-7038.1997] [Cited by in Crossref: 37] [Cited by in F6Publishing: 19] [Article Influence: 1.5] [Reference Citation Analysis]
309 Liang Y, Chang J, Lynch SJ, Lukac DM, Ganem D. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway. Genes Dev 2002;16:1977-89. [PMID: 12154127 DOI: 10.1101/gad.996502] [Cited by in Crossref: 193] [Cited by in F6Publishing: 184] [Article Influence: 9.7] [Reference Citation Analysis]
310 Collins CM, Medveczky MM, Lund T, Medveczky PG. The terminal repeats and latency-associated nuclear antigen of herpesvirus saimiri are essential for episomal persistence of the viral genome. Journal of General Virology 2002;83:2269-78. [DOI: 10.1099/0022-1317-83-9-2269] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
311 Izumiya Y, Lin SF, Ellison T, Chen LY, Izumiya C, Luciw P, Kung HJ. Kaposi's sarcoma-associated herpesvirus K-bZIP is a coregulator of K-Rta: physical association and promoter-dependent transcriptional repression. J Virol 2003;77:1441-51. [PMID: 12502859 DOI: 10.1128/jvi.77.2.1441-1451.2003] [Cited by in Crossref: 83] [Cited by in F6Publishing: 69] [Article Influence: 4.4] [Reference Citation Analysis]
312 Dairaghi DJ, Greaves DR, Schall TJ. Abduction of Chemokine Elements by Herpesviruses. Seminars in Virology 1998;8:377-85. [DOI: 10.1006/smvy.1997.0146] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
313 Remick SC, Patnaik M, Ziran NM, Liegmann KR, Dong J, Dowlati A, Yao Y, Abdul-karim FW, Giam C. Human herpesvirus-8–associated disseminated angiosarcoma in an HIV-seronegative woman: report of a case and limited case-control virologic study in vascular tumors. The American Journal of Medicine 2000;108:660-4. [DOI: 10.1016/s0002-9343(00)00365-x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
314 Seo T, Park J, Lee D, Hwang SG, Choe J. Viral interferon regulatory factor 1 of Kaposi's sarcoma-associated herpesvirus binds to p53 and represses p53-dependent transcription and apoptosis. J Virol 2001;75:6193-8. [PMID: 11390621 DOI: 10.1128/JVI.75.13.6193-6198.2001] [Cited by in Crossref: 84] [Cited by in F6Publishing: 54] [Article Influence: 4.0] [Reference Citation Analysis]
315 Cannell E, Mittnacht S. Viral encoded cyclins. Seminars in Cancer Biology 1999;9:221-9. [DOI: 10.1006/scbi.1999.0090] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 0.7] [Reference Citation Analysis]
316 Taylor GS, Blackbourn DJ. Infectious agents in human cancers: lessons in immunity and immunomodulation from gammaherpesviruses EBV and KSHV. Cancer Lett 2011;305:263-78. [PMID: 21470769 DOI: 10.1016/j.canlet.2010.08.019] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 3.3] [Reference Citation Analysis]
317 Hoppe-seyler F, Butz K. Viral Mechanisms of Human Carcinogenesis. In: Coleman WB, Tsongalis GJ, editors. The Molecular Basis of Human Cancer. Totowa: Humana Press; 2002. pp. 233-47. [DOI: 10.1007/978-1-59259-125-1_12] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
318 Song WC, Sarrias MR, Lambris JD. Complement and innate immunity. Immunopharmacology 2000;49:187-98. [PMID: 10904117 DOI: 10.1016/s0162-3109(00)80303-3] [Cited by in Crossref: 80] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
319 Picard C, Mellouli F, Duprez R, Chédeville G, Neven B, Fraitag S, Delaunay J, Le Deist F, Fischer A, Blanche S, Bodemer C, Gessain A, Casanova JL, Bejaoui M. Kaposi's sarcoma in a child with Wiskott-Aldrich syndrome. Eur J Pediatr 2006;165:453-7. [PMID: 16602009 DOI: 10.1007/s00431-006-0107-2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 28] [Article Influence: 1.8] [Reference Citation Analysis]
320 Majerciak V, Yamanegi K, Zheng ZM. Gene structure and expression of Kaposi's sarcoma-associated herpesvirus ORF56, ORF57, ORF58, and ORF59. J Virol 2006;80:11968-81. [PMID: 17020939 DOI: 10.1128/JVI.01394-06] [Cited by in Crossref: 49] [Cited by in F6Publishing: 46] [Article Influence: 3.1] [Reference Citation Analysis]
321 Konrad A, Wies E, Thurau M, Marquardt G, Naschberger E, Hentschel S, Jochmann R, Schulz TF, Erfle H, Brors B, Lausen B, Neipel F, Stürzl M. A systems biology approach to identify the combination effects of human herpesvirus 8 genes on NF-kappaB activation. J Virol 2009;83:2563-74. [PMID: 19129458 DOI: 10.1128/JVI.01512-08] [Cited by in Crossref: 38] [Cited by in F6Publishing: 30] [Article Influence: 2.9] [Reference Citation Analysis]
322 Jha HC, Lu J, Verma SC, Banerjee S, Mehta D, Robertson ES. Kaposi's sarcoma-associated herpesvirus genome programming during the early stages of primary infection of peripheral blood mononuclear cells. mBio 2014;5:e02261-14. [PMID: 25516617 DOI: 10.1128/mBio.02261-14] [Cited by in Crossref: 10] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
323 Gershengorn MC, Geras-Raaka E, Varma A, Clark-Lewis I. Chemokines activate Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor in mammalian cells in culture. J Clin Invest 1998;102:1469-72. [PMID: 9788958 DOI: 10.1172/JCI4461] [Cited by in Crossref: 111] [Cited by in F6Publishing: 41] [Article Influence: 4.6] [Reference Citation Analysis]
324 Frame FM, Dalziel RG. Transcriptional control by the R-transactivator protein of alcelaphine herpesvirus-1. Vet Res Commun 2008;32:215-23. [PMID: 18027098 DOI: 10.1007/s11259-007-9027-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
325 Toptan T, Fonseca L, Kwun HJ, Chang Y, Moore PS. Complex alternative cytoplasmic protein isoforms of the Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 generated through noncanonical translation initiation. J Virol 2013;87:2744-55. [PMID: 23255808 DOI: 10.1128/JVI.03061-12] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
326 Zhu Y, Huang Y, Jung JU, Lu C, Gao SJ. Viral miRNA targeting of bicistronic and polycistronic transcripts. Curr Opin Virol 2014;7:66-72. [PMID: 24821460 DOI: 10.1016/j.coviro.2014.04.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
327 Othman Z, Sulaiman MK, Willcocks MM, Ulryck N, Blackbourn DJ, Sargueil B, Roberts LO, Locker N. Functional analysis of Kaposi's sarcoma-associated herpesvirus vFLIP expression reveals a new mode of IRES-mediated translation. RNA 2014;20:1803-14. [PMID: 25246653 DOI: 10.1261/rna.045328.114] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
328 Stedman W, Deng Z, Lu F, Lieberman PM. ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol 2004;78:12566-75. [PMID: 15507644 DOI: 10.1128/JVI.78.22.12566-12575.2004] [Cited by in Crossref: 143] [Cited by in F6Publishing: 108] [Article Influence: 7.9] [Reference Citation Analysis]
329 Fishman JA. Overview: cytomegalovirus and the herpesviruses in transplantation. Am J Transplant. 2013;13 Suppl 3:1-8; quiz 8. [PMID: 23347210 DOI: 10.1111/ajt.12002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 8.2] [Reference Citation Analysis]
330 Chen L, Park MS. Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11. Virus Res 2009;142:160-8. [PMID: 19428749 DOI: 10.1016/j.virusres.2009.02.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
331 McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochim Biophys Acta 2008;1782:127-50. [PMID: 18201576 DOI: 10.1016/j.bbadis.2007.12.005] [Cited by in Crossref: 203] [Cited by in F6Publishing: 163] [Article Influence: 13.5] [Reference Citation Analysis]
332 Guito J, Lukac DM. KSHV Rta Promoter Specification and Viral Reactivation. Front Microbiol 2012;3:30. [PMID: 22347875 DOI: 10.3389/fmicb.2012.00030] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 5.5] [Reference Citation Analysis]
333 Haque M, Wang V, Davis DA, Zheng ZM, Yarchoan R. Genetic organization and hypoxic activation of the Kaposi's sarcoma-associated herpesvirus ORF34-37 gene cluster. J Virol 2006;80:7037-51. [PMID: 16809309 DOI: 10.1128/JVI.00553-06] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 3.1] [Reference Citation Analysis]
334 Kolár M, Lässig M, Berg J. From protein interactions to functional annotation: graph alignment in Herpes. BMC Syst Biol 2008;2:90. [PMID: 18957106 DOI: 10.1186/1752-0509-2-90] [Cited by in Crossref: 15] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
335 Pietrek M, Brinkmann MM, Glowacka I, Enlund A, Hävemeier A, Dittrich-Breiholz O, Kracht M, Lewitzky M, Saksela K, Feller SM, Schulz TF. Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation. J Virol 2010;84:8231-40. [PMID: 20534855 DOI: 10.1128/JVI.01696-09] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 2.3] [Reference Citation Analysis]
336 Krishnan HH, Sharma-Walia N, Zeng L, Gao SJ, Chandran B. Envelope glycoprotein gB of Kaposi's sarcoma-associated herpesvirus is essential for egress from infected cells. J Virol 2005;79:10952-67. [PMID: 16103147 DOI: 10.1128/JVI.79.17.10952-10967.2005] [Cited by in Crossref: 48] [Cited by in F6Publishing: 38] [Article Influence: 2.8] [Reference Citation Analysis]
337 Ensser A, Thurau M, Wittmann S, Fickenscher H. The genome of herpesvirus saimiri C488 which is capable of transforming human T cells. Virology 2003;314:471-87. [PMID: 14554077 DOI: 10.1016/s0042-6822(03)00449-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
338 Ozgur S, Damania B, Griffith J. The Kaposi's sarcoma-associated herpesvirus ORF6 DNA binding protein forms long DNA-free helical protein filaments. J Struct Biol 2011;174:37-43. [PMID: 21047556 DOI: 10.1016/j.jsb.2010.10.015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
339 Cinquina CC, Grogan E, Sun R, Lin SF, Beardsley GP, Miller G. Dihydrofolate reductase from Kaposi's sarcoma-associated herpesvirus. Virology 2000;268:201-17. [PMID: 10683342 DOI: 10.1006/viro.1999.0165] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.5] [Reference Citation Analysis]
340 Wang SE, Wu FY, Yu Y, Hayward GS. CCAAT/enhancer-binding protein-alpha is induced during the early stages of Kaposi's sarcoma-associated herpesvirus (KSHV) lytic cycle reactivation and together with the KSHV replication and transcription activator (RTA) cooperatively stimulates the viral RTA, MTA, and PAN promoters. J Virol 2003;77:9590-612. [PMID: 12915572 DOI: 10.1128/jvi.77.17.9590-9612.2003] [Cited by in Crossref: 98] [Cited by in F6Publishing: 84] [Article Influence: 5.2] [Reference Citation Analysis]
341 Yang Z, Wen HJ, Minhas V, Wood C. The zinc finger DNA-binding domain of K-RBP plays an important role in regulating Kaposi's sarcoma-associated herpesvirus RTA-mediated gene expression. Virology 2009;391:221-31. [PMID: 19592062 DOI: 10.1016/j.virol.2009.06.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
342 Quinlivan EB, Ye D, Wehbie RS, Stewart PW, Flepp M, Vernazza PL. Kaposiʼs sarcoma patients in the Swiss HIV Cohort Study with and without detectable human herpesvirus 8 in peripheral blood mononuclear cells: . AIDS 1997;11:1893-5. [DOI: 10.1097/00002030-199715000-00021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
343 Zheng ZM. Split genes and their expression in Kaposi's sarcoma-associated herpesvirus. Rev Med Virol 2003;13:173-84. [PMID: 12740832 DOI: 10.1002/rmv.387] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 1.8] [Reference Citation Analysis]
344 Viejo-Borbolla A, Kati E, Sheldon JA, Nathan K, Mattsson K, Szekely L, Schulz TF. A Domain in the C-terminal region of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated Herpesvirus affects transcriptional activation and binding to nuclear heterochromatin. J Virol 2003;77:7093-100. [PMID: 12768028 DOI: 10.1128/jvi.77.12.7093-7100.2003] [Cited by in Crossref: 38] [Cited by in F6Publishing: 29] [Article Influence: 2.0] [Reference Citation Analysis]
345 Seaman WT, Ye D, Wang RX, Hale EE, Weisse M, Quinlivan EB. Gene expression from the ORF50/K8 region of Kaposi's sarcoma-associated herpesvirus. Virology 1999;263:436-49. [PMID: 10544116 DOI: 10.1006/viro.1999.9963] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 2.0] [Reference Citation Analysis]
346 Stevenson AJ, Clarke D, Meredith DM, Kinsey SE, Whitehouse A, Bonifer C. Herpesvirus saimiri-based gene delivery vectors maintain heterologous expression throughout mouse embryonic stem cell differentiation in vitro. Gene Ther 2000;7:464-71. [DOI: 10.1038/sj.gt.3301130] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
347 Simas JP, Efstathiou S. Murine gammaherpesvirus 68: a model for the study of gammaherpesvirus pathogenesis. Trends Microbiol 1998;6:276-82. [PMID: 9717216 DOI: 10.1016/s0966-842x(98)01306-7] [Cited by in Crossref: 173] [Cited by in F6Publishing: 106] [Article Influence: 7.2] [Reference Citation Analysis]
348 Kumar Singh R, Pei Y, Bose D, Lamplugh ZL, Sun K, Yuan Y, Lieberman P, You J, Robertson ES. KSHV-encoded vCyclin can modulate HIF1α levels to promote DNA replication in hypoxia. Elife 2021;10:e57436. [PMID: 34279223 DOI: 10.7554/eLife.57436] [Reference Citation Analysis]
349 Sakakibara S, Tosato G. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies. J Interferon Cytokine Res 2011;31:791-801. [PMID: 21767154 DOI: 10.1089/jir.2011.0043] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
350 Baillargeon J, Deng J, Hettler E, Harrison C, Grady JJ, Korte LG, Alexander J, Montalvo E, Jenson HB, Gao S. Seroprevalence of Kaposi's Sarcoma-Associated Herpesvirus Infection among Blood Donors from Texas. Annals of Epidemiology 2001;11:512-8. [DOI: 10.1016/s1047-2797(01)00242-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
351 Lubyova B, Pitha PM. Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors. J Virol 2000;74:8194-201. [PMID: 10933732 DOI: 10.1128/jvi.74.17.8194-8201.2000] [Cited by in Crossref: 127] [Cited by in F6Publishing: 64] [Article Influence: 5.8] [Reference Citation Analysis]
352 Günther T, Grundhoff A. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog 2010;6:e1000935. [PMID: 20532208 DOI: 10.1371/journal.ppat.1000935] [Cited by in Crossref: 171] [Cited by in F6Publishing: 163] [Article Influence: 14.3] [Reference Citation Analysis]
353 Speck SH, Ganem D. Viral latency and its regulation: lessons from the gamma-herpesviruses. Cell Host Microbe 2010;8:100-15. [PMID: 20638646 DOI: 10.1016/j.chom.2010.06.014] [Cited by in Crossref: 174] [Cited by in F6Publishing: 159] [Article Influence: 14.5] [Reference Citation Analysis]
354 Zhu FX, Chong JM, Wu L, Yuan Y. Virion proteins of Kaposi's sarcoma-associated herpesvirus. J Virol 2005;79:800-11. [PMID: 15613308 DOI: 10.1128/JVI.79.2.800-811.2005] [Cited by in Crossref: 187] [Cited by in F6Publishing: 139] [Article Influence: 11.0] [Reference Citation Analysis]
355 Gao J, Coulson JM, Whitehouse A, Blake N. Reduction in RNA levels rather than retardation of translation is responsible for the inhibition of major histocompatibility complex class I antigen presentation by the glutamic acid-rich repeat of herpesvirus saimiri open reading frame 73. J Virol 2009;83:273-82. [PMID: 18945762 DOI: 10.1128/JVI.01532-08] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
356 Fejér G, Medveczky MM, Horvath E, Lane B, Chang Y, Medveczky PG. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus interacts preferentially with the terminal repeats of the genome in vivo and this complex is sufficient for episomal DNA replication. J Gen Virol 2003;84:1451-62. [PMID: 12771414 DOI: 10.1099/vir.0.18940-0] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 2.1] [Reference Citation Analysis]
357 Zhang W, Navenot J, Haribabu B, Tamamura H, Hiramatu K, Omagari A, Pei G, Manfredi JP, Fujii N, Broach JR, Peiper SC. A Point Mutation That Confers Constitutive Activity to CXCR4 Reveals That T140 Is an Inverse Agonist and That AMD3100 and ALX40-4C Are Weak Partial Agonists. Journal of Biological Chemistry 2002;277:24515-21. [DOI: 10.1074/jbc.m200889200] [Cited by in Crossref: 191] [Cited by in F6Publishing: 73] [Article Influence: 9.6] [Reference Citation Analysis]
358 Jenson HB. Human herpesvirus 8 infection: . Current Opinion in Pediatrics 2003;15:85-91. [DOI: 10.1097/00008480-200302000-00014] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
359 Ohsaki E, Ueda K, Sakakibara S, Do E, Yada K, Yamanishi K. Poly(ADP-ribose) polymerase 1 binds to Kaposi's sarcoma-associated herpesvirus (KSHV) terminal repeat sequence and modulates KSHV replication in latency. J Virol 2004;78:9936-46. [PMID: 15331727 DOI: 10.1128/JVI.78.18.9936-9946.2004] [Cited by in Crossref: 53] [Cited by in F6Publishing: 40] [Article Influence: 2.9] [Reference Citation Analysis]
360 Blauvelt A. Skin diseases associated with human herpesvirus 6, 7, and 8 infection. J Investig Dermatol Symp Proc 2001;6:197-202. [PMID: 11924827 DOI: 10.1046/j.0022-202x.2001.00040.x] [Cited by in Crossref: 27] [Cited by in F6Publishing: 18] [Article Influence: 1.4] [Reference Citation Analysis]
361 Juillard F, Tan M, Li S, Kaye KM. Kaposi's Sarcoma Herpesvirus Genome Persistence. Front Microbiol 2016;7:1149. [PMID: 27570517 DOI: 10.3389/fmicb.2016.01149] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
362 Kakoola DN, Sheldon J, Byabazaire N, Bowden RJ, Katongole-mbidde E, Schulz TF, Davison AJ. Recombination in human herpesvirus-8 strains from Uganda and evolution of the K15 gene. Journal of General Virology 2001;82:2393-404. [DOI: 10.1099/0022-1317-82-10-2393] [Cited by in Crossref: 47] [Cited by in F6Publishing: 48] [Article Influence: 2.2] [Reference Citation Analysis]
363 Hiatt KM, Nelson AM, Lichy JH, Fanburg-smith JC. Classic Kaposi Sarcoma in the United States over the last two decades: A clinicopathologic and molecular study of 438 non-HIV-related Kaposi Sarcoma patients with comparison to HIV-related Kaposi Sarcoma. Mod Pathol 2008;21:572-82. [DOI: 10.1038/modpathol.2008.15] [Cited by in Crossref: 50] [Cited by in F6Publishing: 33] [Article Influence: 3.6] [Reference Citation Analysis]
364 Paulose-Murphy M, Ha NK, Xiang C, Chen Y, Gillim L, Yarchoan R, Meltzer P, Bittner M, Trent J, Zeichner S. Transcription program of human herpesvirus 8 (kaposi's sarcoma-associated herpesvirus). J Virol 2001;75:4843-53. [PMID: 11312356 DOI: 10.1128/JVI.75.10.4843-4853.2001] [Cited by in Crossref: 173] [Cited by in F6Publishing: 109] [Article Influence: 8.2] [Reference Citation Analysis]
365 Zhang H, Cowan-jacob SW, Simonen M, Greenhalf W, Heim J, Meyhack B. Structural Basis of BFL-1 for Its Interaction with BAX and Its Anti-apoptotic Action in Mammalian and Yeast Cells. Journal of Biological Chemistry 2000;275:11092-9. [DOI: 10.1074/jbc.275.15.11092] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 2.3] [Reference Citation Analysis]
366 Zeng Y, Zhang X, Huang Z, Cheng L, Yao S, Qin D, Chen X, Tang Q, Lv Z, Zhang L. Intracellular Tat of human immunodeficiency virus type 1 activates lytic cycle replication of Kaposi’s sarcoma-associated herpesvirus: role of JAK/STAT signaling. J Virol. 2007;81:2401-2417. [PMID: 17151125 DOI: 10.1128/jvi.02024-06] [Cited by in Crossref: 87] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
367 Sander G, Konrad A, Thurau M, Wies E, Leubert R, Kremmer E, Dinkel H, Schulz T, Neipel F, Stürzl M. Intracellular localization map of human herpesvirus 8 proteins. J Virol 2008;82:1908-22. [PMID: 18077714 DOI: 10.1128/JVI.01716-07] [Cited by in Crossref: 46] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
368 Martínez FP, Tang Q. Leucine zipper domain is required for Kaposi sarcoma-associated herpesvirus (KSHV) K-bZIP protein to interact with histone deacetylase and is important for KSHV replication. J Biol Chem 2012;287:15622-34. [PMID: 22416134 DOI: 10.1074/jbc.M111.315861] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 1.6] [Reference Citation Analysis]
369 Hall KT, Giles MS, Calderwood MA, Goodwin DJ, Matthews DA, Whitehouse A. The Herpesvirus Saimiri open reading frame 73 gene product interacts with the cellular protein p32. J Virol 2002;76:11612-22. [PMID: 12388722 DOI: 10.1128/jvi.76.22.11612-11622.2002] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
370 Chang PJ, Shedd D, Gradoville L, Cho MS, Chen LW, Chang J, Miller G. Open reading frame 50 protein of Kaposi's sarcoma-associated herpesvirus directly activates the viral PAN and K12 genes by binding to related response elements. J Virol 2002;76:3168-78. [PMID: 11884541 DOI: 10.1128/jvi.76.7.3168-3178.2002] [Cited by in Crossref: 103] [Cited by in F6Publishing: 81] [Article Influence: 5.2] [Reference Citation Analysis]
371 Hayward GS. KSHV strains: the origins and global spread of the virus. Semin Cancer Biol 1999;9:187-99. [PMID: 10343070 DOI: 10.1006/scbi.1998.0116] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 3.5] [Reference Citation Analysis]
372 Toth Z, Papp B, Brulois K, Choi YJ, Gao SJ, Jung JU. LANA-Mediated Recruitment of Host Polycomb Repressive Complexes onto the KSHV Genome during De Novo Infection. PLoS Pathog 2016;12:e1005878. [PMID: 27606464 DOI: 10.1371/journal.ppat.1005878] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 6.7] [Reference Citation Analysis]
373 Yu F, Harada JN, Brown HJ, Deng H, Song MJ, Wu TT, Kato-Stankiewicz J, Nelson CG, Vieira J, Tamanoi F, Chanda SK, Sun R. Systematic identification of cellular signals reactivating Kaposi sarcoma-associated herpesvirus. PLoS Pathog 2007;3:e44. [PMID: 17397260 DOI: 10.1371/journal.ppat.0030044] [Cited by in Crossref: 79] [Cited by in F6Publishing: 73] [Article Influence: 5.3] [Reference Citation Analysis]
374 Porter S, Di Alberti L, Kumar N. Human herpes virus 8 (Kaposi’s sarcoma herpesvirus). Oral Oncology 1998;34:5-14. [DOI: 10.1016/s1368-8375(97)00038-9] [Cited by in Crossref: 11] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
375 de Munnik SM, Smit MJ, Leurs R, Vischer HF. Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors. Front Pharmacol 2015;6:40. [PMID: 25805993 DOI: 10.3389/fphar.2015.00040] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.0] [Reference Citation Analysis]
376 Neipel F, Fleckenstein B. The role of HHV-8 in Kaposi's sarcoma. Seminars in Cancer Biology 1999;9:151-64. [DOI: 10.1006/scbi.1999.0129] [Cited by in Crossref: 58] [Cited by in F6Publishing: 43] [Article Influence: 2.5] [Reference Citation Analysis]
377 Ryan JT, Rose TM. Development of whole-virus multiplex luminex-based serological assays for diagnosis of infections with kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 homologs in macaques. Clin Vaccine Immunol 2013;20:409-19. [PMID: 23345584 DOI: 10.1128/CVI.00673-12] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
378 Hu S, Vincenz C, Buller M, Dixit VM. A Novel Family of Viral Death Effector Domain-containing Molecules That Inhibit Both CD-95- and Tumor Necrosis Factor Receptor-1-induced Apoptosis. Journal of Biological Chemistry 1997;272:9621-4. [DOI: 10.1074/jbc.272.15.9621] [Cited by in Crossref: 228] [Cited by in F6Publishing: 212] [Article Influence: 9.1] [Reference Citation Analysis]
379 Dittmer DP, Damania B. KSHV-associated disease in the AIDS patient. Cancer Treat Res 2007;133:129-39. [PMID: 17672039 DOI: 10.1007/978-0-387-46816-7_4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
380 Osborne J, Moore PS, Chang Y. KSHV-encoded viral IL-6 activates multiple human IL-6 signaling pathways. Human Immunology 1999;60:921-7. [DOI: 10.1016/s0198-8859(99)00083-x] [Cited by in Crossref: 95] [Cited by in F6Publishing: 45] [Article Influence: 4.1] [Reference Citation Analysis]
381 Geras-Raaka E, Varma A, Ho H, Clark-Lewis I, Gershengorn MC. Human interferon-gamma-inducible protein 10 (IP-10) inhibits constitutive signaling of Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor. J Exp Med 1998;188:405-8. [PMID: 9670053 DOI: 10.1084/jem.188.2.405] [Cited by in Crossref: 107] [Cited by in F6Publishing: 101] [Article Influence: 4.5] [Reference Citation Analysis]
382 Chang PJ, Miller G. Autoregulation of DNA binding and protein stability of Kaposi's sarcoma-associated herpesvirus ORF50 protein. J Virol 2004;78:10657-73. [PMID: 15367633 DOI: 10.1128/JVI.78.19.10657-10673.2004] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 2.0] [Reference Citation Analysis]
383 Dahlroth SL, Gurmu D, Schmitzberger F, Engman H, Haas J, Erlandsen H, Nordlund P. Crystal structure of the shutoff and exonuclease protein from the oncogenic Kaposi's sarcoma-associated herpesvirus. FEBS J 2009;276:6636-45. [PMID: 19843164 DOI: 10.1111/j.1742-4658.2009.07374.x] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
384 Zhang W, Gao SJ. Exploitation of Cellular Cytoskeletons and Signaling Pathways for Cell Entry by Kaposi's Sarcoma-Associated Herpesvirus and the Closely Related Rhesus Rhadinovirus. Pathogens 2012;1:102-27. [PMID: 23420076 DOI: 10.3390/pathogens1020102] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
385 Portes-sentis S, Manet E, Gourru G, Sergeant A, Gruffat H. Identification of a short amino acid sequence essential for efficient nuclear targeting of the Kaposi’s sarcoma-associated herpesvirus/human herpesvirus-8 K8 protein. Journal of General Virology 2001;82:507-12. [DOI: 10.1099/0022-1317-82-3-507] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.7] [Reference Citation Analysis]
386 Fujimuro M, Inoue H, Teishikata Y, Ishida Y, Yokosawa H. Apoptotic effect of ganciclovir on primary effusion lymphoma cells infected with Kaposi's sarcoma-associated herpesvirus. Nucleosides Nucleotides Nucleic Acids 2006;25:635-45. [PMID: 16838851 DOI: 10.1080/15257770600686311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
387 Xiao J, Wu H, Peng L, Chi M, Feng H. The Cellular Isopeptidase T Deubiquitinating Enzyme Regulates Kaposi’s Sarcoma-Associated Herpesvirus K7 Degradation. Pharm Res 2015;32:749-61. [DOI: 10.1007/s11095-013-1064-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
388 Migliazza A, Bosch F, Komatsu H, Cayanis E, Martinotti S, Toniato E, Guccione E, Qu X, Chien M, Murty VV, Gaidano G, Inghirami G, Zhang P, Fischer S, Kalachikov SM, Russo J, Edelman I, Efstratiadis A, Dalla-Favera R. Nucleotide sequence, transcription map, and mutation analysis of the 13q14 chromosomal region deleted in B-cell chronic lymphocytic leukemia. Blood 2001;97:2098-104. [PMID: 11264177 DOI: 10.1182/blood.v97.7.2098] [Cited by in Crossref: 139] [Cited by in F6Publishing: 49] [Article Influence: 6.6] [Reference Citation Analysis]
389 Tang S, Zheng ZM. Kaposi's sarcoma-associated herpesvirus K8 exon 3 contains three 5'-splice sites and harbors a K8.1 transcription start site. J Biol Chem 2002;277:14547-56. [PMID: 11832484 DOI: 10.1074/jbc.M111308200] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 1.8] [Reference Citation Analysis]
390 Miyagi J, Masuda M, Takasu N, Nagasaki A, Shinjyo T, Uezato H, Kakazu N, Tanaka Y. Establishment of a Primary Effusion Lymphoma Cell Line (RM-P1) and In Vivo Growth System Using SCID Mice. Int J Hematol 2002;76:165-72. [DOI: 10.1007/bf02982580] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
391 Lee SH, Jung JU, Means RE. 'Complementing' viral infection: mechanisms for evading innate immunity. Trends Microbiol 2003;11:449-52. [PMID: 14557025 DOI: 10.1016/j.tim.2003.08.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]
392 Cai X, Lu S, Zhang Z, Gonzalez CM, Damania B, Cullen BR. Kaposi's sarcoma-associated herpesvirus expresses an array of viral microRNAs in latently infected cells. Proc Natl Acad Sci U S A 2005;102:5570-5. [PMID: 15800047 DOI: 10.1073/pnas.0408192102] [Cited by in Crossref: 425] [Cited by in F6Publishing: 419] [Article Influence: 25.0] [Reference Citation Analysis]
393 Stahl JA, Chavan SS, Sifford JM, MacLeod V, Voth DE, Edmondson RD, Forrest JC. Phosphoproteomic analyses reveal signaling pathways that facilitate lytic gammaherpesvirus replication. PLoS Pathog 2013;9:e1003583. [PMID: 24068923 DOI: 10.1371/journal.ppat.1003583] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
394 Steer B, Adler B, Jonjic S, Stewart JP, Adler H. A gammaherpesvirus complement regulatory protein promotes initiation of infection by activation of protein kinase Akt/PKB. PLoS One 2010;5:e11672. [PMID: 20657771 DOI: 10.1371/journal.pone.0011672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
395 Di Bartolo DL, Cannon M, Liu YF, Renne R, Chadburn A, Boshoff C, Cesarman E. KSHV LANA inhibits TGF-beta signaling through epigenetic silencing of the TGF-beta type II receptor. Blood. 2008;111:4731-4740. [PMID: 18199825 DOI: 10.1182/blood-2007-09-110544] [Cited by in Crossref: 83] [Cited by in F6Publishing: 82] [Article Influence: 5.9] [Reference Citation Analysis]
396 Kanno T, Uehara T, Osawa M, Fukumoto H, Mine S, Ueda K, Hasegawa H, Katano H. Fumagillin, a potent angiogenesis inhibitor, induces Kaposi sarcoma-associated herpesvirus replication in primary effusion lymphoma cells. Biochem Biophys Res Commun 2015;463:1267-72. [PMID: 26093300 DOI: 10.1016/j.bbrc.2015.06.100] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]
397 Lorenzo ME, Ploegh HL, Tirabassi RS. Viral immune evasion strategies and the underlying cell biology. Seminars in Immunology 2001;13:1-9. [DOI: 10.1006/smim.2000.0290] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
398 Cavallari I, Scattolin G, Silic-Benussi M, Raimondi V, D'Agostino DM, Ciminale V. Mitochondrial Proteins Coded by Human Tumor Viruses. Front Microbiol 2018;9:81. [PMID: 29467726 DOI: 10.3389/fmicb.2018.00081] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
399 McClure LV, Kincaid RP, Burke JM, Grundhoff A, Sullivan CS. Comprehensive mapping and analysis of Kaposi's sarcoma-associated herpesvirus 3' UTRs identify differential posttranscriptional control of gene expression in lytic versus latent infection. J Virol 2013;87:12838-49. [PMID: 24067953 DOI: 10.1128/JVI.02374-13] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.8] [Reference Citation Analysis]
400 Groves AK, Cotter MA, Subramanian C, Robertson ES. The latency-associated nuclear antigen encoded by Kaposi's sarcoma-associated herpesvirus activates two major essential Epstein-Barr virus latent promoters. J Virol 2001;75:9446-57. [PMID: 11533207 DOI: 10.1128/JVI.75.19.9446-9457.2001] [Cited by in Crossref: 42] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
401 Bower M, Stebbing J. AIDS-associated malignancies. Cancer Chemother Biol Response Modif 2005;22:687-706. [PMID: 16110634 DOI: 10.1016/s0921-4410(04)22030-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
402 Li Y, Liu D, Cao R, Kumar S, Dong C, An J, Wilson SR, Gao YG, Huang Z. Crystal structure of chemically synthesized vMIP-II. Proteins 2007;67:243-6. [PMID: 17243149 DOI: 10.1002/prot.21172] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
403 Rajcáni J, Kúdelová M. Gamma herpesviruses: pathogenesis of infection and cell signaling. Folia Microbiol (Praha) 2003;48:291-318. [PMID: 12879740 DOI: 10.1007/BF02931360] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
404 Goldstein JN, Weller SK. The exonuclease activity of HSV-1 UL12 is required for in vivo function. Virology 1998;244:442-57. [PMID: 9601512 DOI: 10.1006/viro.1998.9129] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 1.8] [Reference Citation Analysis]
405 Ensser A, Pflanz R, Fleckenstein B. Primary structure of the alcelaphine herpesvirus 1 genome. J Virol 1997;71:6517-25. [DOI: 10.1128/jvi.71.9.6517-6525.1997] [Cited by in Crossref: 118] [Cited by in F6Publishing: 49] [Article Influence: 4.7] [Reference Citation Analysis]
406 Ishido S, Wang C, Lee BS, Cohen GB, Jung JU. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol 2000;74:5300-9. [PMID: 10799607 DOI: 10.1128/jvi.74.11.5300-5309.2000] [Cited by in Crossref: 345] [Cited by in F6Publishing: 188] [Article Influence: 15.7] [Reference Citation Analysis]
407 Gómez-Román JJ, Sánchez-Velasco P, Ocejo-Vinyals G, Hernández-Nieto E, Leyva-Cobián F, Val-Bernal JF. Human herpesvirus-8 genes are expressed in pulmonary inflammatory myofibroblastic tumor (inflammatory pseudotumor). Am J Surg Pathol 2001;25:624-9. [PMID: 11342774 DOI: 10.1097/00000478-200105000-00009] [Cited by in Crossref: 104] [Cited by in F6Publishing: 88] [Article Influence: 5.0] [Reference Citation Analysis]
408 Murugaiah V, Varghese PM, Beirag N, De Cordova S, Sim RB, Kishore U. Complement Proteins as Soluble Pattern Recognition Receptors for Pathogenic Viruses. Viruses 2021;13:824. [PMID: 34063241 DOI: 10.3390/v13050824] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
409 Nallar SC, Kalvakolanu DV. GRIM-19: A master regulator of cytokine induced tumor suppression, metastasis and energy metabolism. Cytokine Growth Factor Rev 2017;33:1-18. [PMID: 27659873 DOI: 10.1016/j.cytogfr.2016.09.001] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
410 Rajčáni J, Asványi-Molnár N, Szathmary S. Herpesvirus-associated lymphomas: Investigations in humans and animal models. Acta Microbiol Immunol Hung 2010;57:349-76. [PMID: 21183422 DOI: 10.1556/AMicr.57.2010.4.3] [Reference Citation Analysis]
411 Orzechowska BU, Powers MF, Sprague J, Li H, Yen B, Searles RP, Axthelm MK, Wong SW. Rhesus macaque rhadinovirus-associated non-Hodgkin lymphoma: animal model for KSHV-associated malignancies. Blood 2008;112:4227-34. [PMID: 18757778 DOI: 10.1182/blood-2008-04-151498] [Cited by in Crossref: 51] [Cited by in F6Publishing: 48] [Article Influence: 3.6] [Reference Citation Analysis]
412 Wang Y, Lee S, Cheng LC, Tai M, Su I. Detection of serum antibodies to three different recombinant antigens of human herpesvirus 8 by immunoblotting: seroprevalence studies in Taiwan. Clinica Chimica Acta 2002;320:37-42. [DOI: 10.1016/s0009-8981(02)00023-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
413 Lim C, Gwack Y, Hwang S, Kim S, Choe J. The transcriptional activity of cAMP response element-binding protein-binding protein is modulated by the latency associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Biol Chem 2001;276:31016-22. [PMID: 11425857 DOI: 10.1074/jbc.M102431200] [Cited by in Crossref: 91] [Cited by in F6Publishing: 74] [Article Influence: 4.3] [Reference Citation Analysis]
414 Carbone A, Gloghini A, Bontempo D, Monini P, Tirelli U, Volpe R, Browning PJ, Gaidano G. Proliferation in HHV-8-positive primary effusion lymphomas is associated with expression of HHV-8 cyclin but independent of p27(kip1). Am J Pathol 2000;156:1209-15. [PMID: 10751346 DOI: 10.1016/S0002-9440(10)64991-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
415 Zhou FC, Zhang YJ, Deng JH, Wang XP, Pan HY, Hettler E, Gao SJ. Efficient infection by a recombinant Kaposi's sarcoma-associated herpesvirus cloned in a bacterial artificial chromosome: application for genetic analysis. J Virol 2002;76:6185-96. [PMID: 12021352 DOI: 10.1128/jvi.76.12.6185-6196.2002] [Cited by in Crossref: 200] [Cited by in F6Publishing: 154] [Article Influence: 10.0] [Reference Citation Analysis]
416 Cannon JS, Hamzeh F, Moore S, Nicholas J, Ambinder RF. Human herpesvirus 8-encoded thymidine kinase and phosphotransferase homologues confer sensitivity to ganciclovir. J Virol 1999;73:4786-93. [PMID: 10233939 DOI: 10.1128/JVI.73.6.4786-4793.1999] [Cited by in Crossref: 72] [Cited by in F6Publishing: 39] [Article Influence: 3.1] [Reference Citation Analysis]
417 Lin YT, Kincaid RP, Arasappan D, Dowd SE, Hunicke-Smith SP, Sullivan CS. Small RNA profiling reveals antisense transcription throughout the KSHV genome and novel small RNAs. RNA 2010;16:1540-58. [PMID: 20566670 DOI: 10.1261/rna.1967910] [Cited by in Crossref: 65] [Cited by in F6Publishing: 60] [Article Influence: 5.4] [Reference Citation Analysis]
418 Bruce AG, Bakke AM, Gravett CA, DeMaster LK, Bielefeldt-Ohmann H, Burnside KL, Rose TM. The ORF59 DNA polymerase processivity factor homologs of Old World primate RV2 rhadinoviruses are highly conserved nuclear antigens expressed in differentiated epithelium in infected macaques. Virol J 2009;6:205. [PMID: 19922662 DOI: 10.1186/1743-422X-6-205] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.1] [Reference Citation Analysis]
419 Gwack Y, Nakamura H, Lee SH, Souvlis J, Yustein JT, Gygi S, Kung HJ, Jung JU. Poly(ADP-ribose) polymerase 1 and Ste20-like kinase hKFC act as transcriptional repressors for gamma-2 herpesvirus lytic replication. Mol Cell Biol 2003;23:8282-94. [PMID: 14585985 DOI: 10.1128/MCB.23.22.8282-8294.2003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 48] [Article Influence: 2.9] [Reference Citation Analysis]
420 Rovnak J, Quackenbush SL, Reyes RA, Baines JD, Parrish CR, Casey JW. Detection of a novel bovine lymphotropic herpesvirus. J Virol 1998;72:4237-42. [PMID: 9557713 DOI: 10.1128/JVI.72.5.4237-4242.1998] [Cited by in Crossref: 51] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
421 Reddy SM, Williams M, Cohen JI. Expression of a uracil DNA glycosylase (UNG) inhibitor in mammalian cells: varicella-zoster virus can replicate in vitro in the absence of detectable UNG activity. Virology 1998;251:393-401. [PMID: 9837803 DOI: 10.1006/viro.1998.9428] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
422 Poole LJ, Zong JC, Ciufo DM, Alcendor DJ, Cannon JS, Ambinder R, Orenstein JM, Reitz MS, Hayward GS. Comparison of genetic variability at multiple loci across the genomes of the major subtypes of Kaposi's sarcoma-associated herpesvirus reveals evidence for recombination and for two distinct types of open reading frame K15 alleles at the right-hand end. J Virol 1999;73:6646-60. [PMID: 10400762 DOI: 10.1128/JVI.73.8.6646-6660.1999] [Cited by in Crossref: 155] [Cited by in F6Publishing: 73] [Article Influence: 6.7] [Reference Citation Analysis]
423 Desrosiers RC, Sasseville VG, Czajak SC, Zhang X, Mansfield KG, Kaur A, Johnson RP, Lackner AA, Jung JU. A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol 1997;71:9764-9. [PMID: 9371642 DOI: 10.1128/JVI.71.12.9764-9769.1997] [Cited by in Crossref: 197] [Cited by in F6Publishing: 114] [Article Influence: 7.9] [Reference Citation Analysis]
424 Ishido S, Goto E, Matsuki Y, Ohmura-hoshino M. E3 ubiquitin ligases for MHC molecules. Current Opinion in Immunology 2009;21:78-83. [DOI: 10.1016/j.coi.2009.01.002] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
425 Pertel PE. Human herpesvirus 8 glycoprotein B (gB), gH, and gL can mediate cell fusion. J Virol 2002;76:4390-400. [PMID: 11932406 DOI: 10.1128/jvi.76.9.4390-4400.2002] [Cited by in Crossref: 88] [Cited by in F6Publishing: 66] [Article Influence: 4.4] [Reference Citation Analysis]
426 Renne R, Barry C, Dittmer D, Compitello N, Brown PO, Ganem D. Modulation of cellular and viral gene expression by the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus. J Virol 2001;75:458-68. [PMID: 11119614 DOI: 10.1128/JVI.75.1.458-468.2001] [Cited by in Crossref: 170] [Cited by in F6Publishing: 105] [Article Influence: 8.1] [Reference Citation Analysis]
427 Wang L, Brinkmann MM, Pietrek M, Ottinger M, Dittrich-Breiholz O, Kracht M, Schulz TF. Functional characterization of the M-type K15-encoded membrane protein of Kaposi's sarcoma-associated herpesvirus. J Gen Virol 2007;88:1698-707. [PMID: 17485529 DOI: 10.1099/vir.0.82807-0] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
428 Picchio GR, Sabbe RE, Gulizia RJ, McGrath M, Herndier BG, Mosier DE. The KSHV/HHV8-infected BCBL-1 lymphoma line causes tumors in SCID mice but fails to transmit virus to a human peripheral blood mononuclear cell graft. Virology 1997;238:22-9. [PMID: 9375005 DOI: 10.1006/viro.1997.8822] [Cited by in Crossref: 43] [Cited by in F6Publishing: 42] [Article Influence: 1.7] [Reference Citation Analysis]
429 Wang FZ, Akula SM, Pramod NP, Zeng L, Chandran B. Human herpesvirus 8 envelope glycoprotein K8.1A interaction with the target cells involves heparan sulfate. J Virol 2001;75:7517-27. [PMID: 11462024 DOI: 10.1128/JVI.75.16.7517-7527.2001] [Cited by in Crossref: 107] [Cited by in F6Publishing: 80] [Article Influence: 5.1] [Reference Citation Analysis]
430 Spiller OB, Blackbourn DJ, Mark L, Proctor DG, Blom AM. Functional activity of the complement regulator encoded by Kaposi's sarcoma-associated herpesvirus. J Biol Chem 2003;278:9283-9. [PMID: 12645526 DOI: 10.1074/jbc.m211579200] [Cited by in Crossref: 59] [Cited by in F6Publishing: 31] [Article Influence: 3.1] [Reference Citation Analysis]
431 Low W, Harries M, Ye H, Du MQ, Boshoff C, Collins M. Internal ribosome entry site regulates translation of Kaposi's sarcoma-associated herpesvirus FLICE inhibitory protein. J Virol 2001;75:2938-45. [PMID: 11222719 DOI: 10.1128/JVI.75.6.2938-2945.2001] [Cited by in Crossref: 73] [Cited by in F6Publishing: 46] [Article Influence: 3.5] [Reference Citation Analysis]
432 Yoo SM, Zhou FC, Ye FC, Pan HY, Gao SJ. Early and sustained expression of latent and host modulating genes in coordinated transcriptional program of KSHV productive primary infection of human primary endothelial cells. Virology 2005;343:47-64. [PMID: 16154170 DOI: 10.1016/j.virol.2005.08.018] [Cited by in Crossref: 59] [Cited by in F6Publishing: 59] [Article Influence: 3.5] [Reference Citation Analysis]
433 Feng P, Park J, Lee BS, Lee SH, Bram RJ, Jung JU. Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis. J Virol. 2002;76:11491-11504. [PMID: 12388711 DOI: 10.1128/JVI.76.22.11491-11504.2002] [Cited by in Crossref: 74] [Cited by in F6Publishing: 50] [Article Influence: 3.7] [Reference Citation Analysis]
434 Asou H, Said JW, Yang R, Munker R, Park DJ, Kamada N, Koeffler HP. Mechanisms of Growth Control of Kaposi's Sarcoma–Associated Herpes Virus–Associated Primary Effusion Lymphoma Cells. Blood 1998;91:2475-81. [DOI: 10.1182/blood.v91.7.2475] [Cited by in Crossref: 87] [Article Influence: 3.6] [Reference Citation Analysis]
435 Park J, Lee MS, Yoo SM, Jeong KW, Lee D, Choe J, Seo T. Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1. J Virol 2007;81:12680-4. [PMID: 17855527 DOI: 10.1128/JVI.00556-07] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
436 Schifano JM, Corcoran K, Kelkar H, Dittmer DP. Expression of the Antisense-to-Latency Transcript Long Noncoding RNA in Kaposi's Sarcoma-Associated Herpesvirus. J Virol 2017;91:e01698-16. [PMID: 27928018 DOI: 10.1128/JVI.01698-16] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
437 Jin Z, Kotera M, Goto S. Virus proteins similar to human proteins as possible disturbance on human pathways. Syst Synth Biol 2014;8:283-95. [PMID: 26396652 DOI: 10.1007/s11693-014-9141-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
438 Butnaru M, Gaglia MM. Transcriptional and post-transcriptional regulation of viral gene expression in the gamma-herpesvirus Kaposi's sarcoma-associated herpesvirus. Curr Clin Microbiol Rep 2018;5:219-28. [PMID: 30854283 DOI: 10.1007/s40588-018-0102-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
439 Demba RN, Shaviya N, Aradi SM, Mwanda W. Selected genes of Human herpesvirus-8 associated Kaposi's sarcoma among patients with Human Immunodeficiency Virus-1 and Acquired Immunodeficiency Disease Syndrome. Pan Afr Med J 2019;32:215. [PMID: 31404285 DOI: 10.11604/pamj.2019.32.215.17322] [Reference Citation Analysis]
440 Lagunoff M, Majeti R, Weiss A, Ganem D. Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 1999;96:5704-9. [PMID: 10318948 DOI: 10.1073/pnas.96.10.5704] [Cited by in Crossref: 122] [Cited by in F6Publishing: 114] [Article Influence: 5.3] [Reference Citation Analysis]
441 Walters MS, Hall KT, Whitehouse A. The herpesvirus saimiri Rta gene autostimulates via binding to a non-consensus response element. Journal of General Virology 2005;86:581-7. [DOI: 10.1099/vir.0.80723-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
442 Wong EL, Damania B. Linking KSHV to human cancer. Curr Oncol Rep 2005;7:349-56. [DOI: 10.1007/s11912-005-0061-6] [Cited by in Crossref: 22] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
443 Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer J, Schröter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 1997;386:517-21. [DOI: 10.1038/386517a0] [Cited by in Crossref: 960] [Cited by in F6Publishing: 885] [Article Influence: 38.4] [Reference Citation Analysis]
444 Segal G, Russo JJ, Shuman HA. Relationships between a new type IV secretion system and the icm/dot virulence system of Legionella pneumophila. Mol Microbiol 1999;34:799-809. [PMID: 10564519 DOI: 10.1046/j.1365-2958.1999.01642.x] [Cited by in Crossref: 143] [Cited by in F6Publishing: 130] [Article Influence: 6.5] [Reference Citation Analysis]
445 Cotter MA 2nd, Subramanian C, Robertson ES. The Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen binds to specific sequences at the left end of the viral genome through its carboxy-terminus. Virology 2001;291:241-59. [PMID: 11878894 DOI: 10.1006/viro.2001.1202] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 5.0] [Reference Citation Analysis]
446 Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, Haase A, Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol 1999;73:2232-42. [PMID: 9971806 DOI: 10.1128/JVI.73.3.2232-2242.1999] [Cited by in Crossref: 312] [Cited by in F6Publishing: 211] [Article Influence: 13.6] [Reference Citation Analysis]
447 Lüttichau HR, Lewis I, Gerstoft J, Schwartz T. The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur J Immunol 2001;31:1217-20. [DOI: 10.1002/1521-4141(200104)31:4<1217::aid-immu1217>3.0.co;2-s] [Cited by in Crossref: 40] [Article Influence: 1.9] [Reference Citation Analysis]
448 Nicholas J. Evolutionary aspects of oncogenic herpesviruses. Mol Pathol 2000;53:222-37. [PMID: 11091846 DOI: 10.1136/mp.53.5.222] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
449 Lee HJ, Essani K, Smith GL. The genome sequence of Yaba-like disease virus, a yatapoxvirus. Virology 2001;281:170-92. [PMID: 11277691 DOI: 10.1006/viro.2000.0761] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 4.8] [Reference Citation Analysis]
450 Narita Y, Sugimoto A, Kawashima D, Watanabe T, Kanda T, Kimura H, Tsurumi T, Murata T. A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis. Sci Rep 2015;5:11767. [PMID: 26123572 DOI: 10.1038/srep11767] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
451 Bryan BA, Dyson OF, Akula SM. Identifying cellular genes crucial for the reactivation of Kaposi's sarcoma-associated herpesvirus latency. J Gen Virol 2006;87:519-29. [PMID: 16476973 DOI: 10.1099/vir.0.81603-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
452 Cook PM, Schulz TF, Rascu A, Kalden JR, Harrer T. Lack of serologic evidence for involvement of human herpesvirus 8 in autoimmune diseases. Arthritis & Rheumatism 1997;40:1906-7. [DOI: 10.1002/art.1780401029] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
453 Ueda K, Ohsaki E, Nakano K, Zheng X. Characterization of Kaposi's Sarcoma-Associated Herpesvirus-Related Lymphomas by DNA Microarray Analysis. Leuk Res Treatment 2011;2011:726964. [PMID: 23213546 DOI: 10.4061/2011/726964] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.2] [Reference Citation Analysis]
454 Li DJ, Verma D, Swaminathan S. Binding of cellular export factor REF/Aly by Kaposi's sarcoma-associated herpesvirus (KSHV) ORF57 protein is not required for efficient KSHV lytic replication. J Virol 2012;86:9866-74. [PMID: 22761374 DOI: 10.1128/JVI.01190-12] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
455 Wang SE, Wu FY, Chen H, Shamay M, Zheng Q, Hayward GS. Early activation of the Kaposi's sarcoma-associated herpesvirus RTA, RAP, and MTA promoters by the tetradecanoyl phorbol acetate-induced AP1 pathway. J Virol 2004;78:4248-67. [PMID: 15047839 DOI: 10.1128/jvi.78.8.4248-4267.2004] [Cited by in Crossref: 89] [Cited by in F6Publishing: 66] [Article Influence: 4.9] [Reference Citation Analysis]
456 Habison AC, Beauchemin C, Simas JP, Usherwood EJ, Kaye KM. Murine gammaherpesvirus 68 LANA acts on terminal repeat DNA to mediate episome persistence. J Virol 2012;86:11863-76. [PMID: 22915819 DOI: 10.1128/JVI.01656-12] [Cited by in Crossref: 24] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
457 Calderwood MA, Hall KT, Matthews DA, Whitehouse A. The herpesvirus saimiri ORF73 gene product interacts with host-cell mitotic chromosomes and self-associates via its C terminus. Journal of General Virology 2004;85:147-53. [DOI: 10.1099/vir.0.19437-0] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 1.4] [Reference Citation Analysis]
458 Perkins EM, Anacker D, Davis A, Sankar V, Ambinder RF, Desai P. Small capsid protein pORF65 is essential for assembly of Kaposi's sarcoma-associated herpesvirus capsids. J Virol 2008;82:7201-11. [PMID: 18463150 DOI: 10.1128/JVI.00423-08] [Cited by in Crossref: 34] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
459 Vieira J, Huang ML, Koelle DM, Corey L. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 1997;71:7083-7. [PMID: 9261440 DOI: 10.1128/JVI.71.9.7083-7087.1997] [Cited by in Crossref: 134] [Cited by in F6Publishing: 64] [Article Influence: 5.4] [Reference Citation Analysis]
460 Miranda MB, Handermann M, Darai G. DNA polymerase gene locus of Cercopithecine herpesvirus 1 is a suitable target for specific and rapid identification of viral infection by PCR technology. Virus Genes 2005;30:307-22. [PMID: 15830148 DOI: 10.1007/s11262-004-6773-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
461 BeltCappellino A, Majerciak V, Lobanov A, Lack J, Cam M, Zheng ZM. CRISPR/Cas9-Mediated Knockout and In Situ Inversion of the ORF57 Gene from All Copies of the Kaposi's Sarcoma-Associated Herpesvirus Genome in BCBL-1 Cells. J Virol 2019;93:e00628-19. [PMID: 31413125 DOI: 10.1128/JVI.00628-19] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
462 Cloutier N, Flamand L. Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen inhibits interferon (IFN) beta expression by competing with IFN regulatory factor-3 for binding to IFNB promoter. J Biol Chem 2010;285:7208-21. [PMID: 20048166 DOI: 10.1074/jbc.M109.018838] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
463 Kadyrova E, Lacoste V, Duprez R, Pozharissky K, Molochkov V, Huerre M, Gurtsevitch V, Gessain A. Molecular epidemiology of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 strains from Russian patients with classic, posttransplant, and AIDS-associated Kaposi's sarcoma. J Med Virol 2003;71:548-56. [PMID: 14556268 DOI: 10.1002/jmv.10530] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 1.4] [Reference Citation Analysis]
464 Cho Y, Ramer J, Rivailler P, Quink C, Garber RL, Beier DR, Wang F. An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc Natl Acad Sci U S A 2001;98:1224-9. [PMID: 11158621 DOI: 10.1073/pnas.98.3.1224] [Cited by in Crossref: 74] [Cited by in F6Publishing: 63] [Article Influence: 3.5] [Reference Citation Analysis]
465 Sturzl M, Hohenadl C, Zietz C, Castanos-Velez E, Wunderlich A, Ascherl G, Biberfeld P, Monini P, Browning PJ, Ensoli B. Expression of K13/v-FLIP gene of human herpesvirus 8 and apoptosis in Kaposi's sarcoma spindle cells. J Natl Cancer Inst. 1999;91:1725-1733. [PMID: 10528022 DOI: 10.1093/jnci/91.20.1725] [Cited by in Crossref: 131] [Cited by in F6Publishing: 126] [Article Influence: 5.7] [Reference Citation Analysis]
466 Knight JS, Cotter MA 2nd, Robertson ES. The latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus transactivates the telomerase reverse transcriptase promoter. J Biol Chem 2001;276:22971-8. [PMID: 11313352 DOI: 10.1074/jbc.M101890200] [Cited by in Crossref: 85] [Cited by in F6Publishing: 57] [Article Influence: 4.0] [Reference Citation Analysis]
467 Shin YC, Nakamura H, Liang X, Feng P, Chang H, Kowalik TF, Jung JU. Inhibition of the ATM/p53 signal transduction pathway by Kaposi's sarcoma-associated herpesvirus interferon regulatory factor 1. J Virol 2006;80:2257-66. [PMID: 16474133 DOI: 10.1128/JVI.80.5.2257-2266.2006] [Cited by in Crossref: 100] [Cited by in F6Publishing: 70] [Article Influence: 6.3] [Reference Citation Analysis]
468 Li M, Mackey J, Czajak SC, Desrosiers RC, Lackner AA, Jung JU. Identification and Characterization of Kaposi’s Sarcoma-Associated Herpesvirus K8.1 Virion Glycoprotein. J Virol 1999;73:1341-9. [DOI: 10.1128/jvi.73.2.1341-1349.1999] [Cited by in Crossref: 46] [Cited by in F6Publishing: 31] [Article Influence: 2.0] [Reference Citation Analysis]
469 Wang FZ, Akula SM, Sharma-Walia N, Zeng L, Chandran B. Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence. J Virol 2003;77:3131-47. [PMID: 12584338 DOI: 10.1128/jvi.77.5.3131-3147.2003] [Cited by in Crossref: 95] [Cited by in F6Publishing: 56] [Article Influence: 5.0] [Reference Citation Analysis]
470 Laman H, Mann DJ, Jones NC. Viral-encoded cyclins. Current Opinion in Genetics & Development 2000;10:70-4. [DOI: 10.1016/s0959-437x(99)00045-3] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
471 Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gerhengorn MC, Mesri EA. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 1998;391:86-9. [DOI: 10.1038/34193] [Cited by in Crossref: 645] [Cited by in F6Publishing: 583] [Article Influence: 26.9] [Reference Citation Analysis]
472 Rottman JB. Key Role of Chemokines and Chemokine Receptors in Inflammation, Immunity, Neoplasia, and Infectious Disease. Vet Pathol 1999;36:357-67. [DOI: 10.1354/vp.36-5-357] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 5.8] [Reference Citation Analysis]
473 Zhao Q, Liang D, Sun R, Jia B, Xia T, Xiao H, Lan K. Kaposi's sarcoma-associated herpesvirus-encoded replication and transcription activator impairs innate immunity via ubiquitin-mediated degradation of myeloid differentiation factor 88. J Virol 2015;89:415-27. [PMID: 25320320 DOI: 10.1128/JVI.02591-14] [Cited by in Crossref: 39] [Cited by in F6Publishing: 32] [Article Influence: 4.9] [Reference Citation Analysis]
474 Wang S, Liu S, Wu MH, Geng Y, Wood C. Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation. J Virol 2001;75:11961-73. [PMID: 11711586 DOI: 10.1128/JVI.75.24.11961-11973.2001] [Cited by in Crossref: 68] [Cited by in F6Publishing: 53] [Article Influence: 3.2] [Reference Citation Analysis]
475 Dollery SJ, Santiago-Crespo RJ, Kardava L, Moir S, Berger EA. Efficient infection of a human B cell line with cell-free Kaposi's sarcoma-associated herpesvirus. J Virol 2014;88:1748-57. [PMID: 24257608 DOI: 10.1128/JVI.03063-13] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.0] [Reference Citation Analysis]
476 Lan K, Verma SC, Murakami M, Bajaj B, Kaul R, Robertson ES. Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein. Proc Natl Acad Sci U S A 2007;104:16287-92. [PMID: 17909182 DOI: 10.1073/pnas.0703508104] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 2.6] [Reference Citation Analysis]
477 Zhang X, Wang JF, Chandran B, Persaud K, Pytowski B, Fingeroth J, Groopman JE. Kaposi's Sarcoma-associated Herpesvirus Activation of Vascular Endothelial Growth Factor Receptor 3 Alters Endothelial Function and Enhances Infection. Journal of Biological Chemistry 2005;280:26216-24. [DOI: 10.1074/jbc.m411392200] [Cited by in Crossref: 29] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
478 Purushothaman P, Uppal T, Verma SC. Molecular biology of KSHV lytic reactivation. Viruses 2015;7:116-53. [PMID: 25594835 DOI: 10.3390/v7010116] [Cited by in Crossref: 72] [Cited by in F6Publishing: 65] [Article Influence: 10.3] [Reference Citation Analysis]
479 Chandran B, Smith MS, Koelle DM, Corey L, Horvat R, Goldstein E. Reactivities of Human Sera with Human Herpesvirus-8-Infected BCBL-1 Cells and Identification of HHV-8-Specific Proteins and Glycoproteins and the Encoding cDNAs. Virology 1998;243:208-17. [DOI: 10.1006/viro.1998.9055] [Cited by in Crossref: 59] [Cited by in F6Publishing: 58] [Article Influence: 2.5] [Reference Citation Analysis]
480 Wang X, Ye Y, Lencer W, Hansen TH. The viral E3 ubiquitin ligase mK3 uses the Derlin/p97 endoplasmic reticulum-associated degradation pathway to mediate down-regulation of major histocompatibility complex class I proteins. J Biol Chem 2006;281:8636-44. [PMID: 16446359 DOI: 10.1074/jbc.M513920200] [Cited by in Crossref: 38] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
481 He Z, Zhao J, Zhang J, Jung JU, Feng P. NF-κB activation coordinated by IKKβ and IKKε enables latent infection of Kaposi's sarcoma-associated herpesvirus. J Virol 2014;88:444-55. [PMID: 24155403 DOI: 10.1128/JVI.01716-13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
482 Katano H, Hoshino Y, Morishita Y, Nakamura T, Satoh H, Iwamoto A, Herndier B, Mori S. Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma. J Med Virol 1999;58:394-401. [DOI: 10.1002/(sici)1096-9071(199908)58:4<394::aid-jmv12>3.0.co;2-h] [Cited by in Crossref: 69] [Article Influence: 3.0] [Reference Citation Analysis]
483 Tanaka S, Katano H, Tsukamoto K, Jin M, Oikawa S, Nishihara H, Sawa H, Sawada K, Shimizu M, Sata T, Fujioka Y, Nagashima K. HHV8-negative primary effusion lymphoma of the peritoneal cavity presenting with a distinct immunohistochemical phenotype. Pathol Int 2001;51:293-300. [PMID: 11350613 DOI: 10.1046/j.1440-1827.2001.01189.x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 1.1] [Reference Citation Analysis]
484 Guito J, Gavina A, Palmeri D, Lukac DM. The cellular peptidyl-prolyl cis/trans isomerase Pin1 regulates reactivation of Kaposi's sarcoma-associated herpesvirus from latency. J Virol 2014;88:547-58. [PMID: 24173213 DOI: 10.1128/JVI.02877-13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
485 Zhu L, Puri V, Chandran B. Characterization of human herpesvirus-8 K8.1A/B glycoproteins by monoclonal antibodies. Virology 1999;262:237-49. [PMID: 10489357 DOI: 10.1006/viro.1999.9900] [Cited by in Crossref: 69] [Cited by in F6Publishing: 66] [Article Influence: 3.0] [Reference Citation Analysis]
486 Sakakibara S, Tosato G. Contribution of viral mimics of cellular genes to KSHV infection and disease. Viruses 2014;6:3472-86. [PMID: 25243371 DOI: 10.3390/v6093472] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
487 Gómez-Román JJ, Ocejo-Vinyals G, Sánchez-Velasco P, Nieto EH, Leyva-Cobián F, Val-Bernal JF. Presence of human herpesvirus-8 DNA sequences and overexpression of human IL-6 and cyclin D1 in inflammatory myofibroblastic tumor (inflammatory pseudotumor). Lab Invest. 2000;80:1121-1126. [PMID: 10908158 DOI: 10.1038/labinvest.3780118] [Cited by in Crossref: 82] [Cited by in F6Publishing: 70] [Article Influence: 3.7] [Reference Citation Analysis]
488 Taylor JL, Bennett HN, Snyder BA, Moore PS, Chang Y. Transcriptional analysis of latent and inducible Kaposi's sarcoma-associated herpesvirus transcripts in the K4 to K7 region. J Virol 2005;79:15099-106. [PMID: 16306581 DOI: 10.1128/JVI.79.24.15099-15106.2005] [Cited by in Crossref: 31] [Cited by in F6Publishing: 24] [Article Influence: 1.9] [Reference Citation Analysis]
489 Chan C, Shen DF, Whitcup SM, Nussenblatt RB, Lehoang P, Roberge FG, Cassoux N, Herbort C, Zhuang Z. Detection of Human Herpesvirus-8 and Epstein-Barr Virus DNA in Primary Intraocular Lymphomas. Blood 1999;93:2749-51. [DOI: 10.1182/blood.v93.8.2749] [Cited by in Crossref: 22] [Article Influence: 1.0] [Reference Citation Analysis]
490 Kliche S, Kremmer E, Hammerschmidt W, Koszinowski U, Haas J. Persistent Infection of Epstein-Barr Virus-Positive B Lymphocytes by Human Herpesvirus 8. J Virol 1998;72:8143-9. [DOI: 10.1128/jvi.72.10.8143-8149.1998] [Cited by in Crossref: 41] [Cited by in F6Publishing: 20] [Article Influence: 1.7] [Reference Citation Analysis]
491 Bechtel JT, Winant RC, Ganem D. Host and viral proteins in the virion of Kaposi's sarcoma-associated herpesvirus. J Virol 2005;79:4952-64. [PMID: 15795281 DOI: 10.1128/JVI.79.8.4952-4964.2005] [Cited by in Crossref: 137] [Cited by in F6Publishing: 98] [Article Influence: 8.1] [Reference Citation Analysis]
492 Arias C, Weisburd B, Stern-Ginossar N, Mercier A, Madrid AS, Bellare P, Holdorf M, Weissman JS, Ganem D. KSHV 2.0: a comprehensive annotation of the Kaposi's sarcoma-associated herpesvirus genome using next-generation sequencing reveals novel genomic and functional features. PLoS Pathog 2014;10:e1003847. [PMID: 24453964 DOI: 10.1371/journal.ppat.1003847] [Cited by in Crossref: 185] [Cited by in F6Publishing: 167] [Article Influence: 23.1] [Reference Citation Analysis]
493 Sun R, Lin SF, Gradoville L, Yuan Y, Zhu F, Miller G. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A 1998;95:10866-71. [PMID: 9724796 DOI: 10.1073/pnas.95.18.10866] [Cited by in Crossref: 462] [Cited by in F6Publishing: 454] [Article Influence: 19.3] [Reference Citation Analysis]
494 Lim C, Sohn H, Lee D, Gwack Y, Choe J. Functional dissection of latency-associated nuclear antigen 1 of Kaposi's sarcoma-associated herpesvirus involved in latent DNA replication and transcription of terminal repeats of the viral genome. J Virol 2002;76:10320-31. [PMID: 12239308 DOI: 10.1128/jvi.76.20.10320-10331.2002] [Cited by in Crossref: 95] [Cited by in F6Publishing: 71] [Article Influence: 4.8] [Reference Citation Analysis]
495 Delabesse E, Oksenhendler E, Lebbé C, Vérola O, Varet B, Turhan AG. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol 1997;50:664-8. [PMID: 9301550 DOI: 10.1136/jcp.50.8.664] [Cited by in Crossref: 69] [Cited by in F6Publishing: 57] [Article Influence: 2.8] [Reference Citation Analysis]
496 Doniger J, Muralidhar S, Rosenthal LJ. Human Cytomegalovirus and Human Herpesvirus 6 Genes That Transform and Transactivate. Clin Microbiol Rev 1999;12:367-82. [DOI: 10.1128/cmr.12.3.367] [Cited by in Crossref: 57] [Cited by in F6Publishing: 22] [Article Influence: 2.5] [Reference Citation Analysis]
497 Jha HC, Banerjee S, Robertson ES. The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens 2016;5:E18. [PMID: 26861404 DOI: 10.3390/pathogens5010018] [Cited by in Crossref: 59] [Cited by in F6Publishing: 63] [Article Influence: 9.8] [Reference Citation Analysis]
498 Reitz MS Jr, Nerurkar LS, Gallo RC. Perspective on Kaposi's sarcoma: facts, concepts, and conjectures. J Natl Cancer Inst 1999;91:1453-8. [PMID: 10469745 DOI: 10.1093/jnci/91.17.1453] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 1.3] [Reference Citation Analysis]
499 Laman H, Coverley D, Krude T, Laskey R, Jones N. Viral cyclin-cyclin-dependent kinase 6 complexes initiate nuclear DNA replication. Mol Cell Biol 2001;21:624-35. [PMID: 11134348 DOI: 10.1128/MCB.21.2.624-635.2001] [Cited by in Crossref: 49] [Cited by in F6Publishing: 25] [Article Influence: 2.3] [Reference Citation Analysis]
500 Dahlroth SL, Lieu V, Haas J, Nordlund P. Screening colonies of pooled ORFeomes (SCOOP): a rapid and efficient strategy for expression screening ORFeomes in Escherichia coli. Protein Expr Purif 2009;68:121-7. [PMID: 19635569 DOI: 10.1016/j.pep.2009.07.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
501 Knappe A, Hiller C, Thurau M, Wittmann S, Hofmann H, Fleckenstein B, Fickenscher H. The superantigen-homologous viral immediate-early gene ie14/vsag in herpesvirus saimiri-transformed human T cells. J Virol 1997;71:9124-33. [DOI: 10.1128/jvi.71.12.9124-9133.1997] [Cited by in Crossref: 50] [Cited by in F6Publishing: 25] [Article Influence: 2.0] [Reference Citation Analysis]
502 Stallone G, Infante B, Grandaliano G, Schena FP, Gesualdo L. Kaposi's sarcoma and mTOR: a crossroad between viral infection neoangiogenesis and immunosuppression. Transpl Int 2008;21:825-32. [PMID: 18498314 DOI: 10.1111/j.1432-2277.2008.00697.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
503 Plafker SM, Gibson W. Cytomegalovirus assembly protein precursor and proteinase precursor contain two nuclear localization signals that mediate their own nuclear translocation and that of the major capsid protein. J Virol 1998;72:7722-32. [PMID: 9733808 DOI: 10.1128/JVI.72.10.7722-7732.1998] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 1.0] [Reference Citation Analysis]
504 Pyaram K, Yadav VN, Reza MJ, Sahu A. Virus–complement interactions: an assiduous struggle for dominance. Future Virology 2010;5:709-30. [DOI: 10.2217/fvl.10.60] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
505 Chauhan D, Bharti A, Raje N, Gustafson E, Pinkus GS, Pinkus JL, Teoh G, Hideshima T, Treon SP, Fingeroth JD, Anderson KC. Detection of Kaposi’s Sarcoma Herpesvirus DNA Sequences in Multiple Myeloma Bone Marrow Stromal Cells. Blood 1999;93:1482-6. [DOI: 10.1182/blood.v93.5.1482.405a34_1482_1486] [Cited by in Crossref: 6] [Article Influence: 0.3] [Reference Citation Analysis]
506 Gradoville L, Gerlach J, Grogan E, Shedd D, Nikiforow S, Metroka C, Miller G. Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line. J Virol 2000;74:6207-12. [PMID: 10846108 DOI: 10.1128/jvi.74.13.6207-6212.2000] [Cited by in Crossref: 215] [Cited by in F6Publishing: 170] [Article Influence: 9.8] [Reference Citation Analysis]
507 Burýsek L, Yeow WS, Lubyová B, Kellum M, Schafer SL, Huang YQ, Pitha PM. Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. J Virol 1999;73:7334-42. [PMID: 10438822 DOI: 10.1128/JVI.73.9.7334-7342.1999] [Cited by in Crossref: 166] [Cited by in F6Publishing: 90] [Article Influence: 7.2] [Reference Citation Analysis]
508 Neipel F, Albrecht JC, Fleckenstein B. Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol 1997;71:4187-92. [PMID: 9151804 DOI: 10.1128/JVI.71.6.4187-4192.1997] [Cited by in Crossref: 318] [Cited by in F6Publishing: 140] [Article Influence: 12.7] [Reference Citation Analysis]
509 Brander C, Walker BD. Modulation of host immune responses by clinically relevant human DNA and RNA viruses. Curr Opin Microbiol 2000;3:379-86. [PMID: 10972498 DOI: 10.1016/s1369-5274(00)00108-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
510 Amini AA, Solovyova AS, Sadeghian H, Blackbourn DJ, Rezaee SR. Structural properties of a viral orthologue of cellular CD200 protein: KSHV vOX2. Virology 2015;474:94-104. [DOI: 10.1016/j.virol.2014.10.020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
511 Chang J, Ganem D. On the control of late gene expression in Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol 2000;81:2039-47. [PMID: 10900043 DOI: 10.1099/0022-1317-81-8-2039] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 1.1] [Reference Citation Analysis]
512 Blattman NN, Lagunoff M, Blattman JN, Corey L. Nuclear factor kappa B is required for the production of infectious human herpesvirus 8 virions. Front Microbiol 2014;5:129. [PMID: 24795700 DOI: 10.3389/fmicb.2014.00129] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
513 Boyne J, Whitehouse A. γ-2 herpes virus post-transcriptional gene regulation. Clinical Microbiology and Infection 2006;12:110-7. [DOI: 10.1111/j.1469-0691.2005.01317.x] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
514 Meng YX, Sata T, Stamey FR, Voevodin A, Katano H, Koizumi H, Deleon M, De Cristofano MA, Galimberti R, Pellett PE. Molecular characterization of strains of Human herpesvirus 8 from Japan, Argentina and Kuwait. J Gen Virol 2001;82:499-506. [PMID: 11172090 DOI: 10.1099/0022-1317-82-3-499] [Cited by in Crossref: 47] [Cited by in F6Publishing: 47] [Article Influence: 2.2] [Reference Citation Analysis]
515 Kasolo FC, Spinks J, Bima H, Bates M, Gompels UA. Diverse genotypes of Kaposi's sarcoma associated herpesvirus (KSHV) identified in infant blood infections in African childhood-KS and HIV/AIDS endemic region. J Med Virol 2007;79:1555-61. [PMID: 17705172 DOI: 10.1002/jmv.20952] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.2] [Reference Citation Analysis]
516 Kennedy MM, Biddolph S, Lucas SB, Howells DD, Picton S, McGee JO, O'Leary JJ. CD40 upregulation is independent of HHV-8 in the pathogenesis of Kaposi's sarcoma. Mol Pathol 1999;52:32-6. [PMID: 10439837 DOI: 10.1136/mp.52.1.32] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
517 Angius F, Ingianni A, Pompei R. Human Herpesvirus 8 and Host-Cell Interaction: Long-Lasting Physiological Modifications, Inflammation and Related Chronic Diseases. Microorganisms 2020;8:E388. [PMID: 32168836 DOI: 10.3390/microorganisms8030388] [Reference Citation Analysis]
518 Awazawa R, Utsumi D, Katano H, Awazawa T, Miyagi T, Hayashi K, Matori S, Uezato H, Takahashi K. High Prevalence of Distinct Human Herpesvirus 8 Contributes to the High Incidence of Non-acquired Immune Deficiency Syndrome-Associated Kaposi's Sarcoma in Isolated Japanese Islands. J Infect Dis 2017;216:850-8. [PMID: 28968717 DOI: 10.1093/infdis/jix424] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
519 Liang C, Lee JS, Jung JU. Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis. Semin Cancer Biol. 2008;18:423-436. [PMID: 18948197 DOI: 10.1016/j.semcancer.2008.09.003] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 3.7] [Reference Citation Analysis]
520 Tsurumi S, Watanabe T, Iwaisako Y, Suzuki Y, Nakano T, Fujimuro M. Kaposi's sarcoma-associated herpesvirus ORF17 plays a key role in capsid maturation. Virology 2021;558:76-85. [PMID: 33735753 DOI: 10.1016/j.virol.2021.02.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
521 Sarid R, Klepfish A, Schattner A. Virology, pathogenetic mechanisms, and associated diseases of Kaposi sarcoma-associated herpesvirus (human herpesvirus 8). Mayo Clin Proc 2002;77:941-9. [PMID: 12233927 DOI: 10.4065/77.9.941] [Cited by in Crossref: 7] [Cited by in F6Publishing: 16] [Article Influence: 0.4] [Reference Citation Analysis]
522 Auerbach MR, Czajak SC, Johnson WE, Desrosiers RC, Alexander L. Species specificity of macaque rhadinovirus glycoprotein B sequences. J Virol 2000;74:584-90. [PMID: 10590154 DOI: 10.1128/jvi.74.1.584-590.2000] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
523 Pellett PE, Spira TJ, Bagasra O, Boshoff C, Corey L, de Lellis L, Huang ML, Lin JC, Matthews S, Monini P, Rimessi P, Sosa C, Wood C, Stewart JA. Multicenter comparison of PCR assays for detection of human herpesvirus 8 DNA in semen. J Clin Microbiol 1999;37:1298-301. [PMID: 10203474 DOI: 10.1128/JCM.37.5.1298-1301.1999] [Cited by in Crossref: 48] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
524 Zhang D, Pu X, Wu W, Jin Y, Juhear M, Wu X. Genotypic analysis on the ORF-K1 gene of human herpesvirus 8 from patients with Kaposi's sarcoma in Xinjiang, China. Journal of Genetics and Genomics 2008;35:657-63. [DOI: 10.1016/s1673-8527(08)60087-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
525 Chen J, Ye F, Xie J, Kuhne K, Gao SJ. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA. Virology 2009;386:290-302. [PMID: 19233445 DOI: 10.1016/j.virol.2009.01.031] [Cited by in Crossref: 52] [Cited by in F6Publishing: 44] [Article Influence: 4.0] [Reference Citation Analysis]
526 Iwaisako Y, Watanabe T, Hanajiri M, Sekine Y, Fujimuro M. Kaposi's Sarcoma-Associated Herpesvirus ORF7 Is Essential for Virus Production. Microorganisms 2021;9:1169. [PMID: 34071710 DOI: 10.3390/microorganisms9061169] [Reference Citation Analysis]
527 Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr 1998;:65-71. [PMID: 9709306 DOI: 10.1093/oxfordjournals.jncimonographs.a024176] [Cited by in Crossref: 44] [Cited by in F6Publishing: 42] [Article Influence: 1.8] [Reference Citation Analysis]
528 Zhang R, Chen K, Peng L, Xiong H. Regulation of T helper cell differentiation by interferon regulatory factor family members. Immunol Res 2012;54:169-76. [PMID: 22528124 DOI: 10.1007/s12026-012-8328-0] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
529 Calderwood M, White RE, Griffiths RA, Whitehouse A. Open reading frame 73 is required for herpesvirus saimiri A11-S4 episomal persistence. J Gen Virol 2005;86:2703-8. [PMID: 16186223 DOI: 10.1099/vir.0.81230-0] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
530 Arora A, Chiao E, Tyring SK. AIDS malignancies. Cancer Treat Res 2007;133:21-67. [PMID: 17672037 DOI: 10.1007/978-0-387-46816-7_2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
531 Virgin HW 4th, Presti RM, Li XY, Liu C, Speck SH. Three distinct regions of the murine gammaherpesvirus 68 genome are transcriptionally active in latently infected mice. J Virol 1999;73:2321-32. [PMID: 9971815 DOI: 10.1128/JVI.73.3.2321-2332.1999] [Cited by in Crossref: 116] [Cited by in F6Publishing: 83] [Article Influence: 5.0] [Reference Citation Analysis]
532 Douglas J, Dutia B, Rhind S, Stewart JP, Talbot SJ. Expression in a recombinant murid herpesvirus 4 reveals the in vivo transforming potential of the K1 open reading frame of Kaposi's sarcoma-associated herpesvirus. J Virol 2004;78:8878-84. [PMID: 15280496 DOI: 10.1128/JVI.78.16.8878-8884.2004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
533 Sadler R, Wu L, Forghani B, Renne R, Zhong W, Herndier B, Ganem D. A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol 1999;73:5722-30. [PMID: 10364323 DOI: 10.1128/JVI.73.7.5722-5730.1999] [Cited by in Crossref: 147] [Cited by in F6Publishing: 83] [Article Influence: 6.4] [Reference Citation Analysis]
534 Zhang YJ, Bonaparte RS, Patel D, Stein DA, Iversen PL. Blockade of viral interleukin-6 expression of Kaposi's sarcoma-associated herpesvirus. Mol Cancer Ther 2008;7:712-20. [PMID: 18347156 DOI: 10.1158/1535-7163.MCT-07-2036] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
535 Sarek G, Järviluoma A, Ojala PM. KSHV viral cyclin inactivates p27KIP1 through Ser10 and Thr187 phosphorylation in proliferating primary effusion lymphomas. Blood 2006;107:725-32. [DOI: 10.1182/blood-2005-06-2534] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 2.6] [Reference Citation Analysis]
536 Schafer SL, Lin R, Moore PA, Hiscott J, Pitha PM. Regulation of Type I Interferon Gene Expression by Interferon Regulatory Factor-3. Journal of Biological Chemistry 1998;273:2714-20. [DOI: 10.1074/jbc.273.5.2714] [Cited by in Crossref: 231] [Cited by in F6Publishing: 223] [Article Influence: 9.6] [Reference Citation Analysis]
537 Aljurf M, Owaidah T, Ezzat A, Ibrahim E, Tbakhi A. Antigen- and/or immune-driven lymphoproliferative disorders. Annals of Oncology 2003;14:1595-606. [DOI: 10.1093/annonc/mdg442] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 0.6] [Reference Citation Analysis]
538 Burýsek L, Pitha PM. Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase. J Virol 2001;75:2345-52. [PMID: 11160738 DOI: 10.1128/JVI.75.5.2345-2352.2001] [Cited by in Crossref: 114] [Cited by in F6Publishing: 58] [Article Influence: 5.4] [Reference Citation Analysis]
539 Alkalay E, Gam Ze Letova Refael C, Shoval I, Kinor N, Sarid R, Shav-Tal Y. The Sub-Nuclear Localization of RNA-Binding Proteins in KSHV-Infected Cells. Cells 2020;9:E1958. [PMID: 32854341 DOI: 10.3390/cells9091958] [Reference Citation Analysis]
540 Serio TR, Cahill N, Prout ME, Miller G. A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle. J Virol 1998;72:8338-43. [PMID: 9733880 DOI: 10.1128/JVI.72.10.8338-8343.1998] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 1.5] [Reference Citation Analysis]
541 Rivas C, Thlick AE, Parravicini C, Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus LANA2 is a B-cell-specific latent viral protein that inhibits p53. J Virol 2001;75:429-38. [PMID: 11119611 DOI: 10.1128/JVI.75.1.429-438.2001] [Cited by in Crossref: 214] [Cited by in F6Publishing: 131] [Article Influence: 10.2] [Reference Citation Analysis]
542 Rahman A, Gupta SD, Rahman MA, Tamanna S. An in-silico approach to design potential siRNAs against the ORF57 of Kaposi's sarcoma-associated herpesvirus. Genomics Inform 2021;19:e47. [PMID: 35012290 DOI: 10.5808/gi.21057] [Reference Citation Analysis]
543 Van Leer-Greenberg B, Kole A, Chawla S. Hepatic Kaposi sarcoma: A case report and review of the literature. World J Hepatol 2017; 9(4): 171-179 [PMID: 28217255 DOI: 10.4254/wjh.v9.i4.171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
544 Lee H, Guo J, Li M, Choi JK, DeMaria M, Rosenzweig M, Jung JU. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol 1998;18:5219-28. [PMID: 9710606 DOI: 10.1128/MCB.18.9.5219] [Cited by in Crossref: 152] [Cited by in F6Publishing: 83] [Article Influence: 6.3] [Reference Citation Analysis]
545 Nozawa N, Daikoku T, Yamauchi Y, Takakuwa H, Goshima F, Yoshikawa T, Nishiyama Y. Identification and characterization of the UL7 gene product of herpes simplex virus type 2. Virus Genes 2002;24:257-66. [PMID: 12086147 DOI: 10.1023/a:1015332716927] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
546 Chandran B. Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J Virol 2010;84:2188-99. [PMID: 19923183 DOI: 10.1128/JVI.01334-09] [Cited by in Crossref: 115] [Cited by in F6Publishing: 94] [Article Influence: 8.8] [Reference Citation Analysis]
547 Carbone A, Cilia AM, Gloghini A, Canzonieri V, Pastore C, Todesco M, Cozzi M, Perin T, Volpe R, Pinto A, Gaidano G. Establishment of HHV-8-positive and HHV-8-negative lymphoma cell lines from primary lymphomatous effusions. Int J Cancer 1997;73:562-9. [PMID: 9389573 DOI: 10.1002/(sici)1097-0215(19971114)73:4<562::aid-ijc18>3.0.co;2-b] [Cited by in Crossref: 49] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
548 Stebbing J, Portsmouth S, Bower M. Insights into the molecular biology and sero-epidemiology of Kaposiʼs sarcoma: . Current Opinion in Infectious Diseases 2003;16:25-31. [DOI: 10.1097/00001432-200302000-00005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
549 Sarid R, Olsen SJ, Moore PS. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology, Virology, and Molecular Biology. Elsevier; 1999. pp. 139-232. [DOI: 10.1016/s0065-3527(08)60299-7] [Cited by in Crossref: 95] [Cited by in F6Publishing: 34] [Article Influence: 4.1] [Reference Citation Analysis]
550 Prichard MN. Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir. Rev Med Virol 2009;19:215-29. [PMID: 19434630 DOI: 10.1002/rmv.615] [Cited by in Crossref: 102] [Cited by in F6Publishing: 96] [Article Influence: 7.8] [Reference Citation Analysis]
551 Gonzalez MW, Spouge JL. Domain analysis of symbionts and hosts (DASH) in a genome-wide survey of pathogenic human viruses. BMC Res Notes 2013;6:209. [PMID: 23706066 DOI: 10.1186/1756-0500-6-209] [Reference Citation Analysis]
552 Cameron C, Hota-mitchell S, Chen L, Barrett J, Cao J, Macaulay C, Willer D, Evans D, Mcfadden G. The Complete DNA Sequence of Myxoma Virus. Virology 1999;264:298-318. [DOI: 10.1006/viro.1999.0001] [Cited by in Crossref: 200] [Cited by in F6Publishing: 194] [Article Influence: 8.7] [Reference Citation Analysis]
553 Yamada T, Kaji N, Odawara T, Chiba J, Iwamoto A, Kitamura Y. Proline 78 is crucial for human immunodeficiency virus type 1 Nef to down-regulate class I human leukocyte antigen. J Virol 2003;77:1589-94. [PMID: 12502873 DOI: 10.1128/jvi.77.2.1589-1594.2003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
554 McAllister SC, Hansen SG, Ruhl RA, Raggo CM, DeFilippis VR, Greenspan D, Früh K, Moses AV. Kaposi sarcoma-associated herpesvirus (KSHV) induces heme oxygenase-1 expression and activity in KSHV-infected endothelial cells. Blood 2004;103:3465-73. [PMID: 14726403 DOI: 10.1182/blood-2003-08-2781] [Cited by in Crossref: 63] [Cited by in F6Publishing: 66] [Article Influence: 3.5] [Reference Citation Analysis]
555 Kwun HJ, da Silva SR, Shah IM, Blake N, Moore PS, Chang Y. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen 1 mimics Epstein-Barr virus EBNA1 immune evasion through central repeat domain effects on protein processing. J Virol 2007;81:8225-35. [PMID: 17522213 DOI: 10.1128/JVI.00411-07] [Cited by in Crossref: 74] [Cited by in F6Publishing: 53] [Article Influence: 4.9] [Reference Citation Analysis]
556 Hew K, Dahlroth SL, Venkatachalam R, Nasertorabi F, Lim BT, Cornvik T, Nordlund P. The crystal structure of the DNA-binding domain of vIRF-1 from the oncogenic KSHV reveals a conserved fold for DNA binding and reinforces its role as a transcription factor. Nucleic Acids Res 2013;41:4295-306. [PMID: 23435230 DOI: 10.1093/nar/gkt082] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
557 Takeda K, Haque M, Nagoshi E, Takemoto M, Shimamoto T, Yoneda Y, Yamanishi K. Characterization of Human Herpesvirus 7 U27 Gene Product and Identification of Its Nuclear Localization Signal. Virology 2000;272:394-401. [DOI: 10.1006/viro.2000.0364] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
558 Lan K, Kuppers DA, Verma SC, Sharma N, Murakami M, Robertson ES. Induction of Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen by the lytic transactivator RTA: a novel mechanism for establishment of latency. J Virol 2005;79:7453-65. [PMID: 15919901 DOI: 10.1128/JVI.79.12.7453-7465.2005] [Cited by in Crossref: 87] [Cited by in F6Publishing: 68] [Article Influence: 5.1] [Reference Citation Analysis]
559 Burger R, Neipel F, Fleckenstein B, Savino R, Ciliberto G, Kalden JR, Gramatzki M. Human Herpesvirus Type 8 Interleukin-6 Homologue Is Functionally Active on Human Myeloma Cells. Blood 1998;91:1858-63. [DOI: 10.1182/blood.v91.6.1858.1858_1858_1863] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
560 Kaushik S, Kukreti S. Formation of a DNA triple helical structure at BOLF1 gene of human herpesvirus 4 (HH4) genome. J Biomol Struct Dyn 2021;39:3324-35. [PMID: 32372693 DOI: 10.1080/07391102.2020.1764390] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
561 Chauhan D, Bharti A, Raje N, Gustafson E, Pinkus GS, Pinkus JL, Teoh G, Hideshima T, Treon SP, Fingeroth JD, Anderson KC. Detection of Kaposi’s Sarcoma Herpesvirus DNA Sequences in Multiple Myeloma Bone Marrow Stromal Cells. Blood 1999;93:1482-6. [DOI: 10.1182/blood.v93.5.1482] [Cited by in Crossref: 44] [Article Influence: 1.9] [Reference Citation Analysis]
562 Lubman OY, Cella M, Wang X, Monte K, Lenschow DJ, Huang YH, Fremont DH. Rodent herpesvirus Peru encodes a secreted chemokine decoy receptor. J Virol 2014;88:538-46. [PMID: 24173234 DOI: 10.1128/JVI.02729-13] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
563 Nishimura K, Ueda K, Guwanan E, Sakakibara S, Do E, Osaki E, Yada K, Okuno T, Yamanishi K. A posttranscriptional regulator of Kaposi's sarcoma-associated herpesvirus interacts with RNA-binding protein PCBP1 and controls gene expression through the IRES. Virology 2004;325:364-78. [PMID: 15246275 DOI: 10.1016/j.virol.2004.04.041] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 0.9] [Reference Citation Analysis]
564 Shinohara H, Fukushi M, Higuchi M, Oie M, Hoshi O, Ushiki T, Hayashi J, Fujii M. Chromosome binding site of latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus is essential for persistent episome maintenance and is functionally replaced by histone H1. J Virol 2002;76:12917-24. [PMID: 12438617 DOI: 10.1128/jvi.76.24.12917-12924.2002] [Cited by in Crossref: 60] [Cited by in F6Publishing: 49] [Article Influence: 3.0] [Reference Citation Analysis]
565 Liu Y, Cao Y, Liang D, Gao Y, Xia T, Robertson ES, Lan K. Kaposi's sarcoma-associated herpesvirus RTA activates the processivity factor ORF59 through interaction with RBP-Jkappa and a cis-acting RTA responsive element. Virology 2008;380:264-75. [PMID: 18786687 DOI: 10.1016/j.virol.2008.08.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
566 Xi X, Persson LM, O'Brien MW, Mohr I, Wilson AC. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters. J Virol 2012;86:1021-33. [PMID: 22090118 DOI: 10.1128/JVI.00694-11] [Cited by in Crossref: 21] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
567 Estes JD, Wong SW, Brenchley JM. Nonhuman primate models of human viral infections. Nat Rev Immunol. 2018;18:390-404. [PMID: 29556017 DOI: 10.1038/s41577-018-0005-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 48] [Article Influence: 18.3] [Reference Citation Analysis]
568 Hoge AT, Hendrickson SB, Burns WH. Murine gammaherpesvirus 68 cyclin D homologue is required for efficient reactivation from latency. J Virol 2000;74:7016-23. [PMID: 10888640 DOI: 10.1128/jvi.74.15.7016-7023.2000] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 1.9] [Reference Citation Analysis]
569 Hayward GS, Whitby D. KSHV Epidemiology and Subtype Evolution. In: Damania B, Pipas JM, editors. DNA Tumor Viruses. New York: Springer US; 2009. pp. 403-39. [DOI: 10.1007/978-0-387-68945-6_17] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
570 Martin D, Gutkind JS. Human tumor-associated viruses and new insights into the molecular mechanisms of cancer. Oncogene. 2008;27 Suppl 2:S31-S42. [PMID: 19956178 DOI: 10.1038/onc.2009.351] [Cited by in Crossref: 116] [Cited by in F6Publishing: 95] [Article Influence: 9.7] [Reference Citation Analysis]
571 Pérez CL, Tous MI. Diversity of human herpesvirus 8 genotypes in patients with AIDS and non-AIDS associated Kaposi's sarcoma, Castleman's disease and primary effusion lymphoma in Argentina. J Med Virol 2017;89:2020-8. [PMID: 28617968 DOI: 10.1002/jmv.24876] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.4] [Reference Citation Analysis]
572 Lubyova B, Kellum MJ, Frisancho AJ, Pitha PM. Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. J Biol Chem 2004;279:7643-54. [PMID: 14668346 DOI: 10.1074/jbc.M309485200] [Cited by in Crossref: 64] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
573 Monini P, Carlini F, Stürzl M, Rimessi P, Superti F, Franco M, Melucci-vigo G, Cafaro A, Goletti D, Sgadari C, Butto’ S, Leone P, Leone P, Chiozzini C, Barresi C, Tinari A, Bonaccorsi A, Capobianchi MR, Giuliani M, di Carlo A, Andreoni M, Rezza G, Ensoli B. Alpha Interferon Inhibits Human Herpesvirus 8 (HHV-8) Reactivation in Primary Effusion Lymphoma Cells and Reduces HHV-8 Load in Cultured Peripheral Blood Mononuclear Cells. J Virol 1999;73:4029-41. [DOI: 10.1128/jvi.73.5.4029-4041.1999] [Cited by in Crossref: 60] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
574 Lan K, Choudhuri T, Murakami M, Kuppers DA, Robertson ES. Intracellular activated Notch1 is critical for proliferation of Kaposi's sarcoma-associated herpesvirus-associated B-lymphoma cell lines in vitro. J Virol 2006;80:6411-9. [PMID: 16775329 DOI: 10.1128/JVI.00239-06] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]
575 Wei F, Gan J, Wang C, Zhu C, Cai Q. Cell Cycle Regulatory Functions of the KSHV Oncoprotein LANA. Front Microbiol 2016;7:334. [PMID: 27065950 DOI: 10.3389/fmicb.2016.00334] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
576 Thakker S, Verma SC. Co-infections and Pathogenesis of KSHV-Associated Malignancies. Front Microbiol 2016;7:151. [PMID: 26913028 DOI: 10.3389/fmicb.2016.00151] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
577 Wong SW, Bergquam EP, Swanson RM, Lee FW, Shiigi SM, Avery NA, Fanton JW, Axthelm MK. Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus. J Exp Med 1999;190:827-40. [PMID: 10499921 DOI: 10.1084/jem.190.6.827] [Cited by in Crossref: 100] [Cited by in F6Publishing: 91] [Article Influence: 4.3] [Reference Citation Analysis]
578 Sathish N, Yuan Y. Evasion and subversion of interferon-mediated antiviral immunity by Kaposi's sarcoma-associated herpesvirus: an overview. J Virol 2011;85:10934-44. [PMID: 21775463 DOI: 10.1128/JVI.00687-11] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 2.8] [Reference Citation Analysis]
579 Lan K, Kuppers DA, Verma SC, Robertson ES. Kaposi's sarcoma-associated herpesvirus-encoded latency-associated nuclear antigen inhibits lytic replication by targeting Rta: a potential mechanism for virus-mediated control of latency. J Virol 2004;78:6585-94. [PMID: 15163750 DOI: 10.1128/JVI.78.12.6585-6594.2004] [Cited by in Crossref: 152] [Cited by in F6Publishing: 126] [Article Influence: 8.4] [Reference Citation Analysis]
580 Yu K, Tian H, Deng H. PPM1G restricts innate immune signaling mediated by STING and MAVS and is hijacked by KSHV for immune evasion. Sci Adv 2020;6:eabd0276. [PMID: 33219031 DOI: 10.1126/sciadv.abd0276] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
581 Lim C, Lee D, Seo T, Choi C, Choe J. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus functionally interacts with heterochromatin protein 1. J Biol Chem 2003;278:7397-405. [PMID: 12486118 DOI: 10.1074/jbc.M211912200] [Cited by in Crossref: 63] [Cited by in F6Publishing: 50] [Article Influence: 3.2] [Reference Citation Analysis]
582 Lalani AS, McFadden G. Evasion and exploitation of chemokines by viruses. Cytokine Growth Factor Rev 1999;10:219-33. [PMID: 10647778 DOI: 10.1016/s1359-6101(99)00018-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
583 Watanabe T, Nakamura S, Ono T, Ui S, Yagi S, Kagawa H, Watanabe H, Ohe T, Mashino T, Fujimuro M. Pyrrolidinium fullerene induces apoptosis by activation of procaspase-9 via suppression of Akt in primary effusion lymphoma. Biochemical and Biophysical Research Communications 2014;451:93-100. [DOI: 10.1016/j.bbrc.2014.07.068] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.1] [Reference Citation Analysis]
584 Chen J, Ueda K, Sakakibara S, Okuno T, Yamanishi K. Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor gene. J Virol 2000;74:8623-34. [PMID: 10954564 DOI: 10.1128/jvi.74.18.8623-8634.2000] [Cited by in Crossref: 83] [Cited by in F6Publishing: 59] [Article Influence: 3.8] [Reference Citation Analysis]
585 Katano H, Suda T, Morishita Y, Yamamoto K, Hoshino Y, Nakamura K, Tachikawa N, Sata T, Hamaguchi H, Iwamoto A, Mori S. Human Herpesvirus 8–Associated Solid Lymphomas that Occur in AIDS Patients Take Anaplastic Large Cell Morphology. Mod Pathol 2000;13:77-85. [DOI: 10.1038/modpathol.3880012] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 3.0] [Reference Citation Analysis]
586 Edelman DC. Human herpesvirus 8--a novel human pathogen. Virol J 2005;2:78. [PMID: 16138925 DOI: 10.1186/1743-422X-2-78] [Cited by in Crossref: 61] [Cited by in F6Publishing: 20] [Article Influence: 3.6] [Reference Citation Analysis]
587 Nicholas J, Zong JC, Alcendor DJ, Ciufo DM, Poole LJ, Sarisky RT, Chiou CJ, Zhang X, Wan X, Guo HG, Reitz MS, Hayward GS. Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J Natl Cancer Inst Monogr 1998;:79-88. [PMID: 9709308 DOI: 10.1093/oxfordjournals.jncimonographs.a024179] [Cited by in Crossref: 85] [Cited by in F6Publishing: 102] [Article Influence: 3.5] [Reference Citation Analysis]
588 Suthaus J, Adam N, Grötzinger J, Scheller J, Rose-john S. Viral Interleukin-6: Structure, pathophysiology and strategies of neutralization. European Journal of Cell Biology 2011;90:495-504. [DOI: 10.1016/j.ejcb.2010.10.016] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
589 Liu Z, Fang Q, Zuo J, Minhas V, Wood C, He N, Zhang T. Was Kaposi’s sarcoma-associated herpesvirus introduced into China via the ancient Silk Road? An evolutionary perspective. Arch Virol 2017;162:3061-8. [DOI: 10.1007/s00705-017-3467-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
590 Feeney KM, Parish JL. Targeting mitotic chromosomes: a conserved mechanism to ensure viral genome persistence. Proc Biol Sci 2009;276:1535-44. [PMID: 19203914 DOI: 10.1098/rspb.2008.1642] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
591 Komatsu T, Ballestas ME, Barbera AJ, Kelley-Clarke B, Kaye KM. KSHV LANA1 binds DNA as an oligomer and residues N-terminal to the oligomerization domain are essential for DNA binding, replication, and episome persistence. Virology 2004;319:225-36. [PMID: 14980483 DOI: 10.1016/j.virol.2003.11.002] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 2.8] [Reference Citation Analysis]
592 Longnecker R. Molecular Biology of Epstein-Barr Virus. In: Mccance DJ, editor. Human Tumor Viruses. Washington: ASM Press; 1998. pp. 135-74. [DOI: 10.1128/9781555818289.ch4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
593 Albrecht J, Friedrich U, Kardinal C, Koehn J, Fleckenstein B, Feller SM, Biesinger B. Herpesvirus Ateles Gene Product Tio Interacts with Nonreceptor Protein Tyrosine Kinases. J Virol 1999;73:4631-9. [DOI: 10.1128/jvi.73.6.4631-4639.1999] [Cited by in Crossref: 30] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
594 Wang Y, Chong OT, Yuan Y. Differential regulation of K8 gene expression in immediate-early and delayed-early stages of Kaposi's sarcoma-associated herpesvirus. Virology 2004;325:149-63. [PMID: 15231394 DOI: 10.1016/j.virol.2004.04.030] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 0.9] [Reference Citation Analysis]
595 Scotti E, Deledda S, Milani M. Efficacy of a Film-Forming Medical Device Containing Piroxicam and Sun Filters in the Treatment of Multiple Actinic Keratosis Lesions in a Subject with a History of Kaposi Sarcoma. Case Rep Dermatol 2016;8:254-61. [PMID: 28101017 DOI: 10.1159/000450723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
596 Means RE, Ishido S, Alvarez X, Jung JU. Multiple endocytic trafficking pathways of MHC class I molecules induced by a Herpesvirus protein. EMBO J 2002;21:1638-49. [PMID: 11927548 DOI: 10.1093/emboj/21.7.1638] [Cited by in Crossref: 56] [Cited by in F6Publishing: 56] [Article Influence: 2.8] [Reference Citation Analysis]
597 Sharipo A, Imreh M, Leonchiks A, Brändén C, Masucci MG. cis-Inhibition of proteasomal degradation by viral repeats: impact of length and amino acid composition. FEBS Lett 2001;499:137-42. [PMID: 11418128 DOI: 10.1016/s0014-5793(01)02542-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
598 Krithivas A, Young DB, Liao G, Greene D, Hayward SD. Human herpesvirus 8 LANA interacts with proteins of the mSin3 corepressor complex and negatively regulates Epstein-Barr virus gene expression in dually infected PEL cells. J Virol 2000;74:9637-45. [PMID: 11000236 DOI: 10.1128/jvi.74.20.9637-9645.2000] [Cited by in Crossref: 154] [Cited by in F6Publishing: 115] [Article Influence: 7.0] [Reference Citation Analysis]
599 Lüttichau HR, Johnsen AH, Jurlander J, Rosenkilde MM, Schwartz TW. Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3. J Biol Chem 2007;282:17794-805. [PMID: 17403668 DOI: 10.1074/jbc.M702001200] [Cited by in Crossref: 30] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
600 Mcfadden G, Barry M. How Poxviruses Oppose Apoptosis. Seminars in Virology 1998;8:429-42. [DOI: 10.1006/smvy.1997.0141] [Cited by in Crossref: 28] [Cited by in F6Publishing: 18] [Article Influence: 1.2] [Reference Citation Analysis]
601 Katano H, Sata T, Suda T, Nakamura T, Tachikawa N, Nishizumi H, Sakurada S, Hayashi Y, Koike M, Iwamoto A, Kurata T, Mori S. Expression and antigenicity of human herpesvirus 8 encoded ORF59 protein in AIDS-associated Kaposi's sarcoma. J Med Virol 1999;59:346-55. [DOI: 10.1002/(sici)1096-9071(199911)59:3<346::aid-jmv15>3.0.co;2-4] [Cited by in Crossref: 32] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]
602 Jeong J, Papin J, Dittmer D. Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. J Virol 2001;75:1798-807. [PMID: 11160678 DOI: 10.1128/JVI.75.4.1798-1807.2001] [Cited by in Crossref: 94] [Cited by in F6Publishing: 70] [Article Influence: 4.5] [Reference Citation Analysis]
603 Bruce AG, Barcy S, DiMaio T, Gan E, Garrigues HJ, Lagunoff M, Rose TM. Quantitative Analysis of the KSHV Transcriptome Following Primary Infection of Blood and Lymphatic Endothelial Cells. Pathogens 2017;6:E11. [PMID: 28335496 DOI: 10.3390/pathogens6010011] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 3.2] [Reference Citation Analysis]
604 Wang GH, Bertin J, Wang Y, Martin DA, Wang J, Tomaselli KJ, Armstrong RC, Cohen JI. Bovine herpesvirus 4 BORFE2 protein inhibits Fas- and tumor necrosis factor receptor 1-induced apoptosis and contains death effector domains shared with other gamma-2 herpesviruses. J Virol 1997;71:8928-32. [PMID: 9343261 DOI: 10.1128/JVI.71.11.8928-8932.1997] [Cited by in Crossref: 55] [Cited by in F6Publishing: 17] [Article Influence: 2.2] [Reference Citation Analysis]
605 Mamane Y, Heylbroeck C, Génin P, Algarté M, Servant MJ, LePage C, DeLuca C, Kwon H, Lin R, Hiscott J. Interferon regulatory factors: the next generation. Gene. 1999;237:1-14. [PMID: 10524230 DOI: 10.1016/s0378-1119(99)00262-0] [Cited by in Crossref: 392] [Cited by in F6Publishing: 136] [Article Influence: 17.0] [Reference Citation Analysis]
606 Rose TM. CODEHOP-mediated PCR - a powerful technique for the identification and characterization of viral genomes. Virol J. 2005;2:20. [PMID: 15769292 DOI: 10.1186/1743-422x-2-20] [Cited by in Crossref: 52] [Cited by in F6Publishing: 34] [Article Influence: 3.1] [Reference Citation Analysis]
607 Tomkowicz B, Singh SP, Lai D, Singh A, Mahalingham S, Joseph J, Srivastava S, Srinivasan A. Mutational analysis reveals an essential role for the LXXLL motif in the transformation function of the human herpesvirus-8 oncoprotein, kaposin. DNA Cell Biol 2005;24:10-20. [PMID: 15684715 DOI: 10.1089/dna.2005.24.10] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
608 Uppal T, Jha HC, Verma SC, Robertson ES. Chromatinization of the KSHV Genome During the KSHV Life Cycle. Cancers (Basel) 2015;7:112-42. [PMID: 25594667 DOI: 10.3390/cancers7010112] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 3.6] [Reference Citation Analysis]
609 Kennedy MM, Biddolph S, Lucas SB, Howells DD, Picton S, McGee JO, Silva I, Uhlmann V, Luttich K, O'Leary JJ. Cyclin D1 expression and HHV8 in Kaposi sarcoma. J Clin Pathol. 1999;52:569-573. [PMID: 10645225 DOI: 10.1136/jcp.52.8.569] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
610 Ling PD, Tan J, Sewatanon J, Peng R. Murine gammaherpesvirus 68 open reading frame 75c tegument protein induces the degradation of PML and is essential for production of infectious virus. J Virol 2008;82:8000-12. [PMID: 18508901 DOI: 10.1128/JVI.02752-07] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 2.9] [Reference Citation Analysis]
611 Staudt MR, Dittmer DP. The Rta/Orf50 transactivator proteins of the gamma-herpesviridae. Curr Top Microbiol Immunol 2007;312:71-100. [PMID: 17089794 DOI: 10.1007/978-3-540-34344-8_3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 47] [Article Influence: 0.7] [Reference Citation Analysis]
612 Chang Y. Kaposi's Sarcoma and Kaposi's Sarcoma-Associated Herpesvirus (Human Herpesvirus 8): Where Are We Now? JNCI Journal of the National Cancer Institute 1997;89:1829-31. [DOI: 10.1093/jnci/89.24.1829] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
613 Nakano K, Tadagaki K, Isegawa Y, Aye MM, Zou P, Yamanishi K. Human herpesvirus 7 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 2003;77:8108-15. [PMID: 12829849 DOI: 10.1128/jvi.77.14.8108-8115.2003] [Cited by in Crossref: 33] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
614 Wang Y, Tang Q, Maul GG, Yuan Y. Kaposi's sarcoma-associated herpesvirus ori-Lyt-dependent DNA replication: dual role of replication and transcription activator. J Virol 2006;80:12171-86. [PMID: 17020951 DOI: 10.1128/JVI.00990-06] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 3.4] [Reference Citation Analysis]
615 Järviluoma A, Ojala PM. Cell signaling pathways engaged by KSHV. Biochim Biophys Acta 2006;1766:140-58. [PMID: 16828973 DOI: 10.1016/j.bbcan.2006.05.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 26] [Article Influence: 0.6] [Reference Citation Analysis]
616 Sharma-Walia N, Chandran K, Patel K, Veettil MV, Marginean A. The Kaposi's sarcoma-associated herpesvirus (KSHV)-induced 5-lipoxygenase-leukotriene B4 cascade plays key roles in KSHV latency, monocyte recruitment, and lipogenesis. J Virol 2014;88:2131-56. [PMID: 24335295 DOI: 10.1128/JVI.02786-13] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
617 Lukac DM. Editorial: quality versus quantity in myeloid infection by a herpesvirus: more than one way to skin the CCAAT? J Leukoc Biol 2010;87:9-12. [PMID: 20047884 DOI: 10.1189/jlb.0809534] [Reference Citation Analysis]
618 Wells R, Stensland L, Vieira J. The human cytomegalovirus UL112-113 locus can activate the full Kaposi's sarcoma-associated herpesvirus lytic replication cycle. J Virol 2009;83:4695-9. [PMID: 19211735 DOI: 10.1128/JVI.02241-08] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.2] [Reference Citation Analysis]
619 Flore O, Gao SJ. Effect of DNA synthesis inhibitors on Kaposi's sarcoma-associated herpesvirus cyclin and major capsid protein gene expression. AIDS Res Hum Retroviruses 1997;13:1229-33. [PMID: 9310290 DOI: 10.1089/aid.1997.13.1229] [Cited by in Crossref: 21] [Cited by in F6Publishing: 19] [Article Influence: 0.8] [Reference Citation Analysis]
620 Sun Y, Huang PL, Li JJ, Huang YQ, Zhang L, Huang PL, Lee-huang S. Anti-HIV Agent MAP30 Modulates the Expression Profile of Viral and Cellular Genes for Proliferation and Apoptosis in AIDS-Related Lymphoma Cells Infected with Kaposi's Sarcoma-Associated Virus. Biochemical and Biophysical Research Communications 2001;287:983-94. [DOI: 10.1006/bbrc.2001.5689] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 2.2] [Reference Citation Analysis]
621 Jackson CC, Dickson MA, Sadjadi M, Gessain A, Abel L, Jouanguy E, Casanova JL. Kaposi Sarcoma of Childhood: Inborn or Acquired Immunodeficiency to Oncogenic HHV-8. Pediatr Blood Cancer 2016;63:392-7. [PMID: 26469702 DOI: 10.1002/pbc.25779] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 4.1] [Reference Citation Analysis]
622 Tamanaha-Nakasone A, Uehara K, Tanabe Y, Ishikawa H, Yamakawa N, Toyoda Z, Kurima K, Kina S, Tsuneki M, Okubo Y, Yamaguchi S, Utsumi D, Takahashi K, Arakawa H, Arasaki A, Kinjo T. K1 gene transformation activities in AIDS-related and classic type Kaposi's sarcoma: Correlation with clinical presentation. Sci Rep 2019;9:6416. [PMID: 31015491 DOI: 10.1038/s41598-019-42763-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
623 Akula SM, Ford PW, Whitman AG, Hamden KE, Shelton JG, McCubrey JA. Raf promotes human herpesvirus-8 (HHV-8/KSHV) infection. Oncogene 2004;23:5227-41. [PMID: 15122343 DOI: 10.1038/sj.onc.1207643] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 1.7] [Reference Citation Analysis]
624 Whitehouse A, Cooper M, Hall KT, Meredith DM. The open reading frame (ORF) 50a gene product regulates ORF 57 gene expression in herpesvirus saimiri. J Virol 1998;72:1967-73. [PMID: 9499050 DOI: 10.1128/JVI.72.3.1967-1973.1998] [Cited by in Crossref: 31] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
625 Nicholas J. Human herpesvirus 8-encoded cytokines. Future Virol 2010;5:197-206. [PMID: 20436945 DOI: 10.2217/fvl.10.2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
626 Cannon M, Philpott NJ, Cesarman E. The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor has broad signaling effects in primary effusion lymphoma cells. J Virol 2003;77:57-67. [PMID: 12477810 DOI: 10.1128/jvi.77.1.57-67.2003] [Cited by in Crossref: 90] [Cited by in F6Publishing: 45] [Article Influence: 4.7] [Reference Citation Analysis]
627 Montaner S, Sodhi A, Molinolo A, Bugge TH, Sawai ET, He Y, Li Y, Ray PE, Gutkind J. Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 2003;3:23-36. [DOI: 10.1016/s1535-6108(02)00237-4] [Cited by in Crossref: 266] [Cited by in F6Publishing: 126] [Article Influence: 14.0] [Reference Citation Analysis]
628 Yen-moore A, Hudnall S, Rady PL, Wagner RF, Moore TO, Memar O, Hughes TK, Tyring SK. Differential Expression of the HHV-8 vGCR Cellular Homolog Gene in AIDS-Associated and Classic Kaposi's Sarcoma: Potential Role of HIV-1 Tat. Virology 2000;267:247-51. [DOI: 10.1006/viro.1999.0125] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
629 Hong A, Lee CS. The emerging role of the human herpesvirus 8 (HHV8) in human neoplasia. Pathology 2001;33:461-8. [PMID: 11827413 DOI: 10.1080/00313020120083000] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
630 Davison AJ. Evolution of the herpesviruses. Vet Microbiol 2002;86:69-88. [PMID: 11888691 DOI: 10.1016/s0378-1135(01)00492-8] [Cited by in Crossref: 203] [Cited by in F6Publishing: 85] [Article Influence: 10.2] [Reference Citation Analysis]
631 Uppal T, Meyer D, Agarwal A, Verma SC. The DNase Activity of Kaposi's Sarcoma-Associated Herpesvirus SOX Protein Serves an Important Role in Viral Genome Processing during Lytic Replication. J Virol 2019;93:e01983-18. [PMID: 30728255 DOI: 10.1128/JVI.01983-18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
632 Kronstad LM, Brulois KF, Jung JU, Glaunsinger BA. Reinitiation after translation of two upstream open reading frames (ORF) governs expression of the ORF35-37 Kaposi's sarcoma-associated herpesvirus polycistronic mRNA. J Virol 2014;88:6512-8. [PMID: 24623444 DOI: 10.1128/JVI.00202-14] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
633 Kong X, Li D, Mansouri A, Kang G, Sayood K, West J, Wood C. Bone Marrow-Derived SH-SY5Y Neuroblastoma Cells Infected with Kaposi's Sarcoma-Associated Herpesvirus Display Unique Infection Phenotypes and Growth Properties. J Virol 2021;95:e0000321. [PMID: 33853962 DOI: 10.1128/JVI.00003-21] [Reference Citation Analysis]
634 Teo C. Conceptual Emergence of Human Herpesvirus 8 (Kaposi’s Sarcoma-associated Herpesvirus) as an Oral Herpesvirus. Adv Dent Res 2006;19:85-90. [DOI: 10.1177/154407370601900117] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
635 Leach CT, Frantz C, Head DR, Gao S, Mcclain KL, Cohen M, Campbell AB, Pollock BH, Murphy SB, Jenson HB. Human herpesvirus-8 (HHV-8) associated with small non-cleaved cell lymphoma in a child with AIDS. Am J Hematol 1999;60:215-21. [DOI: 10.1002/(sici)1096-8652(199903)60:3<215::aid-ajh8>3.0.co;2-f] [Cited by in Crossref: 11] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
636 Mariggiò G, Koch S, Zhang G, Weidner-Glunde M, Rückert J, Kati S, Santag S, Schulz TF. Kaposi Sarcoma Herpesvirus (KSHV) Latency-Associated Nuclear Antigen (LANA) recruits components of the MRN (Mre11-Rad50-NBS1) repair complex to modulate an innate immune signaling pathway and viral latency. PLoS Pathog 2017;13:e1006335. [PMID: 28430817 DOI: 10.1371/journal.ppat.1006335] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
637 Deng H, Young A, Sun R. Auto-activation of the rta gene of human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus. J Gen Virol 2000;81:3043-8. [PMID: 11086135 DOI: 10.1099/0022-1317-81-12-3043] [Cited by in Crossref: 119] [Cited by in F6Publishing: 118] [Article Influence: 5.7] [Reference Citation Analysis]
638 Tedeschi R, Dillner J, De Paoli P. Laboratory Diagnosis of Human Herpesvirus 8 Infection in Humans. Eur J Clin Microbiol Infect Dis 2002;21:831-44. [DOI: 10.1007/s10096-002-0836-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
639 Dhillon T, Stebbing J, Bower M. Paclitaxel for AIDS-associated Kaposi’s sarcoma. Expert Review of Anticancer Therapy 2014;5:215-9. [DOI: 10.1586/14737140.5.2.215] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
640 Milne RSB, Mattick C, Nicholson L, Devaraj P, Alcami A, Gompels UA. RANTES Binding and Down-Regulation by a Novel Human Herpesvirus-6 β Chemokine Receptor. J Immunol 2000;164:2396-404. [DOI: 10.4049/jimmunol.164.5.2396] [Cited by in Crossref: 106] [Cited by in F6Publishing: 93] [Article Influence: 4.8] [Reference Citation Analysis]
641 Humphrey RW, Davis DA, Newcomb FM, Yarchoan R. Human herpesvirus 8 (HHV-8) in the pathogenesis of Kaposi's sarcoma and other diseases. Leuk Lymphoma 1998;28:255-64. [PMID: 9517497 DOI: 10.3109/10428199809092681] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
642 Martinelli PT, Tyring SK. Human herpesvirus 8. Dermatologic Clinics 2002;20:307-14. [DOI: 10.1016/s0733-8635(01)00004-3] [Cited by in Crossref: 9] [Article Influence: 0.5] [Reference Citation Analysis]
643 Gable JE, Acker TM, Craik CS. Current and potential treatments for ubiquitous but neglected herpesvirus infections. Chem Rev 2014;114:11382-412. [PMID: 25275644 DOI: 10.1021/cr500255e] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
644 van der Meulen E, Anderton M, Blumenthal MJ, Schäfer G. Cellular Receptors Involved in KSHV Infection. Viruses 2021;13:118. [PMID: 33477296 DOI: 10.3390/v13010118] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
645 Samols MA, Skalsky RL, Maldonado AM, Riva A, Lopez MC, Baker HV, Renne R. Identification of cellular genes targeted by KSHV-encoded microRNAs. PLoS Pathog 2007;3:e65. [PMID: 17500590 DOI: 10.1371/journal.ppat.0030065] [Cited by in Crossref: 220] [Cited by in F6Publishing: 219] [Article Influence: 14.7] [Reference Citation Analysis]
646 Yao S, Jia X, Wang F, Sheng L, Song P, Cao Y, Shi H, Fan W, Ding X, Gao SJ, Lu C. CircRNA ARFGEF1 functions as a ceRNA to promote oncogenic KSHV-encoded viral interferon regulatory factor induction of cell invasion and angiogenesis by upregulating glutaredoxin 3. PLoS Pathog 2021;17:e1009294. [PMID: 33539420 DOI: 10.1371/journal.ppat.1009294] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
647 Bugert JJ, Lohmüller C, Damon I, Moss B, Darai G. Chemokine Homolog of Molluscum Contagiosum Virus: Sequence Conservation and Expression. Virology 1998;242:51-9. [DOI: 10.1006/viro.1997.9001] [Cited by in Crossref: 23] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
648 Roan F, Zimring JC, Goodbourn S, Offermann MK. Transcriptional activation by the human herpesvirus-8-encoded interferon regulatory factor. Journal of General Virology 1999;80:2205-9. [DOI: 10.1099/0022-1317-80-8-2205] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
649 Ashizawa A, Higashi C, Masuda K, Ohga R, Taira T, Fujimuro M. The Ubiquitin System and Kaposi's Sarcoma-Associated Herpesvirus. Front Microbiol 2012;3:66. [PMID: 22375140 DOI: 10.3389/fmicb.2012.00066] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
650 Stamey FR, Patel MM, Holloway BP, Pellett PE. Quantitative, fluorogenic probe PCR assay for detection of human herpesvirus 8 DNA in clinical specimens. J Clin Microbiol 2001;39:3537-40. [PMID: 11574569 DOI: 10.1128/JCM.39.10.3537-3540.2001] [Cited by in Crossref: 38] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
651 Angeletti PC, Zhang L, Wood C. The viral etiology of AIDS-associated malignancies. Adv Pharmacol 2008;56:509-57. [PMID: 18086422 DOI: 10.1016/S1054-3589(07)56016-3] [Cited by in Crossref: 42] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
652 Griffiths P. The Herpesvirus Family in the 21st Century. Antivir Chem Chemother 1997;8:11-5. [DOI: 10.1177/09563202970080s604] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
653 Zimring JC, Goodbourn S, Offermann MK. Human Herpesvirus 8 Encodes an Interferon Regulatory Factor (IRF) Homolog That Represses IRF-1-Mediated Transcription. J Virol 1998;72:701-7. [DOI: 10.1128/jvi.72.1.701-707.1998] [Cited by in Crossref: 170] [Cited by in F6Publishing: 67] [Article Influence: 7.1] [Reference Citation Analysis]
654 Kwun HJ, Toptan T, Ramos da Silva S, Atkins JF, Moore PS, Chang Y. Human DNA tumor viruses generate alternative reading frame proteins through repeat sequence recoding. Proc Natl Acad Sci U S A 2014;111:E4342-9. [PMID: 25271323 DOI: 10.1073/pnas.1416122111] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
655 Shimada K, Hayakawa F, Kiyoi H. Biology and management of primary effusion lymphoma. Blood 2018;132:1879-88. [DOI: 10.1182/blood-2018-03-791426] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
656 Cuninghame S, Jackson R, Zehbe I. Hypoxia-inducible factor 1 and its role in viral carcinogenesis. Virology. 2014;456-457:370-383. [PMID: 24698149 DOI: 10.1016/j.virol.2014.02.027] [Cited by in Crossref: 37] [Cited by in F6Publishing: 42] [Article Influence: 4.6] [Reference Citation Analysis]
657 Dahlke C, Maul K, Christalla T, Walz N, Schult P, Stocking C, Grundhoff A. A microRNA encoded by Kaposi sarcoma-associated herpesvirus promotes B-cell expansion in vivo. PLoS One 2012;7:e49435. [PMID: 23185331 DOI: 10.1371/journal.pone.0049435] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 5.3] [Reference Citation Analysis]
658 Juhász A, Remenyik E, Szarka K, Veress G, Hunyadi J, Gergely L. Consistent polymerse chain reaction–single-strand conformation polymorphism pattern of human herpesvirus-8 in the course of classical Kaposi's sarcoma assumes its clonal origin. J Med Virol 1998;54:300-4. [DOI: 10.1002/(sici)1096-9071(199804)54:4<300::aid-jmv10>3.0.co;2-j] [Cited by in Crossref: 3] [Article Influence: 0.1] [Reference Citation Analysis]
659 Lacoste V, Kadyrova E, Chistiakova I, Gurtsevitch V, Judde JG, Gessain A. Molecular characterization of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 strains from Russia. J Gen Virol 2000;81:1217-22. [PMID: 10769063 DOI: 10.1099/0022-1317-81-5-1217] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 0.9] [Reference Citation Analysis]
660 Hoffmann HH, Schneider WM, Rice CM. Interferons and viruses: an evolutionary arms race of molecular interactions. Trends Immunol 2015;36:124-38. [PMID: 25704559 DOI: 10.1016/j.it.2015.01.004] [Cited by in Crossref: 212] [Cited by in F6Publishing: 196] [Article Influence: 30.3] [Reference Citation Analysis]
661 Sato H, Pesnicak L, Cohen JI. Varicella-zoster virus ORF47 protein kinase, which is required for replication in human T cells, and ORF66 protein kinase, which is expressed during latency, are dispensable for establishment of latency. J Virol 2003;77:11180-5. [PMID: 14512565 DOI: 10.1128/jvi.77.20.11180-11185.2003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
662 Sallah N, Palser AL, Watson SJ, Labo N, Asiki G, Marshall V, Newton R, Whitby D, Kellam P, Barroso I. Genome-Wide Sequence Analysis of Kaposi Sarcoma-Associated Herpesvirus Shows Diversification Driven by Recombination. J Infect Dis 2018;218:1700-10. [PMID: 30010810 DOI: 10.1093/infdis/jiy427] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
663 Kang S, Myoung J. Primary lymphocyte infection models for KSHV and its putative tumorigenesis mechanisms in B cell lymphomas. J Microbiol 2017;55:319-29. [PMID: 28455586 DOI: 10.1007/s12275-017-7075-2] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.2] [Reference Citation Analysis]
664 Hiscott J, Pitha P, Genin P, Nguyen H, Heylbroeck C, Mamane Y, Algarte M, Lin R. Triggering the interferon response: the role of IRF-3 transcription factor. J Interferon Cytokine Res 1999;19:1-13. [PMID: 10048763 DOI: 10.1089/107999099314360] [Cited by in Crossref: 174] [Cited by in F6Publishing: 170] [Article Influence: 7.6] [Reference Citation Analysis]
665 Krown SE, Li P, Von Roenn JH, Paredes J, Huang J, Testa MA. Efficacy of Low-Dose Interferon with Antiretroviral Therapy in Kaposi's Sarcoma: A Randomized Phase II AIDS Clinical Trials Group Study. Journal of Interferon & Cytokine Research 2002;22:295-303. [DOI: 10.1089/107999002753675712] [Cited by in Crossref: 52] [Cited by in F6Publishing: 38] [Article Influence: 2.6] [Reference Citation Analysis]
666 Nador RG, Milligan LL, Flore O, Wang X, Arvanitakis L, Knowles DM, Cesarman E. Expression of Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor monocistronic and bicistronic transcripts in primary effusion lymphomas. Virology. 2001;287:62-70. [PMID: 11504542 DOI: 10.1006/viro.2001.1016] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 2.0] [Reference Citation Analysis]
667 Feng H, Taylor JL, Benos PV, Newton R, Waddell K, Lucas SB, Chang Y, Moore PS. Human transcriptome subtraction by using short sequence tags to search for tumor viruses in conjunctival carcinoma. J Virol 2007;81:11332-40. [PMID: 17686852 DOI: 10.1128/JVI.00875-07] [Cited by in Crossref: 88] [Cited by in F6Publishing: 48] [Article Influence: 5.9] [Reference Citation Analysis]
668 Dialyna IA, Graham D, Rezaee R, Blue CE, Stavrianeas NG, Neisters HG, Spandidos DA, Blackbourn DJ. Anti-HHV-8/KSHV antibodies in infected individuals inhibit infection in vitro: . AIDS 2004;18:1263-70. [DOI: 10.1097/00002030-200406180-00004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
669 West JT, Wood C. The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression. Oncogene 2003;22:5150-63. [PMID: 12910252 DOI: 10.1038/sj.onc.1206555] [Cited by in Crossref: 88] [Cited by in F6Publishing: 85] [Article Influence: 4.6] [Reference Citation Analysis]
670 Hayajneh WA, Colberg-Poley AM, Skaletskaya A, Bartle LM, Lesperance MM, Contopoulos-Ioannidis DG, Kedersha NL, Goldmacher VS. The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. Virology 2001;279:233-40. [PMID: 11145905 DOI: 10.1006/viro.2000.0726] [Cited by in Crossref: 68] [Cited by in F6Publishing: 70] [Article Influence: 3.2] [Reference Citation Analysis]
671 Chang PJ, Boonsiri J, Wang SS, Chen LY, Miller G. Binding of RBP-Jkappa (CSL) protein to the promoter of the Kaposi's sarcoma-associated herpesvirus ORF47 (gL) gene is a critical but not sufficient determinant of transactivation by ORF50 protein. Virology 2010;398:38-48. [PMID: 20006367 DOI: 10.1016/j.virol.2009.11.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.5] [Reference Citation Analysis]
672 Watanabe T, Nishimura M, Izumi T, Kuriyama K, Iwaisako Y, Hosokawa K, Takaori-Kondo A, Fujimuro M. Kaposi's Sarcoma-Associated Herpesvirus ORF66 Is Essential for Late Gene Expression and Virus Production via Interaction with ORF34. J Virol 2020;94:e01300-19. [PMID: 31694948 DOI: 10.1128/JVI.01300-19] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
673 Bai Z, Zhou F, Lei X, Ma X, Lu C, Gao SJ. A cluster of transcripts encoded by KSHV ORF30-33 gene locus. Virus Genes 2012;44:225-36. [PMID: 22180077 DOI: 10.1007/s11262-011-0698-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
674 Krischer J, Rutschmann O, Hirschel B, Vollenweider-roten S, Saurat J, Pechère M. Regression of Kaposi’s sarcoma during therapy with HIV-1 protease inhibitors: A prospective pilot study. Journal of the American Academy of Dermatology 1998;38:594-8. [DOI: 10.1016/s0190-9622(98)70124-0] [Cited by in Crossref: 47] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
675 Luna RE, Zhou F, Baghian A, Chouljenko V, Forghani B, Gao SJ, Kousoulas KG. Kaposi's sarcoma-associated herpesvirus glycoprotein K8.1 is dispensable for virus entry. J Virol 2004;78:6389-98. [PMID: 15163732 DOI: 10.1128/JVI.78.12.6389-6398.2004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 33] [Article Influence: 2.2] [Reference Citation Analysis]
676 Stebbing J, Mazhar D, Lewis R, Palmieri C, Hatzimichael E, Nelson M, Gazzard B, Bower M. The presentation and survival of patients with non-cutaneous AIDS-associated Kaposi's sarcoma. Annals of Oncology 2006;17:503-6. [DOI: 10.1093/annonc/mdj091] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
677 Kaplan D, Meyerson H, Husel W, Lewandowska K, Maclennan G. D cyclins in lymphocytes. Cytometry 2005;63A:1-9. [DOI: 10.1002/cyto.a.20103] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
678 Kelley-Clarke B, Ballestas ME, Komatsu T, Kaye KM. Kaposi's sarcoma herpesvirus C-terminal LANA concentrates at pericentromeric and peri-telomeric regions of a subset of mitotic chromosomes. Virology 2007;357:149-57. [PMID: 16979209 DOI: 10.1016/j.virol.2006.07.052] [Cited by in Crossref: 37] [Cited by in F6Publishing: 36] [Article Influence: 2.3] [Reference Citation Analysis]
679 Jong JE, Park J, Kim S, Seo T. Kaposi's sarcoma-associated herpesvirus viral protein kinase interacts with RNA helicase a and regulates host gene expression. J Microbiol 2010;48:206-12. [PMID: 20437153 DOI: 10.1007/s12275-010-0021-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
680 Chang H, Wachtman LM, Pearson CB, Lee JS, Lee HR, Lee SH, Vieira J, Mansfield KG, Jung JU. Non-human primate model of Kaposi's sarcoma-associated herpesvirus infection. PLoS Pathog 2009;5:e1000606. [PMID: 19798430 DOI: 10.1371/journal.ppat.1000606] [Cited by in Crossref: 47] [Cited by in F6Publishing: 41] [Article Influence: 3.6] [Reference Citation Analysis]
681 Bihl F, Berger C, Chisholm JV 3rd, Henry LM, Bertisch B, Trojan A, Nadal D, Speck RF, Flepp M, Brander C, Mueller NJ; Swiss HIV Cohort Study. Cellular immune responses and disease control in acute AIDS-associated Kaposi's sarcoma. AIDS 2009;23:1918-22. [PMID: 19609199 DOI: 10.1097/QAD.0b013e3283300a91] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.3] [Reference Citation Analysis]
682 Mikala G, Xie J, Berencsi G, Kiss C, Márton I, Domján G, Vályi-nagy I. Human Herpesvirus 8 in Hematologic Diseases. Pathol Oncol Res 1999;5:73-9. [DOI: 10.1053/paor.1999.0073] [Cited by in Crossref: 18] [